data_2kmp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kmp _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 45.3 m . . . . . 0 CA--C 1.549 0.911 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.87 154.98 43.55 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.371 2.714 . . . . 0.0 111.482 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -104.58 5.42 33.78 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.911 2.084 . . . . 0.0 114.135 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 9.1 mt -70.16 143.07 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.897 1.679 . . . . 0.0 110.102 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.6 tt -80.75 74.99 7.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.558 1.943 . . . . 0.0 110.293 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -133.58 68.23 76.1 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 125.391 1.476 . . . . 0.0 111.509 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -67.6 165.95 25.66 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.024 2.483 . . . . 0.0 112.54 -176.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.6 m -142.94 152.23 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.973 1.709 . . . . 0.0 110.694 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.5 t -90.59 118.15 29.82 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 167.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.57 165.02 54.3 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-N 119.177 0.898 . . . . 0.0 112.799 172.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.7 p -67.42 -16.0 63.99 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.34 -9.28 58.53 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.227 1.411 . . . . 0.0 114.053 167.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.59 -1.58 88.21 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.609 1.576 . . . . 0.0 114.931 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.5 mmt-85 -72.28 159.44 34.06 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.011 1.324 . . . . 0.0 111.277 168.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 59.4 m -114.56 131.24 56.73 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.176 1.39 . . . . 0.0 109.564 169.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -118.11 166.62 12.34 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.688 1.595 . . . . 0.0 109.916 175.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.73 -24.21 62.58 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -167.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -165.09 176.33 8.62 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.727 2.011 . . . . 0.0 111.12 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.1 m -65.26 -34.58 78.69 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.7 t -62.32 -45.65 92.25 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.953 1.701 . . . . 0.0 113.244 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.8 tp -69.96 -39.36 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.194 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.04 -54.87 37.51 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.102 0.961 . . . . 0.0 111.685 170.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -63.18 -32.22 73.56 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.9 m -62.82 -20.23 64.84 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -80.93 -2.81 49.21 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.526 1.13 . . . . 0.0 113.673 169.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.75 16.32 58.43 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.418 1.485 . . . . 0.0 114.774 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 t -129.8 148.99 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.332 1.453 . . . . 0.0 111.277 -172.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.1 p -85.25 158.31 20.36 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.929 1.692 . . . . 0.0 112.721 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.66 124.77 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 125.578 1.551 . . . . 0.0 109.606 172.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -76.15 -39.86 54.02 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.879 1.272 . . . . 0.0 111.317 172.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.3 p -158.98 162.91 36.84 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.54 1.536 . . . . 0.0 112.785 172.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -74.89 152.41 38.88 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.025 1.33 . . . . 0.0 112.539 170.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.24 162.42 20.09 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.597 1.57 . . . . 0.0 112.538 -172.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.4 t -59.93 148.04 36.51 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.987 -0.713 . . . . 0.0 110.87 164.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 CA--C 1.544 0.714 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -177.982 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 13.7 m . . . . . 0 CA--C 1.552 1.047 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -76.62 171.74 17.49 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.952 3.101 . . . . 0.0 112.211 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.1 tttm -119.37 9.41 11.62 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.97 1.708 . . . . 0.0 114.581 -174.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.5 mt -63.11 143.66 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.182 1.393 . . . . 0.0 110.069 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 71.6 mt -75.01 70.61 2.03 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.054 1.741 . . . . 0.0 111.108 173.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -132.92 63.38 66.94 Favored Pre-proline 0 N--CA 1.471 0.622 0 C-N-CA 125.374 1.469 . . . . 0.0 109.934 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.26 160.25 48.46 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.987 2.458 . . . . 0.0 111.455 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.7 m -144.71 162.39 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.833 1.253 . . . . 0.0 111.639 -172.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.4 t -98.45 113.81 25.95 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.171 1.388 . . . . 0.0 110.201 173.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.37 166.37 54.71 Favored Glycine 0 CA--C 1.535 1.34 0 O-C-N 121.604 -0.685 . . . . 0.0 113.425 172.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.1 t -60.13 -25.1 65.21 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.071 1.349 . . . . 0.0 113.717 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -68.08 -14.12 62.73 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.918 1.287 . . . . 0.0 113.827 172.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.84 -4.04 84.87 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 126.088 1.804 . . . . 0.0 114.634 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -78.13 159.87 28.38 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.782 1.233 . . . . 0.0 111.685 173.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 59.6 m -109.91 131.56 54.95 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.519 1.528 . . . . 0.0 109.793 170.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -119.72 167.95 11.55 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.66 1.184 . . . . 0.0 110.756 171.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.63 -25.24 59.86 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -175.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -167.34 177.24 6.18 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.569 1.548 . . . . 0.0 111.329 174.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.0 p -60.49 -47.1 87.61 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 176.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.5 t -55.69 -42.06 74.64 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.503 1.921 . . . . 0.0 113.424 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.43 -52.71 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 125.38 1.472 . . . . 0.0 111.032 175.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.58 -46.93 83.4 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.36 0.664 . . . . 0.0 111.96 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -65.77 -28.86 69.34 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.3 t -59.46 -33.98 71.97 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.248 1.019 . . . . 0.0 112.69 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -72.44 -3.63 25.4 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.145 1.778 . . . . 0.0 113.998 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.92 -12.29 65.77 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 126.807 2.146 . . . . 0.0 115.334 172.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.5 m -88.22 135.71 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.836 1.654 . . . . 0.0 111.855 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.3 p -68.62 164.66 20.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.928 1.291 . . . . 0.0 112.726 173.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.3 mm -90.79 110.8 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 123.996 0.918 . . . . 0.0 110.263 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -45.97 90.78 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.256 1.022 . . . . 0.0 110.97 172.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.7 t -164.18 166.06 21.49 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.727 0.775 . . . . 0.0 112.777 173.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -86.78 154.99 20.5 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.628 1.971 . . . . 0.0 112.719 176.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.06 157.56 11.6 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.958 1.266 . . . . 0.0 111.806 -168.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.3 m -59.45 126.95 29.68 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.784 -0.833 . . . . 0.0 109.958 168.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.544 0.739 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -176.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.1 m . . . . . 0 CA--C 1.55 0.955 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.98 158.2 38.43 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.35 2.7 . . . . 0.0 112.106 -174.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -100.14 4.37 44.45 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.573 1.949 . . . . 0.0 114.435 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.7 mt -68.29 143.2 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.744 1.618 . . . . 0.0 109.905 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.89 79.58 9.58 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.129 1.772 . . . . 0.0 110.199 173.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -131.64 63.07 67.98 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 125.605 1.562 . . . . 0.0 111.721 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.33 166.12 24.57 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.309 2.672 . . . . 0.0 112.714 -173.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.6 m -142.55 152.54 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.835 1.654 . . . . 0.0 110.904 -175.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.8 t -89.42 113.55 24.9 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 166.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.87 162.56 52.96 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-N 118.906 0.776 . . . . 0.0 112.939 175.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 t -67.05 -14.08 62.55 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -72.53 -14.2 61.59 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.942 1.297 . . . . 0.0 113.479 168.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.55 -6.86 77.77 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 126.245 1.878 . . . . 0.0 114.706 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.2 mmt85 -74.29 161.99 29.35 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.776 1.631 . . . . 0.0 112.006 170.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.5 m -115.05 137.47 51.97 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.456 1.502 . . . . 0.0 109.763 167.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -127.18 166.84 16.95 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.894 1.678 . . . . 0.0 110.622 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.09 -23.75 64.05 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -165.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -164.42 -176.53 4.42 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.703 2.001 . . . . 0.0 111.353 172.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 54.8 m -67.17 -34.62 77.93 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 176.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.2 t -65.91 -38.1 87.83 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.796 1.638 . . . . 0.0 113.48 -175.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.0 tp -70.9 -50.22 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.843 170.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.53 -51.06 64.07 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.139 1.376 . . . . 0.0 112.882 -177.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.42 -34.82 72.96 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.044 1.337 . . . . 0.0 113.543 175.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.8 t -63.87 -30.92 71.96 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.504 1.122 . . . . 0.0 113.075 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -67.8 -8.15 33.52 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.059 1.344 . . . . 0.0 114.045 173.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.34 11.91 60.48 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.994 1.283 . . . . 0.0 115.086 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -128.74 151.26 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.538 1.535 . . . . 0.0 110.321 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 p -82.29 160.36 22.93 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.319 1.848 . . . . 0.0 112.847 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -73.09 126.04 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 125.75 1.62 . . . . 0.0 109.495 171.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -81.41 -38.21 26.88 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.557 1.143 . . . . 0.0 111.617 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.6 p -157.57 162.7 38.78 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.337 1.455 . . . . 0.0 112.788 169.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -75.1 150.25 38.87 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.238 1.415 . . . . 0.0 112.445 171.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.77 161.29 19.56 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.554 1.549 . . . . 0.0 112.403 -171.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.0 t -58.97 148.55 30.2 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 122.012 -0.699 . . . . 0.0 111.024 165.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 CA--C 1.542 0.65 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 179.807 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 43.0 m . . . . . 0 CA--C 1.548 0.892 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.1 146.8 41.81 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.272 2.648 . . . . 0.0 110.981 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -80.26 6.57 11.55 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.944 1.698 . . . . 0.0 115.006 176.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.7 tt -57.91 139.63 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 126.291 1.837 . . . . 0.0 113.186 -173.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.8 mt -84.9 72.01 10.83 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.11 1.364 . . . . 0.0 110.683 175.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -139.16 71.48 40.29 Favored Pre-proline 0 N--CA 1.47 0.54 0 C-N-CA 125.243 1.417 . . . . 0.0 109.944 173.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -66.64 166.64 21.42 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.367 2.045 . . . . 0.0 112.179 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.8 m -144.71 154.43 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.112 1.765 . . . . 0.0 111.027 -172.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 t -94.23 115.18 27.4 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.522 0.729 . . . . 0.0 109.186 167.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.9 160.66 53.58 Favored Glycine 0 CA--C 1.536 1.369 0 O-C-N 121.336 -0.853 . . . . 0.0 113.085 173.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.1 t -64.56 -20.62 66.34 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -70.79 -6.18 35.76 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.084 1.353 . . . . 0.0 114.364 170.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.48 19.97 55.52 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.71 1.148 . . . . 0.0 114.833 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -118.25 162.89 17.51 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.448 1.899 . . . . 0.0 111.332 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.1 m -116.53 129.62 56.29 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.237 1.415 . . . . 0.0 110.748 -175.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -123.9 165.86 16.65 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.721 1.608 . . . . 0.0 110.767 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.8 -29.96 70.53 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -167.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -166.41 171.06 12.34 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.908 1.683 . . . . 0.0 111.358 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.3 m -59.16 -42.78 91.55 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -171.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.2 t -56.08 -43.56 78.12 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.236 1.814 . . . . 0.0 113.264 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.5 tp -72.8 -38.77 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.899 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.33 -52.61 64.54 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.926 0.89 . . . . 0.0 111.766 174.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -60.05 -28.45 67.79 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.8 t -58.04 -31.51 67.08 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.118 1.367 . . . . 0.0 113.413 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -73.75 -3.97 31.7 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.238 1.415 . . . . 0.0 114.31 173.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.11 11.46 63.07 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.214 1.388 . . . . 0.0 114.908 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.35 146.83 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 126.076 1.75 . . . . 0.0 110.57 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 p -79.87 162.45 25.01 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.868 1.667 . . . . 0.0 113.111 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.3 pp -72.11 123.04 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.371 1.468 . . . . 0.0 109.611 170.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -68.66 -41.47 79.26 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.915 1.286 . . . . 0.0 111.173 170.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.9 p -156.98 158.17 36.1 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.17 1.788 . . . . 0.0 112.362 174.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -72.69 149.78 43.51 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.099 1.36 . . . . 0.0 110.653 171.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.32 158.46 20.77 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.922 1.249 . . . . 0.0 112.057 -174.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.3 t -59.87 145.02 47.2 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.739 -0.86 . . . . 0.0 110.912 167.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.542 0.64 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -178.147 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 16.6 m . . . . . 0 CA--C 1.551 1.005 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -73.85 171.78 17.19 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.819 3.013 . . . . 0.0 111.449 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.75 17.8 10.27 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.877 1.671 . . . . 0.0 113.978 -173.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.9 mt -63.84 141.56 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.505 1.522 . . . . 0.0 109.814 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.4 mt -79.59 70.47 6.07 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.732 1.213 . . . . 0.0 110.584 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -134.9 72.16 68.65 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 124.941 1.296 . . . . 0.0 109.866 172.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.17 164.03 33.79 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.109 1.873 . . . . 0.0 111.745 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.7 m -144.48 140.69 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.884 1.673 . . . . 0.0 110.58 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 t -79.14 114.78 18.35 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.85 163.09 45.44 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 121.546 -0.721 . . . . 0.0 113.159 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.1 m -68.11 -11.91 59.92 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -77.23 -10.52 59.47 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.929 1.692 . . . . 0.0 114.192 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.05 13.98 35.07 Favored Glycine 0 CA--C 1.539 1.541 0 N-CA-C 115.894 1.118 . . . . 0.0 115.894 175.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -137.05 168.24 19.97 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.317 1.847 . . . . 0.0 110.944 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.0 t -105.47 150.31 25.42 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.61 1.164 . . . . 0.0 111.699 175.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -124.19 170.28 10.89 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.233 1.813 . . . . 0.0 110.39 173.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.04 -35.17 77.8 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -167.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -163.16 168.04 21.32 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.474 1.51 . . . . 0.0 112.077 175.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.2 m -60.13 -32.11 70.7 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -167.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.7 t -61.22 -43.94 98.07 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.905 1.682 . . . . 0.0 113.514 176.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.9 tp -72.44 -39.59 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.747 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.48 -28.64 69.97 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.451 1.1 . . . . 0.0 113.418 176.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -88.04 -30.13 20.16 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.141 1.376 . . . . 0.0 114.377 173.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 37.5 t -55.09 -39.82 69.73 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.99 1.316 . . . . 0.0 113.13 -174.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -70.26 -11.34 60.83 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 126.076 1.75 . . . . 0.0 115.164 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.91 -8.29 42.45 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 126.488 1.994 . . . . 0.0 116.247 175.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.5 t -93.58 168.99 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 125.507 1.523 . . . . 0.0 110.654 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.6 p -112.24 155.9 23.27 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 127.477 2.311 . . . . 0.0 112.37 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -67.64 123.17 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.623 1.569 . . . . 0.0 110.075 176.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -77.34 -42.23 37.4 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.507 1.123 . . . . 0.0 110.832 172.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.0 p -153.75 157.93 40.2 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.461 1.504 . . . . 0.0 112.508 174.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -82.74 149.25 27.38 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.721 1.208 . . . . 0.0 111.269 177.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.81 162.04 24.34 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.54 1.066 . . . . 0.0 111.676 -169.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.1 t -60.33 148.27 37.59 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 122.125 -0.633 . . . . 0.0 110.942 167.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -179.58 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 18.6 m . . . . . 0 CA--C 1.549 0.932 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.48 147.26 31.97 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.354 2.702 . . . . 0.0 111.664 -176.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.61 3.63 55.2 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.263 1.825 . . . . 0.0 114.645 177.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.2 mt -65.06 140.6 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.207 1.403 . . . . 0.0 109.995 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tt -80.75 74.2 7.7 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.981 1.712 . . . . 0.0 109.357 175.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.23 69.73 77.87 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 124.424 1.09 . . . . 0.0 110.474 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.29 167.28 18.85 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.835 2.356 . . . . 0.0 112.5 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.6 m -144.84 153.18 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 126.006 1.722 . . . . 0.0 110.358 -173.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.5 t -98.53 113.62 25.72 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.181 0.992 . . . . 0.0 108.766 171.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.63 159.16 53.53 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 118.773 0.715 . . . . 0.0 113.296 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.3 t -59.83 -24.09 63.89 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -67.57 -13.7 62.29 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 125.227 1.411 . . . . 0.0 114.017 171.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.97 -3.29 64.62 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 126.439 1.971 . . . . 0.0 114.697 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -84.11 164.64 19.08 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.941 1.696 . . . . 0.0 111.937 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.6 m -114.76 138.68 50.44 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.997 1.319 . . . . 0.0 110.508 171.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -124.92 166.87 15.53 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.981 1.712 . . . . 0.0 110.624 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.48 -24.23 61.96 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -167.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -164.18 179.28 6.99 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.158 2.183 . . . . 0.0 110.629 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.5 p -65.24 -42.47 93.32 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.8 t -57.17 -41.52 79.38 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.522 1.929 . . . . 0.0 113.972 -176.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.6 tt -70.59 -48.38 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.948 1.299 . . . . 0.0 111.966 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.54 -52.94 42.86 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.183 0.993 . . . . 0.0 112.051 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -62.75 -27.64 69.42 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 178.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.9 t -61.93 -31.69 72.03 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.562 1.145 . . . . 0.0 112.786 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -73.84 -4.16 33.15 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.625 1.57 . . . . 0.0 114.178 171.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.82 -7.02 83.09 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 126.207 1.861 . . . . 0.0 115.072 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.7 m -93.31 146.0 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 126.341 1.857 . . . . 0.0 111.581 176.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.2 p -84.99 160.95 19.95 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.074 1.35 . . . . 0.0 112.0 171.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.4 pt -73.24 128.02 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.48 1.112 . . . . 0.0 110.031 172.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -77.54 -39.48 45.84 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.058 0.943 . . . . 0.0 111.494 169.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.4 t -154.76 170.59 21.25 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.474 1.109 . . . . 0.0 113.071 173.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -85.06 151.57 24.06 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.433 2.293 . . . . 0.0 112.684 174.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.29 162.5 10.65 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.475 1.512 . . . . 0.0 112.286 -170.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.7 m -59.39 130.0 44.75 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.85 -0.794 . . . . 0.0 109.588 163.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.542 0.666 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.0 m . . . . . 0 CA--C 1.549 0.914 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.56 167.87 26.13 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.691 2.927 . . . . 0.0 112.027 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.69 8.24 13.73 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.345 2.258 . . . . 0.0 114.008 -173.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.9 mt -68.8 140.74 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.3 1.44 . . . . 0.0 109.785 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tt -82.01 72.93 9.07 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.166 1.787 . . . . 0.0 110.584 -176.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -134.73 68.67 71.82 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 125.554 1.541 . . . . 0.0 111.406 -175.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.27 162.2 43.26 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.0 2.466 . . . . 0.0 112.914 -175.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.8 m -144.85 163.73 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 127.045 2.138 . . . . 0.0 111.244 -172.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.2 t -94.41 122.46 37.0 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.523 0.729 . . . . 0.0 110.39 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.46 161.39 53.56 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.079 0.847 . . . . 0.0 113.61 172.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.0 t -61.73 -27.48 68.75 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.239 1.016 . . . . 0.0 113.567 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -82.86 -5.92 59.21 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.311 1.844 . . . . 0.0 114.488 174.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.17 2.04 66.47 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.556 1.55 . . . . 0.0 115.956 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -73.38 166.03 23.95 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 119.814 1.807 . . . . 0.0 111.622 170.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.5 m -121.54 123.7 42.62 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.814 1.646 . . . . 0.0 109.203 172.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -113.21 170.58 8.11 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.763 1.625 . . . . 0.0 110.812 174.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.29 -31.85 71.58 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -168.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.09 170.32 19.39 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.634 1.574 . . . . 0.0 110.96 176.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.3 m -59.74 -40.8 89.33 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -172.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.9 t -55.89 -45.71 78.54 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.079 1.752 . . . . 0.0 113.203 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.2 tp -72.27 -36.25 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.183 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.04 -55.24 37.44 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.395 0.678 . . . . 0.0 111.299 169.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -63.91 -26.75 68.74 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.3 t -57.6 -34.62 69.45 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.585 1.154 . . . . 0.0 112.909 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -74.23 -4.35 35.48 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.699 1.6 . . . . 0.0 114.435 173.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.87 -11.28 72.55 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 126.39 1.947 . . . . 0.0 115.263 175.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 m -83.07 151.43 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.811 1.644 . . . . 0.0 111.495 173.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.7 t -80.55 176.02 10.15 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.937 0.875 . . . . 0.0 111.634 167.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 pp -101.2 119.95 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 128.307 2.643 . . . . 0.0 109.661 174.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -59.94 -44.8 94.14 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.542 0.737 . . . . 0.0 111.552 176.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.1 t -161.49 171.01 18.86 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.42 1.488 . . . . 0.0 112.129 170.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -72.83 152.85 41.33 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.258 1.823 . . . . 0.0 112.641 171.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.51 146.15 4.42 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.858 1.218 . . . . 0.0 112.248 -175.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 p -59.37 133.75 56.38 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.528 -0.983 . . . . 0.0 111.569 171.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.541 0.601 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -172.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 33.2 m . . . . . 0 CA--C 1.546 0.826 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.59 140.06 23.48 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.054 2.502 . . . . 0.0 111.242 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -75.16 -1.98 25.65 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.8 mt -66.36 140.79 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.637 1.575 . . . . 0.0 109.724 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.1 mt -89.1 80.11 7.06 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.159 1.784 . . . . 0.0 110.085 175.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -127.66 68.56 74.61 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 124.003 0.921 . . . . 0.0 110.593 176.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.6 163.34 27.69 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.95 2.434 . . . . 0.0 112.453 -173.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.1 m -145.24 157.01 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.889 1.676 . . . . 0.0 110.7 -171.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.6 t -101.18 110.34 22.35 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.987 0.915 . . . . 0.0 109.424 170.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.74 158.21 52.17 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-N 118.981 0.81 . . . . 0.0 112.905 173.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.5 p -70.09 -9.19 54.68 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -64.32 -14.59 57.03 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.37 1.468 . . . . 0.0 113.45 163.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.17 19.58 45.71 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.324 1.44 . . . . 0.0 114.085 -177.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.9 ttm-85 -119.24 160.27 22.5 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.528 1.931 . . . . 0.0 111.682 -174.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.9 m -116.61 131.52 56.93 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.386 1.475 . . . . 0.0 110.683 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -125.23 169.97 11.73 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.621 1.568 . . . . 0.0 110.925 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.87 -21.6 61.63 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -165.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -161.01 -174.54 4.44 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.987 2.115 . . . . 0.0 109.815 174.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.7 p -72.64 -38.34 67.74 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.1 t -58.2 -41.81 84.78 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.777 1.631 . . . . 0.0 113.953 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 tp -72.1 -43.75 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.836 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.61 -49.49 76.25 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.288 1.035 . . . . 0.0 112.106 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -60.97 -25.45 66.85 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.0 t -59.27 -31.26 68.94 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.92 1.288 . . . . 0.0 113.146 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -74.73 -2.83 28.15 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.362 1.465 . . . . 0.0 114.211 172.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.61 15.08 62.32 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.089 1.328 . . . . 0.0 114.951 177.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 t -128.46 149.04 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.559 1.544 . . . . 0.0 110.856 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 p -87.81 162.8 16.78 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 126.53 1.932 . . . . 0.0 112.43 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.4 pt -73.47 126.54 34.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.708 1.203 . . . . 0.0 110.113 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -75.35 -40.53 58.09 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.641 1.177 . . . . 0.0 111.032 169.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.7 p -150.33 161.4 42.54 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.585 1.554 . . . . 0.0 112.751 171.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.17 153.49 25.97 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.286 1.434 . . . . 0.0 111.034 170.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.41 160.17 12.2 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.172 1.368 . . . . 0.0 112.073 -169.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.2 m -59.51 130.61 47.74 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.729 -0.865 . . . . 0.0 109.981 165.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.546 0.792 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -176.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.8 m . . . . . 0 CA--C 1.548 0.866 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.21 166.93 27.93 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.403 2.735 . . . . 0.0 111.265 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -109.86 10.79 24.43 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.35 1.46 . . . . 0.0 114.36 -173.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.7 mt -58.66 139.16 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.27 1.428 . . . . 0.0 110.217 -176.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.1 mt -80.94 71.9 7.93 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.461 1.505 . . . . 0.0 110.055 172.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -135.62 71.21 65.41 Favored Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 124.718 1.207 . . . . 0.0 109.136 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -68.83 159.07 55.32 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.141 1.894 . . . . 0.0 111.599 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 m -144.85 146.93 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.1 1.36 . . . . 0.0 111.52 -169.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.9 t -89.65 115.24 26.89 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.752 1.221 . . . . 0.0 110.583 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.59 164.61 50.82 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 121.78 -0.575 . . . . 0.0 113.905 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.2 m -62.27 -20.08 63.9 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.56 -8.82 57.58 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.407 1.483 . . . . 0.0 113.571 171.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.36 -2.64 85.16 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.949 1.737 . . . . 0.0 114.929 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -86.18 165.07 16.84 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.019 1.328 . . . . 0.0 111.884 172.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 65.2 m -115.13 138.37 50.97 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.13 1.372 . . . . 0.0 110.455 175.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -121.63 164.32 17.51 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.42 1.888 . . . . 0.0 110.08 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.18 -26.94 67.64 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -168.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -167.12 172.51 9.96 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.382 1.873 . . . . 0.0 111.031 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 t -60.21 -43.57 95.86 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -176.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.4 t -57.8 -44.19 86.16 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.654 1.582 . . . . 0.0 113.41 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.4 tp -70.41 -38.41 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.05 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.08 -55.12 39.04 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.417 1.087 . . . . 0.0 111.279 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -60.1 -37.96 81.53 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.606 0.762 . . . . 0.0 112.865 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 23.6 t -65.16 -38.68 91.34 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.097 0.959 . . . . 0.0 112.817 174.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.12 -21.85 66.46 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.225 1.41 . . . . 0.0 113.866 173.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.34 8.8 18.82 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.088 1.328 . . . . 0.0 115.618 174.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.84 149.05 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 119.301 1.55 . . . . 0.0 110.937 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.57 151.1 29.28 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.225 1.41 . . . . 0.0 111.394 172.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.13 126.75 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 126.849 2.06 . . . . 0.0 107.985 165.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -85.47 -48.21 9.19 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.18 0.592 . . . . 0.0 111.337 162.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.5 m -138.53 156.58 47.37 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.022 1.329 . . . . 0.0 112.501 -176.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -82.62 155.05 24.63 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.855 1.262 . . . . 0.0 112.483 172.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.25 159.42 13.14 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.042 1.306 . . . . 0.0 112.012 -172.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 m -60.18 128.02 34.69 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 121.956 -0.732 . . . . 0.0 109.673 164.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.546 0.802 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -175.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.6 m . . . . . 0 CA--C 1.548 0.886 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -73.38 142.24 33.08 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.217 2.611 . . . . 0.0 110.986 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -78.45 6.4 8.58 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.998 1.719 . . . . 0.0 114.877 176.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.3 tt -58.47 143.4 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 126.117 1.767 . . . . 0.0 112.723 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 tt -92.85 70.11 4.69 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.047 1.339 . . . . 0.0 109.643 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -135.4 72.6 64.81 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 125.603 1.561 . . . . 0.0 110.358 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.65 166.21 26.77 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.565 2.177 . . . . 0.0 112.24 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.8 m -141.26 156.27 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.356 1.863 . . . . 0.0 110.515 -176.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.2 t -90.13 113.87 25.71 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 164.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.32 160.05 47.37 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 121.454 -0.779 . . . . 0.0 113.263 176.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.7 t -62.11 -22.65 65.99 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.563 1.145 . . . . 0.0 113.603 -178.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -68.87 -13.15 62.24 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.434 1.494 . . . . 0.0 114.239 172.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.0 9.84 65.29 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.079 1.324 . . . . 0.0 114.53 -175.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -103.45 163.26 12.4 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.316 1.846 . . . . 0.0 111.409 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.5 m -115.29 129.02 56.5 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.19 1.796 . . . . 0.0 109.747 175.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -120.31 169.57 10.15 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.95 1.7 . . . . 0.0 110.72 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.77 -28.44 65.77 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -171.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.5 172.19 17.66 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.537 1.535 . . . . 0.0 111.093 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.9 p -63.04 -40.27 97.23 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.5 t -56.89 -46.88 81.6 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.23 1.812 . . . . 0.0 113.439 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.2 tp -70.68 -36.82 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.841 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.79 -55.42 35.15 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.694 0.798 . . . . 0.0 111.605 170.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -60.69 -28.6 68.75 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.158 1.169 . . . . 0.0 114.158 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.6 m -63.25 -20.36 65.38 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 174.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -84.91 -6.42 59.34 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.756 1.222 . . . . 0.0 113.787 167.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.43 -10.84 63.26 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 126.705 2.098 . . . . 0.0 115.157 177.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.0 m -99.02 142.56 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 126.39 1.876 . . . . 0.0 111.771 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.6 t -91.31 169.18 11.03 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.307 1.051 . . . . 0.0 112.584 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -72.16 132.04 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 127.58 2.352 . . . . 0.0 110.246 176.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -91.35 -36.6 13.74 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.049 1.34 . . . . 0.0 112.209 173.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.5 p -157.09 160.56 39.0 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.219 1.407 . . . . 0.0 112.75 171.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -73.35 146.91 44.87 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.065 1.346 . . . . 0.0 112.454 172.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.98 153.01 6.05 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.165 1.364 . . . . 0.0 111.871 -172.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.1 p -59.32 142.88 50.97 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.731 -0.864 . . . . 0.0 112.036 169.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.541 0.627 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -178.036 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.5 m . . . . . 0 CA--C 1.55 0.959 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -72.91 144.34 38.34 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 123.368 2.712 . . . . 0.0 111.767 -175.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -75.39 5.96 5.12 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.293 1.837 . . . . 0.0 115.18 175.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.8 tt -61.8 149.91 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.987 1.715 . . . . 0.0 112.829 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 tt -102.81 75.0 1.37 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.167 1.787 . . . . 0.0 109.512 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -142.69 73.88 19.38 Favored Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 124.791 1.236 . . . . 0.0 110.593 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.77 167.29 17.8 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.056 2.504 . . . . 0.0 112.743 -176.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.9 m -141.93 158.97 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.839 1.655 . . . . 0.0 110.789 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.9 t -99.81 118.3 35.98 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.928 0.891 . . . . 0.0 109.116 166.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.17 163.57 54.55 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 118.963 0.801 . . . . 0.0 113.268 172.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.5 t -63.43 -20.95 66.0 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -67.35 -14.29 62.78 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.37 1.468 . . . . 0.0 113.784 169.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.55 1.49 71.31 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 126.028 1.775 . . . . 0.0 114.666 -178.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -87.03 160.74 18.51 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.043 1.737 . . . . 0.0 111.591 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 91.1 m -109.79 136.37 49.23 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.303 1.441 . . . . 0.0 110.517 175.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -126.75 168.44 14.39 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.48 1.512 . . . . 0.0 111.603 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.46 -23.79 61.89 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -166.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -162.18 -179.64 7.21 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.218 1.807 . . . . 0.0 111.239 171.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 61.0 p -63.89 -40.96 97.73 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 175.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.2 t -59.18 -44.34 92.17 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.077 1.751 . . . . 0.0 113.57 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.4 tp -70.33 -42.93 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.054 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.88 -52.98 62.17 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.975 0.91 . . . . 0.0 111.522 177.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -60.12 -27.89 67.41 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.0 t -58.55 -29.69 66.55 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.775 1.23 . . . . 0.0 113.064 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -70.47 -12.63 61.7 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.651 1.58 . . . . 0.0 114.387 174.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.53 -0.39 77.36 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.878 1.704 . . . . 0.0 114.998 -175.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -104.33 149.54 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.759 1.624 . . . . 0.0 109.89 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.85 160.17 20.23 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.775 1.63 . . . . 0.0 112.209 174.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.6 pt -71.84 129.05 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 124.284 1.034 . . . . 0.0 110.13 170.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -73.69 -38.29 64.93 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.907 1.283 . . . . 0.0 111.227 170.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.0 p -158.59 163.79 36.66 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.009 1.724 . . . . 0.0 112.359 168.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.47 154.94 34.27 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.569 1.548 . . . . 0.0 112.007 166.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.41 158.61 9.96 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 125.404 1.478 . . . . 0.0 112.022 -168.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.0 t -62.17 146.71 49.89 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.657 -0.907 . . . . 0.0 110.743 166.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.541 0.605 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -177.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 35.5 m . . . . . 0 CA--C 1.549 0.909 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.67 159.14 53.72 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.588 2.859 . . . . 0.0 111.884 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -113.35 4.01 16.16 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.554 1.542 . . . . 0.0 114.024 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.2 mp -69.75 146.19 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.425 1.09 . . . . 0.0 109.914 175.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.7 tt -77.84 74.3 4.4 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.837 2.055 . . . . 0.0 109.672 176.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.4 mmmt -129.39 63.56 68.07 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 125.63 1.572 . . . . 0.0 111.851 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.65 166.22 28.19 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.27 2.647 . . . . 0.0 112.625 -176.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.0 m -146.98 143.02 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.348 1.859 . . . . 0.0 110.553 -172.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.7 t -79.77 111.64 16.28 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.72 153.84 39.02 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 119.233 0.924 . . . . 0.0 112.851 175.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 90.2 p -69.92 -9.8 56.29 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -69.86 -15.93 63.17 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.354 1.461 . . . . 0.0 113.779 169.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.42 15.65 22.56 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 124.675 1.131 . . . . 0.0 115.645 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 51.6 ttm-85 -136.08 168.08 20.04 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.237 1.815 . . . . 0.0 111.021 178.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.2 t -106.44 151.74 24.54 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.44 1.096 . . . . 0.0 111.697 172.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -121.36 175.74 6.0 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.569 1.947 . . . . 0.0 110.018 173.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.31 -25.74 61.69 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -171.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -160.66 -176.49 5.59 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.901 1.68 . . . . 0.0 111.487 174.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.4 p -72.77 -25.99 61.38 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 177.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.5 t -71.48 -43.78 65.95 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.698 1.599 . . . . 0.0 112.54 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.5 tp -68.75 -41.44 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.637 0.775 . . . . 0.0 111.12 176.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.54 -56.17 19.32 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.72 1.208 . . . . 0.0 111.844 173.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -61.71 -36.11 79.99 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 32.3 m -59.06 -33.76 71.16 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.428 0.691 . . . . 0.0 112.722 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -67.52 -9.92 46.89 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 173.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.82 10.38 72.64 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.762 1.172 . . . . 0.0 114.88 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 t -116.88 156.37 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.318 1.847 . . . . 0.0 109.085 176.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.2 t -107.42 167.63 9.8 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 122.515 1.15 . . . . 0.0 111.754 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.6 pt -77.49 123.81 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 126.009 1.723 . . . . 0.0 109.965 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.3 tttt -71.89 -40.76 68.65 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.168 0.987 . . . . 0.0 111.349 168.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.0 t -156.93 171.53 20.28 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.079 1.352 . . . . 0.0 112.871 172.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -75.54 148.16 39.14 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.014 2.126 . . . . 0.0 112.528 171.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.98 159.09 6.97 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.175 1.369 . . . . 0.0 112.594 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.7 m -58.69 138.66 56.89 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.748 0.819 . . . . 0.0 111.18 170.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 CA--C 1.54 0.567 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -179.709 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.4 m . . . . . 0 CA--C 1.55 0.965 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -74.64 168.37 24.97 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.57 2.847 . . . . 0.0 112.419 -175.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -114.19 8.7 16.95 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.18 2.192 . . . . 0.0 114.164 -177.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 26.6 mt -66.32 144.03 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.356 1.462 . . . . 0.0 109.854 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 tt -84.62 71.79 10.75 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.417 1.887 . . . . 0.0 110.001 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -135.03 67.13 69.41 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 125.135 1.374 . . . . 0.0 111.38 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.58 168.51 18.05 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.329 2.686 . . . . 0.0 112.792 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.3 m -145.82 162.63 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.444 1.898 . . . . 0.0 110.765 -174.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.0 t -102.81 121.84 43.31 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.957 0.903 . . . . 0.0 109.364 166.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.97 166.8 53.17 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 119.108 0.867 . . . . 0.0 112.951 174.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.0 m -65.32 -15.45 62.55 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -74.91 -6.61 50.11 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.451 1.1 . . . . 0.0 113.851 168.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.96 19.41 61.27 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.955 1.264 . . . . 0.0 114.56 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.46 153.8 24.53 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.384 1.874 . . . . 0.0 111.45 -174.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.8 m -102.9 117.96 35.77 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.956 1.702 . . . . 0.0 111.886 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -104.29 163.11 12.65 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 128.078 2.551 . . . . 0.0 110.949 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.78 -25.38 56.38 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -175.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -161.43 178.61 8.98 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.007 1.723 . . . . 0.0 111.432 173.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.9 m -63.96 -37.4 87.26 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 177.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.6 t -59.68 -45.18 92.85 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.872 1.669 . . . . 0.0 112.966 -177.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.8 tt -73.39 -40.1 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.566 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.06 -28.53 67.87 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 174.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -90.44 -27.29 19.37 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 174.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.3 t -55.26 -38.99 69.26 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.966 1.307 . . . . 0.0 113.044 -176.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -69.82 -10.66 59.26 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 126.17 1.788 . . . . 0.0 115.25 175.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.33 -8.2 52.31 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 126.377 1.941 . . . . 0.0 116.131 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 t -92.94 164.99 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 125.496 1.518 . . . . 0.0 110.203 177.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 p -98.16 165.89 11.67 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.806 2.042 . . . . 0.0 112.089 174.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 pt -75.67 128.35 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.182 0.993 . . . . 0.0 109.731 169.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -69.43 -44.15 71.91 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.46 1.104 . . . . 0.0 110.784 168.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.0 t -156.49 170.71 21.72 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.067 1.347 . . . . 0.0 112.072 170.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -77.4 153.03 34.06 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.46 1.904 . . . . 0.0 111.528 173.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.89 152.67 5.77 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.372 1.463 . . . . 0.0 112.45 -173.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 p -58.03 139.72 53.96 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.836 0.855 . . . . 0.0 111.675 167.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.542 0.657 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -175.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.9 m . . . . . 0 CA--C 1.551 0.99 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -81.77 173.67 11.03 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.492 2.795 . . . . 0.0 113.068 -173.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -124.09 15.04 9.16 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.324 1.85 . . . . 0.0 114.152 -171.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.3 pp -61.43 174.03 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 125.714 1.605 . . . . 0.0 112.575 165.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.4 mt -110.7 85.96 2.22 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.17 1.388 . . . . 0.0 109.489 171.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.09 69.9 41.54 Favored Pre-proline 0 N--CA 1.473 0.693 0 C-N-CA 123.989 0.916 . . . . 0.0 110.756 174.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.15 171.99 11.72 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.745 2.297 . . . . 0.0 112.376 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.7 m -141.59 163.58 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.228 1.811 . . . . 0.0 111.455 -173.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.5 t -104.25 115.45 30.41 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.001 0.92 . . . . 0.0 109.213 166.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.41 162.2 54.0 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 123.891 0.757 . . . . 0.0 114.14 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.9 t -59.11 -28.63 66.7 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.567 1.147 . . . . 0.0 114.036 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -79.64 -1.14 36.83 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 125.97 1.708 . . . . 0.0 113.861 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.62 5.63 86.47 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.172 1.367 . . . . 0.0 113.983 -171.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.59 163.86 15.37 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.637 1.975 . . . . 0.0 112.344 176.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 27.4 m -135.57 113.01 10.67 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.447 1.499 . . . . 0.0 109.659 170.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -105.55 157.26 17.51 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.7 1.2 . . . . 0.0 111.131 173.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.57 -36.03 73.29 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.386 1.474 . . . . 0.0 113.893 -176.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.59 171.62 16.82 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.43 0.692 . . . . 0.0 111.448 171.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.8 m -60.87 -40.71 94.02 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.9 t -53.57 -41.95 67.05 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.674 1.99 . . . . 0.0 112.89 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 44.9 mm -70.99 -46.87 65.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 114.191 -1.368 . . . . 0.0 111.09 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.05 -53.63 47.4 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 173.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -61.26 -37.52 83.41 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 177.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.9 t -61.71 -39.0 89.96 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.041 0.936 . . . . 0.0 112.343 176.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -72.53 -2.46 19.83 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.812 1.645 . . . . 0.0 114.376 172.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.03 4.93 64.48 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.03 1.3 . . . . 0.0 115.777 169.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 m -119.48 135.85 58.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 126.382 1.873 . . . . 0.0 111.271 -177.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -75.41 154.93 36.86 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.605 1.162 . . . . 0.0 112.231 176.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 pt -78.58 125.49 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.861 1.264 . . . . 0.0 109.557 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -78.67 -36.42 43.79 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.386 1.075 . . . . 0.0 111.829 172.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.8 t -153.83 168.84 24.97 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.672 1.189 . . . . 0.0 112.461 169.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -85.06 146.49 27.14 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.584 2.354 . . . . 0.0 110.807 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.64 149.22 5.2 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.67 1.128 . . . . 0.0 111.767 -170.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.0 p -59.1 135.57 57.68 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.569 -0.959 . . . . 0.0 111.287 168.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -177.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.6 m . . . . . 0 CA--C 1.551 0.993 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.34 160.24 35.87 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.535 2.823 . . . . 0.0 112.317 -172.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.85 4.09 13.86 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.194 1.797 . . . . 0.0 115.582 -172.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pp -71.59 168.81 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 126.897 2.079 . . . . 0.0 112.894 173.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.6 mt -96.33 89.93 5.26 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.426 1.49 . . . . 0.0 109.915 169.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -139.42 69.3 39.48 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 123.475 0.71 . . . . 0.0 110.976 169.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.45 167.16 17.48 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.046 2.497 . . . . 0.0 112.506 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.4 m -144.88 155.89 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.766 1.626 . . . . 0.0 110.678 -174.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.5 t -102.05 117.88 35.72 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.055 0.942 . . . . 0.0 109.666 172.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.55 165.99 53.12 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 121.51 -0.744 . . . . 0.0 113.659 175.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.7 p -61.63 -21.39 64.35 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -70.11 -12.77 61.84 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.559 1.543 . . . . 0.0 113.681 171.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.37 -0.85 75.47 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.935 1.731 . . . . 0.0 115.112 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -90.43 160.54 15.99 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.331 1.452 . . . . 0.0 111.512 176.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 40.4 m -109.26 131.65 54.87 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.279 1.431 . . . . 0.0 110.513 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -113.3 167.95 10.14 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.793 1.637 . . . . 0.0 110.481 173.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.73 -26.42 62.46 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -167.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -161.25 177.63 10.02 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.949 2.099 . . . . 0.0 110.681 174.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.8 p -62.17 -43.1 99.58 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 t -56.69 -37.98 71.62 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.471 1.908 . . . . 0.0 114.554 -176.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 tt -73.18 -52.75 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.844 0.858 . . . . 0.0 111.528 172.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.79 -56.05 6.87 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.799 1.24 . . . . 0.0 112.305 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.13 -27.69 69.25 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.205 1.802 . . . . 0.0 115.385 177.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 9.5 t -59.78 -33.29 71.52 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.361 1.064 . . . . 0.0 112.79 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -67.33 -17.83 64.92 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.171 1.389 . . . . 0.0 113.917 173.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.47 -9.95 57.6 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 126.594 2.045 . . . . 0.0 115.242 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.6 m -86.55 149.87 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 119.164 1.482 . . . . 0.0 111.516 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.01 156.18 20.55 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.921 1.289 . . . . 0.0 111.607 170.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.9 pt -71.2 129.02 35.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.195 0.998 . . . . 0.0 110.018 171.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.4 tptp -78.49 -35.32 46.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.449 1.099 . . . . 0.0 111.28 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.0 p -156.36 162.48 40.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.879 1.672 . . . . 0.0 112.503 172.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -84.84 157.2 21.0 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.119 0.968 . . . . 0.0 112.418 169.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.14 161.74 11.69 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.15 1.357 . . . . 0.0 111.975 -166.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.1 m -59.02 131.74 51.96 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.95 -0.735 . . . . 0.0 109.765 164.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.545 0.774 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 14.3 m . . . . . 0 CA--C 1.547 0.862 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -77.97 166.96 24.33 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.238 2.625 . . . . 0.0 111.966 -176.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -119.74 15.33 12.68 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.763 2.025 . . . . 0.0 114.538 -170.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -60.64 170.29 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 126.736 2.014 . . . . 0.0 113.73 170.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.0 mt -104.83 80.1 1.6 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.565 1.546 . . . . 0.0 110.221 172.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.6 mmtt -138.92 66.24 39.46 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 125.132 1.373 . . . . 0.0 110.796 173.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.82 163.16 31.77 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.86 2.373 . . . . 0.0 111.944 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.0 m -146.51 160.75 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.561 1.544 . . . . 0.0 111.48 -170.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.5 t -96.28 116.88 29.72 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.012 1.325 . . . . 0.0 110.486 172.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.26 165.48 54.8 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 121.407 -0.808 . . . . 0.0 113.368 172.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.8 t -61.95 -26.93 68.49 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.35 1.06 . . . . 0.0 113.164 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -69.02 -8.01 40.96 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.603 1.961 . . . . 0.0 114.912 169.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.37 2.12 90.55 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.813 1.673 . . . . 0.0 115.3 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.2 mmt-85 -84.92 163.23 19.1 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.435 1.618 . . . . 0.0 111.615 173.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.3 m -118.42 117.59 29.45 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.589 1.555 . . . . 0.0 109.893 173.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -103.72 176.51 5.13 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.138 1.375 . . . . 0.0 110.298 170.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.87 -24.66 64.36 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -169.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.54 176.56 10.29 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.534 1.534 . . . . 0.0 110.869 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.7 p -62.24 -45.41 93.47 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 174.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.2 t -56.85 -44.26 81.97 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.404 1.882 . . . . 0.0 114.08 -177.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.44 -44.38 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.745 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.26 -49.56 77.38 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.022 0.929 . . . . 0.0 111.756 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -61.95 -28.65 69.69 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 174.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.9 t -61.29 -34.83 75.85 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.091 0.956 . . . . 0.0 112.844 176.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -72.47 -8.72 56.56 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.33 1.452 . . . . 0.0 114.144 170.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.93 -12.09 64.12 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.579 2.038 . . . . 0.0 115.335 174.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.6 m -79.97 141.18 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.266 1.426 . . . . 0.0 111.863 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.6 t -78.06 173.72 11.89 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.762 0.791 . . . . 0.0 112.036 171.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.0 mm -99.2 112.8 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 126.085 1.754 . . . . 0.0 110.196 -175.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -66.06 -38.6 88.73 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.533 0.733 . . . . 0.0 111.377 172.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.9 p -168.17 156.88 9.02 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.037 0.935 . . . . 0.0 112.949 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -82.11 153.87 25.85 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 122.304 1.05 . . . . 0.0 111.545 172.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.82 153.71 8.54 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.911 1.72 . . . . 0.0 111.618 -168.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.8 m -56.05 128.2 34.21 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.74 -0.859 . . . . 0.0 110.078 167.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.546 0.824 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -176.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 27.2 m . . . . . 0 CA--C 1.551 1.004 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.57 141.75 35.13 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.024 2.483 . . . . 0.0 111.441 -175.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -77.61 8.14 4.75 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.978 1.711 . . . . 0.0 114.868 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.4 tt -58.36 143.73 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 125.974 1.71 . . . . 0.0 112.702 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.5 tt -91.98 72.07 5.57 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.141 1.376 . . . . 0.0 109.573 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -138.24 72.45 45.51 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 125.415 1.486 . . . . 0.0 110.559 177.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -67.52 165.97 25.45 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.473 2.115 . . . . 0.0 112.037 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.7 m -141.35 156.68 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 126.238 1.815 . . . . 0.0 110.557 -175.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.4 t -91.95 117.0 29.4 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 165.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.18 162.18 45.93 Favored Glycine 0 CA--C 1.535 1.288 0 O-C-N 121.459 -0.776 . . . . 0.0 113.007 174.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.7 m -68.91 -14.27 62.94 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -176.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -74.31 -5.82 44.44 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.723 1.609 . . . . 0.0 113.27 169.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.82 21.08 54.43 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.787 1.184 . . . . 0.0 114.541 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -119.54 162.91 18.11 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.196 1.798 . . . . 0.0 111.788 -176.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.4 m -114.57 122.61 47.06 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.916 1.686 . . . . 0.0 110.133 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -115.34 169.07 9.42 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.635 1.574 . . . . 0.0 110.817 174.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.85 -30.35 66.73 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -166.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -164.51 170.3 16.06 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.28 1.432 . . . . 0.0 111.954 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.7 p -60.97 -39.85 91.16 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -171.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -54.08 -51.77 63.08 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.787 2.035 . . . . 0.0 112.997 176.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.6 tp -67.41 -40.43 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 121.387 -0.821 . . . . 0.0 110.865 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.97 -3.58 5.53 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.897 1.679 . . . . 0.0 114.905 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -116.09 -31.97 5.52 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.832 1.653 . . . . 0.0 114.489 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 56.4 m -60.41 -26.41 66.68 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.715 1.206 . . . . 0.0 113.633 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -72.94 -10.75 60.14 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 127.53 2.332 . . . . 0.0 115.472 170.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.27 1.17 59.43 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 125.642 1.591 . . . . 0.0 116.518 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 p -102.05 169.39 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-N 119.359 1.579 . . . . 0.0 111.064 172.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.1 149.79 29.53 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 127.115 2.166 . . . . 0.0 112.121 175.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -66.93 124.15 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 125.096 1.358 . . . . 0.0 110.089 176.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -78.98 -37.82 38.46 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.717 1.207 . . . . 0.0 111.523 174.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.8 p -160.03 162.13 34.15 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.472 1.509 . . . . 0.0 112.942 172.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -76.96 151.55 35.64 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.878 1.271 . . . . 0.0 112.615 171.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.54 156.94 8.48 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.097 1.332 . . . . 0.0 111.701 -169.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.2 p -60.1 146.08 44.4 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.71 -0.876 . . . . 0.0 111.837 167.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.542 0.652 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.6 m . . . . . 0 CA--C 1.55 0.944 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -79.61 173.71 12.69 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.973 3.116 . . . . 0.0 112.546 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -122.76 14.01 10.02 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.206 1.802 . . . . 0.0 114.065 -173.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.88 161.92 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 125.347 1.459 . . . . 0.0 112.52 172.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tt -98.25 75.94 2.3 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.765 1.226 . . . . 0.0 109.804 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -140.08 69.85 34.94 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 124.3 1.04 . . . . 0.0 111.428 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.88 168.04 24.17 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.176 2.584 . . . . 0.0 112.644 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.6 m -137.77 167.32 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 128.332 2.653 . . . . 0.0 111.518 -171.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.7 t -109.67 108.46 18.86 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.905 0.882 . . . . 0.0 109.569 167.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.13 156.17 53.55 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.008 0.813 . . . . 0.0 114.319 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.3 t -69.08 -14.26 62.91 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -78.3 -5.99 53.72 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.01 1.724 . . . . 0.0 113.86 168.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.23 4.43 74.3 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.752 1.644 . . . . 0.0 115.06 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -101.34 168.04 9.79 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.164 1.482 . . . . 0.0 111.727 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.2 m -121.27 135.51 55.11 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.733 1.613 . . . . 0.0 110.108 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -125.66 156.97 38.42 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.37 1.468 . . . . 0.0 110.863 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.84 -31.04 64.35 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.14 1.376 . . . . 0.0 114.108 -174.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -156.64 169.29 25.03 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.806 0.843 . . . . 0.0 111.605 175.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.1 t -60.61 -44.71 95.98 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.0 t -50.27 -44.19 53.65 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.113 1.765 . . . . 0.0 113.059 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.0 mm -64.03 -57.09 13.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.859 176.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.59 -52.87 16.31 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.396 0.678 . . . . 0.0 112.689 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -61.55 -38.19 86.56 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 30.6 t -63.16 -38.96 93.24 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.238 1.015 . . . . 0.0 112.138 176.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -67.51 -13.17 61.81 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.187 1.395 . . . . 0.0 113.463 173.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.12 -0.18 41.12 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 126.286 1.898 . . . . 0.0 115.529 172.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.2 m -112.91 134.07 56.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 126.229 1.812 . . . . 0.0 111.465 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 p -74.85 152.51 38.92 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.176 -0.953 . . . . 0.0 111.665 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.5 pt -73.49 127.47 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.114 0.965 . . . . 0.0 109.311 172.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -78.57 -37.05 43.56 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.838 -0.538 . . . . 0.0 111.269 171.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.0 p -152.74 162.39 41.33 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.588 1.555 . . . . 0.0 112.966 170.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -74.84 152.84 38.9 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.947 1.699 . . . . 0.0 111.22 169.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.54 152.63 6.32 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.215 1.388 . . . . 0.0 111.942 -175.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.5 t -58.33 147.39 31.17 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.783 -0.833 . . . . 0.0 110.871 167.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 CA--C 1.54 0.585 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -178.055 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 18.7 m . . . . . 0 CA--C 1.549 0.917 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.38 166.22 26.38 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.632 2.888 . . . . 0.0 112.197 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -115.04 25.52 10.84 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.311 1.844 . . . . 0.0 113.408 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.3 pt -58.01 173.71 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 127.195 2.198 . . . . 0.0 112.726 169.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 tt -123.57 75.12 1.31 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.029 1.332 . . . . 0.0 109.237 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -141.99 71.76 23.49 Favored Pre-proline 0 N--CA 1.471 0.622 0 C-N-CA 124.305 1.042 . . . . 0.0 110.371 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.66 159.54 53.22 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.262 1.975 . . . . 0.0 112.079 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.4 m -145.82 147.33 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.149 1.38 . . . . 0.0 111.724 -169.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.2 t -90.55 116.81 28.74 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.665 1.186 . . . . 0.0 110.762 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.99 165.18 53.38 Favored Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.56 -0.712 . . . . 0.0 113.197 174.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.9 p -65.55 -17.25 64.43 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -68.84 -16.87 63.9 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.759 1.624 . . . . 0.0 113.589 168.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.07 -4.91 78.42 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.993 1.758 . . . . 0.0 114.961 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.7 ttt85 -83.77 161.82 20.85 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.356 1.462 . . . . 0.0 111.458 170.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 62.5 m -111.35 135.48 51.83 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.296 1.838 . . . . 0.0 110.952 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -119.87 165.52 14.5 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.739 1.616 . . . . 0.0 110.958 174.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.84 -30.45 70.63 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -167.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.44 173.88 15.53 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.282 1.833 . . . . 0.0 110.353 172.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.1 p -59.8 -41.72 91.83 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -56.36 -45.67 80.37 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.709 1.604 . . . . 0.0 113.301 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.7 tp -69.21 -41.82 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.931 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.66 -56.21 19.26 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.283 1.033 . . . . 0.0 111.32 174.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -59.32 -37.95 79.06 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 63.9 m -71.33 -23.85 62.0 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 175.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -74.1 -20.46 60.25 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.029 1.332 . . . . 0.0 112.934 172.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.68 7.66 17.48 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.851 1.691 . . . . 0.0 115.807 174.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 t -133.36 151.52 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.043 1.421 . . . . 0.0 110.545 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.8 t -92.99 158.46 15.78 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.169 0.985 . . . . 0.0 112.184 174.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.62 122.5 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 128.667 2.787 . . . . 0.0 108.51 171.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -79.22 -49.8 11.95 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.745 -0.597 . . . . 0.0 110.584 161.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.8 p -143.61 161.24 39.01 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.161 1.385 . . . . 0.0 113.227 -176.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.31 154.0 20.44 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.485 1.514 . . . . 0.0 112.597 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.17 160.9 19.98 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.03 1.3 . . . . 0.0 111.818 -169.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 m -61.37 126.95 29.2 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.783 -0.833 . . . . 0.0 109.564 164.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -173.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.8 m . . . . . 0 CA--C 1.547 0.847 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.63 168.51 24.24 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.261 2.641 . . . . 0.0 111.916 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -122.81 16.2 10.16 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.822 2.049 . . . . 0.0 114.497 -170.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.95 168.28 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 126.584 1.954 . . . . 0.0 112.925 170.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 tt -105.47 69.28 0.83 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.943 1.297 . . . . 0.0 110.583 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -137.31 72.13 52.52 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 124.822 1.249 . . . . 0.0 110.572 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.79 166.87 18.93 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.728 2.286 . . . . 0.0 111.937 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 m -142.99 150.98 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.81 1.644 . . . . 0.0 110.55 -176.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.5 t -87.98 114.49 24.64 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 169.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.56 159.68 53.75 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 119.409 1.004 . . . . 0.0 112.364 171.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t -65.2 -20.13 66.29 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 121.271 -1.135 . . . . 0.0 114.024 -177.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.67 -17.15 64.39 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.057 1.743 . . . . 0.0 113.859 168.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.68 -6.63 62.84 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 126.44 1.971 . . . . 0.0 114.826 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -77.9 164.67 24.93 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 118.712 1.256 . . . . 0.0 111.859 173.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 60.5 m -117.93 133.7 55.67 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.422 1.489 . . . . 0.0 110.027 169.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -121.81 170.19 10.01 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.857 1.663 . . . . 0.0 110.565 172.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.04 -30.64 71.21 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -165.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -163.36 172.77 14.13 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.833 1.253 . . . . 0.0 111.609 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.5 m -59.8 -39.18 84.12 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -173.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.6 t -58.92 -44.55 91.32 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.529 1.931 . . . . 0.0 113.479 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.89 -40.34 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.317 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.67 -53.22 60.85 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.634 0.774 . . . . 0.0 111.292 174.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -61.58 -29.02 69.76 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 176.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 10.8 t -60.12 -35.13 74.58 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.102 0.961 . . . . 0.0 112.705 176.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -75.37 -3.67 34.95 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.872 1.669 . . . . 0.0 114.068 172.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.71 -10.55 73.27 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 126.528 2.013 . . . . 0.0 115.173 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.5 m -85.08 138.02 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.81 1.644 . . . . 0.0 111.637 176.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -76.96 154.67 33.35 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.396 1.079 . . . . 0.0 112.238 169.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 pp -74.05 123.15 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.384 1.474 . . . . 0.0 109.744 174.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -75.4 -42.59 53.41 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.806 1.242 . . . . 0.0 111.57 173.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.4 t -158.09 169.4 24.63 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.093 1.357 . . . . 0.0 112.209 173.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -79.93 152.2 29.69 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.756 2.022 . . . . 0.0 113.012 174.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.46 163.96 13.46 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.476 1.512 . . . . 0.0 112.309 -173.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 m -59.47 128.66 38.17 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.602 0.761 . . . . 0.0 109.563 164.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.544 0.739 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -176.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 120.497 0.189 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.0 mtpp -143.1 159.66 41.85 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.301 1.841 . . . . 0.0 110.754 173.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.4 m -74.9 -28.36 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.854 1.262 . . . . 0.0 113.206 173.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 86.3 m -82.59 152.49 25.92 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.874 1.27 . . . . 0.0 111.715 173.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -146.76 131.71 18.16 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.278 1.431 . . . . 0.0 110.525 173.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 45.3 m -64.56 154.76 83.62 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.426 1.091 . . . . 0.0 112.052 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.87 154.98 43.55 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.371 2.714 . . . . 0.0 111.482 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -104.58 5.42 33.78 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.911 2.084 . . . . 0.0 114.135 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 9.1 mt -70.16 143.07 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.897 1.679 . . . . 0.0 110.102 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.6 tt -80.75 74.99 7.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.558 1.943 . . . . 0.0 110.293 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -133.58 68.23 76.1 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 125.391 1.476 . . . . 0.0 111.509 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -67.6 165.95 25.66 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.024 2.483 . . . . 0.0 112.54 -176.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.6 m -142.94 152.23 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.973 1.709 . . . . 0.0 110.694 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.5 t -90.59 118.15 29.82 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 167.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.57 165.02 54.3 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-N 119.177 0.898 . . . . 0.0 112.799 172.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.7 p -67.42 -16.0 63.99 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.34 -9.28 58.53 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.227 1.411 . . . . 0.0 114.053 167.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.59 -1.58 88.21 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.609 1.576 . . . . 0.0 114.931 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.5 mmt-85 -72.28 159.44 34.06 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.011 1.324 . . . . 0.0 111.277 168.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 59.4 m -114.56 131.24 56.73 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.176 1.39 . . . . 0.0 109.564 169.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -118.11 166.62 12.34 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.688 1.595 . . . . 0.0 109.916 175.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.73 -24.21 62.58 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -167.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -165.09 176.33 8.62 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.727 2.011 . . . . 0.0 111.12 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.1 m -65.26 -34.58 78.69 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.7 t -62.32 -45.65 92.25 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.953 1.701 . . . . 0.0 113.244 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.8 tp -69.96 -39.36 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.194 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.04 -54.87 37.51 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.102 0.961 . . . . 0.0 111.685 170.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -63.18 -32.22 73.56 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.9 m -62.82 -20.23 64.84 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -80.93 -2.81 49.21 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.526 1.13 . . . . 0.0 113.673 169.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.75 16.32 58.43 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.418 1.485 . . . . 0.0 114.774 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 t -129.8 148.99 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.332 1.453 . . . . 0.0 111.277 -172.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.1 p -85.25 158.31 20.36 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.929 1.692 . . . . 0.0 112.721 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.66 124.77 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 125.578 1.551 . . . . 0.0 109.606 172.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -76.15 -39.86 54.02 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.879 1.272 . . . . 0.0 111.317 172.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.3 p -158.98 162.91 36.84 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.54 1.536 . . . . 0.0 112.785 172.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -74.89 152.41 38.88 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.025 1.33 . . . . 0.0 112.539 170.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.24 162.42 20.09 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.597 1.57 . . . . 0.0 112.538 -172.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.4 t -59.93 148.04 36.51 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.987 -0.713 . . . . 0.0 110.87 164.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.6 p -100.6 153.35 37.79 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.59 122.56 8.7 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 124.03 3.153 . . . . 0.0 112.475 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.3 m -72.36 -12.29 61.06 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.937 1.295 . . . . 0.0 113.615 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -83.15 2.06 87.64 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 126.347 1.927 . . . . 0.0 115.742 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 52.9 mt . . . . . 0 C--O 1.253 1.247 0 C-N-CA 126.634 1.974 . . . . 0.0 110.278 -178.386 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 120.712 0.291 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -141.27 28.87 1.83 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 126.116 1.766 . . . . 0.0 113.297 -169.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.9 t -56.01 120.18 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 125.225 1.41 . . . . 0.0 111.96 -175.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 77.1 m -87.75 -35.72 17.73 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.101 1.36 . . . . 0.0 112.84 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.36 112.6 5.53 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.035 1.734 . . . . 0.0 110.731 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 13.7 m -63.47 159.26 52.33 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 125.027 1.331 . . . . 0.0 112.984 174.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -76.62 171.74 17.49 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.952 3.101 . . . . 0.0 112.211 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.1 tttm -119.37 9.41 11.62 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.97 1.708 . . . . 0.0 114.581 -174.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.5 mt -63.11 143.66 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.182 1.393 . . . . 0.0 110.069 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 71.6 mt -75.01 70.61 2.03 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.054 1.741 . . . . 0.0 111.108 173.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -132.92 63.38 66.94 Favored Pre-proline 0 N--CA 1.471 0.622 0 C-N-CA 125.374 1.469 . . . . 0.0 109.934 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.26 160.25 48.46 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.987 2.458 . . . . 0.0 111.455 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.7 m -144.71 162.39 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.833 1.253 . . . . 0.0 111.639 -172.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.4 t -98.45 113.81 25.95 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.171 1.388 . . . . 0.0 110.201 173.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.37 166.37 54.71 Favored Glycine 0 CA--C 1.535 1.34 0 O-C-N 121.604 -0.685 . . . . 0.0 113.425 172.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.1 t -60.13 -25.1 65.21 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.071 1.349 . . . . 0.0 113.717 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -68.08 -14.12 62.73 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.918 1.287 . . . . 0.0 113.827 172.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.84 -4.04 84.87 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 126.088 1.804 . . . . 0.0 114.634 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -78.13 159.87 28.38 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.782 1.233 . . . . 0.0 111.685 173.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 59.6 m -109.91 131.56 54.95 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.519 1.528 . . . . 0.0 109.793 170.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -119.72 167.95 11.55 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.66 1.184 . . . . 0.0 110.756 171.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.63 -25.24 59.86 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -175.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -167.34 177.24 6.18 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.569 1.548 . . . . 0.0 111.329 174.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.0 p -60.49 -47.1 87.61 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 176.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.5 t -55.69 -42.06 74.64 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.503 1.921 . . . . 0.0 113.424 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.43 -52.71 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 125.38 1.472 . . . . 0.0 111.032 175.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.58 -46.93 83.4 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.36 0.664 . . . . 0.0 111.96 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -65.77 -28.86 69.34 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.3 t -59.46 -33.98 71.97 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.248 1.019 . . . . 0.0 112.69 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -72.44 -3.63 25.4 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.145 1.778 . . . . 0.0 113.998 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.92 -12.29 65.77 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 126.807 2.146 . . . . 0.0 115.334 172.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.5 m -88.22 135.71 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.836 1.654 . . . . 0.0 111.855 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.3 p -68.62 164.66 20.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.928 1.291 . . . . 0.0 112.726 173.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.3 mm -90.79 110.8 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 123.996 0.918 . . . . 0.0 110.263 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -45.97 90.78 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.256 1.022 . . . . 0.0 110.97 172.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.7 t -164.18 166.06 21.49 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.727 0.775 . . . . 0.0 112.777 173.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -86.78 154.99 20.5 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.628 1.971 . . . . 0.0 112.719 176.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.06 157.56 11.6 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.958 1.266 . . . . 0.0 111.806 -168.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.3 m -59.45 126.95 29.68 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.784 -0.833 . . . . 0.0 109.958 168.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -72.99 156.96 89.27 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -176.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -66.19 140.62 59.82 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.451 2.768 . . . . 0.0 111.742 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.5 t -160.99 113.96 1.96 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.544 1.538 . . . . 0.0 110.594 -177.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 157.08 -27.5 0.51 Allowed Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.37 1.462 . . . . 0.0 115.227 171.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.7 tp . . . . . 0 C--O 1.253 1.264 0 C-N-CA 126.636 1.974 . . . . 0.0 111.999 176.005 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -131.49 72.61 1.5 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.814 1.646 . . . . 0.0 113.242 -173.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.2 t -89.52 -31.27 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.759 1.224 . . . . 0.0 112.385 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.8 p -115.45 -55.98 2.39 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.775 1.63 . . . . 0.0 112.362 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.91 84.75 3.46 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.73 1.212 . . . . 0.0 111.708 174.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.1 m -61.84 157.52 49.19 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.389 1.476 . . . . 0.0 112.198 171.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.98 158.2 38.43 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.35 2.7 . . . . 0.0 112.106 -174.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -100.14 4.37 44.45 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.573 1.949 . . . . 0.0 114.435 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.7 mt -68.29 143.2 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.744 1.618 . . . . 0.0 109.905 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.89 79.58 9.58 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.129 1.772 . . . . 0.0 110.199 173.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -131.64 63.07 67.98 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 125.605 1.562 . . . . 0.0 111.721 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.33 166.12 24.57 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.309 2.672 . . . . 0.0 112.714 -173.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.6 m -142.55 152.54 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.835 1.654 . . . . 0.0 110.904 -175.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.8 t -89.42 113.55 24.9 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 166.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.87 162.56 52.96 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-N 118.906 0.776 . . . . 0.0 112.939 175.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 t -67.05 -14.08 62.55 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -72.53 -14.2 61.59 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.942 1.297 . . . . 0.0 113.479 168.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.55 -6.86 77.77 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 126.245 1.878 . . . . 0.0 114.706 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.2 mmt85 -74.29 161.99 29.35 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.776 1.631 . . . . 0.0 112.006 170.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.5 m -115.05 137.47 51.97 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.456 1.502 . . . . 0.0 109.763 167.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -127.18 166.84 16.95 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.894 1.678 . . . . 0.0 110.622 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.09 -23.75 64.05 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -165.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -164.42 -176.53 4.42 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.703 2.001 . . . . 0.0 111.353 172.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 54.8 m -67.17 -34.62 77.93 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 176.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.2 t -65.91 -38.1 87.83 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.796 1.638 . . . . 0.0 113.48 -175.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.0 tp -70.9 -50.22 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.843 170.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.53 -51.06 64.07 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.139 1.376 . . . . 0.0 112.882 -177.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.42 -34.82 72.96 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.044 1.337 . . . . 0.0 113.543 175.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.8 t -63.87 -30.92 71.96 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.504 1.122 . . . . 0.0 113.075 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -67.8 -8.15 33.52 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.059 1.344 . . . . 0.0 114.045 173.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.34 11.91 60.48 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.994 1.283 . . . . 0.0 115.086 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -128.74 151.26 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.538 1.535 . . . . 0.0 110.321 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 p -82.29 160.36 22.93 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.319 1.848 . . . . 0.0 112.847 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -73.09 126.04 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 125.75 1.62 . . . . 0.0 109.495 171.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -81.41 -38.21 26.88 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.557 1.143 . . . . 0.0 111.617 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.6 p -157.57 162.7 38.78 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.337 1.455 . . . . 0.0 112.788 169.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -75.1 150.25 38.87 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.238 1.415 . . . . 0.0 112.445 171.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.77 161.29 19.56 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.554 1.549 . . . . 0.0 112.403 -171.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.0 t -58.97 148.55 30.2 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 122.012 -0.699 . . . . 0.0 111.024 165.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.7 p -101.36 152.96 38.08 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.0 131.63 18.47 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.901 3.067 . . . . 0.0 111.936 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.21 -3.58 37.17 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.322 1.449 . . . . 0.0 114.278 -176.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.89 -14.53 82.08 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 125.209 1.385 . . . . 0.0 116.468 -169.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mp . . . . . 0 C--O 1.253 1.257 0 C-N-CA 125.982 1.713 . . . . 0.0 109.934 177.546 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -143.03 116.52 9.12 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 126.156 1.782 . . . . 0.0 110.611 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.8 m -65.13 133.69 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.379 1.072 . . . . 0.0 112.115 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.1 t -78.64 -27.68 45.39 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.196 0.998 . . . . 0.0 112.842 175.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.99 96.71 5.28 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.178 1.791 . . . . 0.0 111.034 -176.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 43.0 m -60.7 156.17 46.56 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 125.568 1.547 . . . . 0.0 113.049 173.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.1 146.8 41.81 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.272 2.648 . . . . 0.0 110.981 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -80.26 6.57 11.55 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.944 1.698 . . . . 0.0 115.006 176.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.7 tt -57.91 139.63 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 126.291 1.837 . . . . 0.0 113.186 -173.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.8 mt -84.9 72.01 10.83 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.11 1.364 . . . . 0.0 110.683 175.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -139.16 71.48 40.29 Favored Pre-proline 0 N--CA 1.47 0.54 0 C-N-CA 125.243 1.417 . . . . 0.0 109.944 173.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -66.64 166.64 21.42 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.367 2.045 . . . . 0.0 112.179 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.8 m -144.71 154.43 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.112 1.765 . . . . 0.0 111.027 -172.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 t -94.23 115.18 27.4 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.522 0.729 . . . . 0.0 109.186 167.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.9 160.66 53.58 Favored Glycine 0 CA--C 1.536 1.369 0 O-C-N 121.336 -0.853 . . . . 0.0 113.085 173.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.1 t -64.56 -20.62 66.34 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -70.79 -6.18 35.76 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.084 1.353 . . . . 0.0 114.364 170.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.48 19.97 55.52 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.71 1.148 . . . . 0.0 114.833 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -118.25 162.89 17.51 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.448 1.899 . . . . 0.0 111.332 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.1 m -116.53 129.62 56.29 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.237 1.415 . . . . 0.0 110.748 -175.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -123.9 165.86 16.65 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.721 1.608 . . . . 0.0 110.767 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.8 -29.96 70.53 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -167.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -166.41 171.06 12.34 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.908 1.683 . . . . 0.0 111.358 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.3 m -59.16 -42.78 91.55 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -171.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.2 t -56.08 -43.56 78.12 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.236 1.814 . . . . 0.0 113.264 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.5 tp -72.8 -38.77 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.899 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.33 -52.61 64.54 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.926 0.89 . . . . 0.0 111.766 174.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -60.05 -28.45 67.79 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.8 t -58.04 -31.51 67.08 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.118 1.367 . . . . 0.0 113.413 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -73.75 -3.97 31.7 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.238 1.415 . . . . 0.0 114.31 173.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.11 11.46 63.07 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.214 1.388 . . . . 0.0 114.908 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.35 146.83 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 126.076 1.75 . . . . 0.0 110.57 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 p -79.87 162.45 25.01 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.868 1.667 . . . . 0.0 113.111 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.3 pp -72.11 123.04 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.371 1.468 . . . . 0.0 109.611 170.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -68.66 -41.47 79.26 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.915 1.286 . . . . 0.0 111.173 170.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.9 p -156.98 158.17 36.1 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.17 1.788 . . . . 0.0 112.362 174.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -72.69 149.78 43.51 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.099 1.36 . . . . 0.0 110.653 171.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.32 158.46 20.77 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.922 1.249 . . . . 0.0 112.057 -174.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.3 t -59.87 145.02 47.2 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.739 -0.86 . . . . 0.0 110.912 167.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.2 p -93.6 155.41 40.66 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -70.11 143.73 50.05 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.527 2.818 . . . . 0.0 111.92 177.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.04 5.87 9.05 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.957 1.703 . . . . 0.0 113.956 -177.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.99 20.77 17.49 Favored Glycine 0 CA--C 1.54 1.616 0 C-N-CA 125.387 1.47 . . . . 0.0 114.224 -173.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.9 pt . . . . . 0 C--O 1.252 1.23 0 C-N-CA 127.19 2.196 . . . . 0.0 114.279 178.929 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.39 153.68 42.2 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.425 1.49 . . . . 0.0 112.273 173.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.4 t -85.12 129.11 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.283 1.433 . . . . 0.0 110.396 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 84.1 m -73.67 -32.55 64.03 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.222 1.009 . . . . 0.0 113.603 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.56 94.0 2.68 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.174 1.789 . . . . 0.0 110.77 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 16.6 m -60.14 155.86 42.38 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 125.045 1.338 . . . . 0.0 112.847 176.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -73.85 171.78 17.19 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.819 3.013 . . . . 0.0 111.449 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.75 17.8 10.27 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.877 1.671 . . . . 0.0 113.978 -173.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.9 mt -63.84 141.56 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.505 1.522 . . . . 0.0 109.814 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.4 mt -79.59 70.47 6.07 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.732 1.213 . . . . 0.0 110.584 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -134.9 72.16 68.65 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 124.941 1.296 . . . . 0.0 109.866 172.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.17 164.03 33.79 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.109 1.873 . . . . 0.0 111.745 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.7 m -144.48 140.69 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.884 1.673 . . . . 0.0 110.58 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 t -79.14 114.78 18.35 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.85 163.09 45.44 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 121.546 -0.721 . . . . 0.0 113.159 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.1 m -68.11 -11.91 59.92 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -77.23 -10.52 59.47 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.929 1.692 . . . . 0.0 114.192 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.05 13.98 35.07 Favored Glycine 0 CA--C 1.539 1.541 0 N-CA-C 115.894 1.118 . . . . 0.0 115.894 175.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -137.05 168.24 19.97 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.317 1.847 . . . . 0.0 110.944 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.0 t -105.47 150.31 25.42 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.61 1.164 . . . . 0.0 111.699 175.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -124.19 170.28 10.89 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.233 1.813 . . . . 0.0 110.39 173.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.04 -35.17 77.8 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -167.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -163.16 168.04 21.32 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.474 1.51 . . . . 0.0 112.077 175.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.2 m -60.13 -32.11 70.7 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -167.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.7 t -61.22 -43.94 98.07 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.905 1.682 . . . . 0.0 113.514 176.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.9 tp -72.44 -39.59 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.747 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.48 -28.64 69.97 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.451 1.1 . . . . 0.0 113.418 176.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -88.04 -30.13 20.16 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.141 1.376 . . . . 0.0 114.377 173.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 37.5 t -55.09 -39.82 69.73 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.99 1.316 . . . . 0.0 113.13 -174.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -70.26 -11.34 60.83 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 126.076 1.75 . . . . 0.0 115.164 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.91 -8.29 42.45 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 126.488 1.994 . . . . 0.0 116.247 175.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.5 t -93.58 168.99 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 125.507 1.523 . . . . 0.0 110.654 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.6 p -112.24 155.9 23.27 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 127.477 2.311 . . . . 0.0 112.37 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -67.64 123.17 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.623 1.569 . . . . 0.0 110.075 176.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -77.34 -42.23 37.4 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.507 1.123 . . . . 0.0 110.832 172.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.0 p -153.75 157.93 40.2 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.461 1.504 . . . . 0.0 112.508 174.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -82.74 149.25 27.38 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.721 1.208 . . . . 0.0 111.269 177.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.81 162.04 24.34 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.54 1.066 . . . . 0.0 111.676 -169.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.1 t -60.33 148.27 37.59 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 122.125 -0.633 . . . . 0.0 110.942 167.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.2 p -98.48 157.47 34.28 Favored Pre-proline 0 CA--C 1.541 0.63 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -72.62 162.44 41.3 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.828 3.019 . . . . 0.0 112.038 173.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.9 p -133.36 80.13 1.86 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.604 1.562 . . . . 0.0 111.38 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.69 -18.38 6.1 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 125.14 1.352 . . . . 0.0 115.442 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.213 0 C-N-CA 126.69 1.996 . . . . 0.0 110.608 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 21.2 tptp . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 120.518 0.199 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -130.03 -18.59 3.33 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -172.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.9 m -71.94 -20.7 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.942 1.297 . . . . 0.0 113.895 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.4 p -67.85 137.76 55.56 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.441 1.096 . . . . 0.0 111.951 174.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.18 87.61 2.67 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.197 1.399 . . . . 0.0 110.333 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 18.6 m -60.15 154.95 48.29 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.856 1.263 . . . . 0.0 111.916 173.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.48 147.26 31.97 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.354 2.702 . . . . 0.0 111.664 -176.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.61 3.63 55.2 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.263 1.825 . . . . 0.0 114.645 177.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.2 mt -65.06 140.6 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.207 1.403 . . . . 0.0 109.995 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tt -80.75 74.2 7.7 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.981 1.712 . . . . 0.0 109.357 175.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.23 69.73 77.87 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 124.424 1.09 . . . . 0.0 110.474 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.29 167.28 18.85 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.835 2.356 . . . . 0.0 112.5 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.6 m -144.84 153.18 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 126.006 1.722 . . . . 0.0 110.358 -173.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.5 t -98.53 113.62 25.72 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.181 0.992 . . . . 0.0 108.766 171.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.63 159.16 53.53 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 118.773 0.715 . . . . 0.0 113.296 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.3 t -59.83 -24.09 63.89 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -67.57 -13.7 62.29 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 125.227 1.411 . . . . 0.0 114.017 171.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.97 -3.29 64.62 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 126.439 1.971 . . . . 0.0 114.697 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -84.11 164.64 19.08 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.941 1.696 . . . . 0.0 111.937 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.6 m -114.76 138.68 50.44 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.997 1.319 . . . . 0.0 110.508 171.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -124.92 166.87 15.53 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.981 1.712 . . . . 0.0 110.624 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.48 -24.23 61.96 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -167.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -164.18 179.28 6.99 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.158 2.183 . . . . 0.0 110.629 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.5 p -65.24 -42.47 93.32 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.8 t -57.17 -41.52 79.38 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.522 1.929 . . . . 0.0 113.972 -176.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.6 tt -70.59 -48.38 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.948 1.299 . . . . 0.0 111.966 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.54 -52.94 42.86 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.183 0.993 . . . . 0.0 112.051 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -62.75 -27.64 69.42 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 178.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.9 t -61.93 -31.69 72.03 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.562 1.145 . . . . 0.0 112.786 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -73.84 -4.16 33.15 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.625 1.57 . . . . 0.0 114.178 171.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.82 -7.02 83.09 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 126.207 1.861 . . . . 0.0 115.072 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.7 m -93.31 146.0 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 126.341 1.857 . . . . 0.0 111.581 176.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.2 p -84.99 160.95 19.95 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.074 1.35 . . . . 0.0 112.0 171.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.4 pt -73.24 128.02 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.48 1.112 . . . . 0.0 110.031 172.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -77.54 -39.48 45.84 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.058 0.943 . . . . 0.0 111.494 169.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.4 t -154.76 170.59 21.25 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.474 1.109 . . . . 0.0 113.071 173.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -85.06 151.57 24.06 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.433 2.293 . . . . 0.0 112.684 174.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.29 162.5 10.65 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.475 1.512 . . . . 0.0 112.286 -170.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.7 m -59.39 130.0 44.75 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.85 -0.794 . . . . 0.0 109.588 163.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.75 153.15 89.32 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -175.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -65.56 122.43 10.08 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.597 2.865 . . . . 0.0 110.755 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.9 m 55.1 28.58 11.12 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.531 1.533 . . . . 0.0 112.85 -172.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.89 -11.56 69.85 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 125.497 1.522 . . . . 0.0 115.733 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.2 mm . . . . . 0 C--O 1.254 1.315 0 C-N-CA 126.404 1.882 . . . . 0.0 110.44 173.397 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.34 -5.37 12.93 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 125.44 1.496 . . . . 0.0 114.446 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 t -78.09 138.89 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.211 1.404 . . . . 0.0 110.658 176.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 80.4 m -108.19 -37.51 6.01 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.758 1.223 . . . . 0.0 113.6 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.3 130.18 41.32 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.402 1.081 . . . . 0.0 111.849 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.0 m -63.06 152.92 82.87 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.772 0.829 . . . . 0.0 112.547 173.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.56 167.87 26.13 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.691 2.927 . . . . 0.0 112.027 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.69 8.24 13.73 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.345 2.258 . . . . 0.0 114.008 -173.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.9 mt -68.8 140.74 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.3 1.44 . . . . 0.0 109.785 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tt -82.01 72.93 9.07 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.166 1.787 . . . . 0.0 110.584 -176.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -134.73 68.67 71.82 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 125.554 1.541 . . . . 0.0 111.406 -175.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.27 162.2 43.26 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.0 2.466 . . . . 0.0 112.914 -175.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.8 m -144.85 163.73 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 127.045 2.138 . . . . 0.0 111.244 -172.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.2 t -94.41 122.46 37.0 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.523 0.729 . . . . 0.0 110.39 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.46 161.39 53.56 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.079 0.847 . . . . 0.0 113.61 172.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.0 t -61.73 -27.48 68.75 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.239 1.016 . . . . 0.0 113.567 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -82.86 -5.92 59.21 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.311 1.844 . . . . 0.0 114.488 174.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.17 2.04 66.47 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.556 1.55 . . . . 0.0 115.956 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -73.38 166.03 23.95 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 119.814 1.807 . . . . 0.0 111.622 170.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.5 m -121.54 123.7 42.62 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.814 1.646 . . . . 0.0 109.203 172.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -113.21 170.58 8.11 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.763 1.625 . . . . 0.0 110.812 174.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.29 -31.85 71.58 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -168.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.09 170.32 19.39 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.634 1.574 . . . . 0.0 110.96 176.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.3 m -59.74 -40.8 89.33 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -172.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.9 t -55.89 -45.71 78.54 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.079 1.752 . . . . 0.0 113.203 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.2 tp -72.27 -36.25 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.183 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.04 -55.24 37.44 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.395 0.678 . . . . 0.0 111.299 169.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -63.91 -26.75 68.74 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.3 t -57.6 -34.62 69.45 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.585 1.154 . . . . 0.0 112.909 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -74.23 -4.35 35.48 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.699 1.6 . . . . 0.0 114.435 173.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.87 -11.28 72.55 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 126.39 1.947 . . . . 0.0 115.263 175.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 m -83.07 151.43 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.811 1.644 . . . . 0.0 111.495 173.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.7 t -80.55 176.02 10.15 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.937 0.875 . . . . 0.0 111.634 167.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 pp -101.2 119.95 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 128.307 2.643 . . . . 0.0 109.661 174.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -59.94 -44.8 94.14 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.542 0.737 . . . . 0.0 111.552 176.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.1 t -161.49 171.01 18.86 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.42 1.488 . . . . 0.0 112.129 170.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -72.83 152.85 41.33 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.258 1.823 . . . . 0.0 112.641 171.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.51 146.15 4.42 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.858 1.218 . . . . 0.0 112.248 -175.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 p -59.37 133.75 56.38 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.528 -0.983 . . . . 0.0 111.569 171.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -88.41 156.36 50.99 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -172.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.49 153.17 78.99 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.272 2.648 . . . . 0.0 110.758 170.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.1 m 63.54 1.18 0.97 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.853 1.661 . . . . 0.0 114.593 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.21 -12.9 34.93 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.49 1.519 . . . . 0.0 115.054 -177.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.7 pt . . . . . 0 C--O 1.253 1.241 0 C-N-CA 126.237 1.815 . . . . 0.0 113.309 175.429 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.3 mmtp -140.81 146.64 37.86 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.328 1.851 . . . . 0.0 111.418 177.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.9 t -93.25 -31.2 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.975 1.31 . . . . 0.0 111.814 174.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.4 t -145.9 159.79 42.73 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.004 1.722 . . . . 0.0 111.845 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.96 -26.85 54.45 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.632 1.173 . . . . 0.0 113.946 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 33.2 m -65.8 159.33 69.95 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.484 1.514 . . . . 0.0 113.401 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.59 140.06 23.48 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.054 2.502 . . . . 0.0 111.242 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -75.16 -1.98 25.65 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.8 mt -66.36 140.79 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.637 1.575 . . . . 0.0 109.724 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.1 mt -89.1 80.11 7.06 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.159 1.784 . . . . 0.0 110.085 175.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -127.66 68.56 74.61 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 124.003 0.921 . . . . 0.0 110.593 176.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.6 163.34 27.69 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.95 2.434 . . . . 0.0 112.453 -173.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.1 m -145.24 157.01 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.889 1.676 . . . . 0.0 110.7 -171.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.6 t -101.18 110.34 22.35 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.987 0.915 . . . . 0.0 109.424 170.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.74 158.21 52.17 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-N 118.981 0.81 . . . . 0.0 112.905 173.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.5 p -70.09 -9.19 54.68 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -64.32 -14.59 57.03 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.37 1.468 . . . . 0.0 113.45 163.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.17 19.58 45.71 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.324 1.44 . . . . 0.0 114.085 -177.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.9 ttm-85 -119.24 160.27 22.5 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.528 1.931 . . . . 0.0 111.682 -174.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.9 m -116.61 131.52 56.93 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.386 1.475 . . . . 0.0 110.683 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -125.23 169.97 11.73 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.621 1.568 . . . . 0.0 110.925 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.87 -21.6 61.63 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -165.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -161.01 -174.54 4.44 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.987 2.115 . . . . 0.0 109.815 174.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.7 p -72.64 -38.34 67.74 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.1 t -58.2 -41.81 84.78 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.777 1.631 . . . . 0.0 113.953 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 tp -72.1 -43.75 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.836 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.61 -49.49 76.25 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.288 1.035 . . . . 0.0 112.106 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -60.97 -25.45 66.85 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.0 t -59.27 -31.26 68.94 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.92 1.288 . . . . 0.0 113.146 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -74.73 -2.83 28.15 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.362 1.465 . . . . 0.0 114.211 172.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.61 15.08 62.32 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.089 1.328 . . . . 0.0 114.951 177.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 t -128.46 149.04 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.559 1.544 . . . . 0.0 110.856 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 p -87.81 162.8 16.78 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 126.53 1.932 . . . . 0.0 112.43 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.4 pt -73.47 126.54 34.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.708 1.203 . . . . 0.0 110.113 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -75.35 -40.53 58.09 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.641 1.177 . . . . 0.0 111.032 169.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.7 p -150.33 161.4 42.54 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.585 1.554 . . . . 0.0 112.751 171.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.17 153.49 25.97 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.286 1.434 . . . . 0.0 111.034 170.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.41 160.17 12.2 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.172 1.368 . . . . 0.0 112.073 -169.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.2 m -59.51 130.61 47.74 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.729 -0.865 . . . . 0.0 109.981 165.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -71.73 153.78 93.19 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -176.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -71.43 140.14 36.01 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.568 2.846 . . . . 0.0 112.004 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -5.49 49.27 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.932 1.693 . . . . 0.0 114.993 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.03 -36.82 50.94 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.877 1.227 . . . . 0.0 115.563 -171.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.4 mp . . . . . 0 C--O 1.253 1.263 0 C-N-CA 126.436 1.895 . . . . 0.0 110.014 -178.692 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? . . . . . 0 N--CA 1.493 1.718 0 N-CA-C 110.48 -0.192 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -83.49 -34.25 25.39 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.5 m -61.77 142.74 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.756 1.222 . . . . 0.0 112.235 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.7 p -144.69 -39.72 0.26 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.879 1.271 . . . . 0.0 113.362 -177.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.03 87.19 0.74 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.094 1.357 . . . . 0.0 111.706 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.8 m -62.29 153.8 73.97 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 125.577 1.551 . . . . 0.0 112.693 176.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.21 166.93 27.93 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.403 2.735 . . . . 0.0 111.265 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -109.86 10.79 24.43 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.35 1.46 . . . . 0.0 114.36 -173.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.7 mt -58.66 139.16 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.27 1.428 . . . . 0.0 110.217 -176.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.1 mt -80.94 71.9 7.93 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.461 1.505 . . . . 0.0 110.055 172.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -135.62 71.21 65.41 Favored Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 124.718 1.207 . . . . 0.0 109.136 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -68.83 159.07 55.32 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.141 1.894 . . . . 0.0 111.599 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 m -144.85 146.93 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.1 1.36 . . . . 0.0 111.52 -169.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.9 t -89.65 115.24 26.89 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.752 1.221 . . . . 0.0 110.583 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.59 164.61 50.82 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 121.78 -0.575 . . . . 0.0 113.905 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.2 m -62.27 -20.08 63.9 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.56 -8.82 57.58 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.407 1.483 . . . . 0.0 113.571 171.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.36 -2.64 85.16 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.949 1.737 . . . . 0.0 114.929 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -86.18 165.07 16.84 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.019 1.328 . . . . 0.0 111.884 172.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 65.2 m -115.13 138.37 50.97 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.13 1.372 . . . . 0.0 110.455 175.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -121.63 164.32 17.51 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.42 1.888 . . . . 0.0 110.08 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.18 -26.94 67.64 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -168.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -167.12 172.51 9.96 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.382 1.873 . . . . 0.0 111.031 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 t -60.21 -43.57 95.86 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -176.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.4 t -57.8 -44.19 86.16 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.654 1.582 . . . . 0.0 113.41 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.4 tp -70.41 -38.41 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.05 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.08 -55.12 39.04 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.417 1.087 . . . . 0.0 111.279 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -60.1 -37.96 81.53 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.606 0.762 . . . . 0.0 112.865 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 23.6 t -65.16 -38.68 91.34 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.097 0.959 . . . . 0.0 112.817 174.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.12 -21.85 66.46 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.225 1.41 . . . . 0.0 113.866 173.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.34 8.8 18.82 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.088 1.328 . . . . 0.0 115.618 174.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.84 149.05 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 119.301 1.55 . . . . 0.0 110.937 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.57 151.1 29.28 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.225 1.41 . . . . 0.0 111.394 172.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.13 126.75 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 126.849 2.06 . . . . 0.0 107.985 165.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -85.47 -48.21 9.19 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.18 0.592 . . . . 0.0 111.337 162.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.5 m -138.53 156.58 47.37 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.022 1.329 . . . . 0.0 112.501 -176.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -82.62 155.05 24.63 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.855 1.262 . . . . 0.0 112.483 172.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.25 159.42 13.14 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.042 1.306 . . . . 0.0 112.012 -172.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 m -60.18 128.02 34.69 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 121.956 -0.732 . . . . 0.0 109.673 164.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.99 157.4 89.85 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -175.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.7 166.55 28.38 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.596 2.864 . . . . 0.0 112.116 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.67 1.88 32.47 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.746 1.218 . . . . 0.0 113.069 -173.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.53 56.39 0.56 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.606 1.574 . . . . 0.0 113.682 -173.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.4 mp . . . . . 0 C--O 1.254 1.312 0 C-N-CA 125.798 1.639 . . . . 0.0 110.696 172.628 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 61.1 mttp . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 120.196 0.046 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -104.09 57.86 0.72 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.397 1.879 . . . . 0.0 111.427 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.0 t -67.21 127.48 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.899 0.88 . . . . 0.0 111.091 -176.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 78.7 m -102.37 -22.49 14.09 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.931 1.292 . . . . 0.0 113.719 177.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.3 94.91 2.46 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.618 1.567 . . . . 0.0 111.186 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.6 m -62.6 155.82 67.02 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.722 1.209 . . . . 0.0 112.209 171.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -73.38 142.24 33.08 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.217 2.611 . . . . 0.0 110.986 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -78.45 6.4 8.58 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.998 1.719 . . . . 0.0 114.877 176.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.3 tt -58.47 143.4 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 126.117 1.767 . . . . 0.0 112.723 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 tt -92.85 70.11 4.69 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.047 1.339 . . . . 0.0 109.643 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -135.4 72.6 64.81 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 125.603 1.561 . . . . 0.0 110.358 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.65 166.21 26.77 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.565 2.177 . . . . 0.0 112.24 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.8 m -141.26 156.27 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.356 1.863 . . . . 0.0 110.515 -176.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.2 t -90.13 113.87 25.71 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 164.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.32 160.05 47.37 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 121.454 -0.779 . . . . 0.0 113.263 176.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.7 t -62.11 -22.65 65.99 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.563 1.145 . . . . 0.0 113.603 -178.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -68.87 -13.15 62.24 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.434 1.494 . . . . 0.0 114.239 172.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.0 9.84 65.29 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.079 1.324 . . . . 0.0 114.53 -175.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -103.45 163.26 12.4 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.316 1.846 . . . . 0.0 111.409 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.5 m -115.29 129.02 56.5 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.19 1.796 . . . . 0.0 109.747 175.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -120.31 169.57 10.15 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.95 1.7 . . . . 0.0 110.72 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.77 -28.44 65.77 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -171.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.5 172.19 17.66 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.537 1.535 . . . . 0.0 111.093 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.9 p -63.04 -40.27 97.23 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.5 t -56.89 -46.88 81.6 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.23 1.812 . . . . 0.0 113.439 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.2 tp -70.68 -36.82 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.841 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.79 -55.42 35.15 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.694 0.798 . . . . 0.0 111.605 170.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -60.69 -28.6 68.75 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.158 1.169 . . . . 0.0 114.158 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.6 m -63.25 -20.36 65.38 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 174.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -84.91 -6.42 59.34 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.756 1.222 . . . . 0.0 113.787 167.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.43 -10.84 63.26 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 126.705 2.098 . . . . 0.0 115.157 177.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.0 m -99.02 142.56 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 126.39 1.876 . . . . 0.0 111.771 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.6 t -91.31 169.18 11.03 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.307 1.051 . . . . 0.0 112.584 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -72.16 132.04 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 127.58 2.352 . . . . 0.0 110.246 176.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -91.35 -36.6 13.74 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.049 1.34 . . . . 0.0 112.209 173.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.5 p -157.09 160.56 39.0 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.219 1.407 . . . . 0.0 112.75 171.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -73.35 146.91 44.87 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.065 1.346 . . . . 0.0 112.454 172.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.98 153.01 6.05 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.165 1.364 . . . . 0.0 111.871 -172.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.1 p -59.32 142.88 50.97 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.731 -0.864 . . . . 0.0 112.036 169.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.2 p -92.05 155.07 43.33 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.83 144.61 43.92 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.795 2.997 . . . . 0.0 111.757 175.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.2 t -80.75 -15.27 56.91 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.74 -16.53 1.8 Allowed Glycine 0 CA--C 1.538 1.481 0 C-N-CA 126.663 2.078 . . . . 0.0 115.021 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.2 mt . . . . . 0 C--O 1.252 1.221 0 C-N-CA 127.15 2.18 . . . . 0.0 109.615 176.032 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 48.8 tptt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -142.4 131.36 23.04 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.632 1.573 . . . . 0.0 110.611 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.0 m -67.26 143.73 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.787 1.235 . . . . 0.0 112.539 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.6 m -138.93 -62.48 0.55 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.462 1.505 . . . . 0.0 111.039 177.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.25 112.92 5.44 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.882 1.273 . . . . 0.0 111.785 174.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.5 m -62.39 156.28 62.43 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.79 1.236 . . . . 0.0 112.31 170.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -72.91 144.34 38.34 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 123.368 2.712 . . . . 0.0 111.767 -175.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -75.39 5.96 5.12 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.293 1.837 . . . . 0.0 115.18 175.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.8 tt -61.8 149.91 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.987 1.715 . . . . 0.0 112.829 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 tt -102.81 75.0 1.37 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.167 1.787 . . . . 0.0 109.512 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -142.69 73.88 19.38 Favored Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 124.791 1.236 . . . . 0.0 110.593 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.77 167.29 17.8 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.056 2.504 . . . . 0.0 112.743 -176.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.9 m -141.93 158.97 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.839 1.655 . . . . 0.0 110.789 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.9 t -99.81 118.3 35.98 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.928 0.891 . . . . 0.0 109.116 166.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.17 163.57 54.55 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 118.963 0.801 . . . . 0.0 113.268 172.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.5 t -63.43 -20.95 66.0 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -67.35 -14.29 62.78 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.37 1.468 . . . . 0.0 113.784 169.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.55 1.49 71.31 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 126.028 1.775 . . . . 0.0 114.666 -178.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -87.03 160.74 18.51 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.043 1.737 . . . . 0.0 111.591 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 91.1 m -109.79 136.37 49.23 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.303 1.441 . . . . 0.0 110.517 175.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -126.75 168.44 14.39 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.48 1.512 . . . . 0.0 111.603 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.46 -23.79 61.89 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -166.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -162.18 -179.64 7.21 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.218 1.807 . . . . 0.0 111.239 171.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 61.0 p -63.89 -40.96 97.73 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 175.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.2 t -59.18 -44.34 92.17 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.077 1.751 . . . . 0.0 113.57 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.4 tp -70.33 -42.93 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.054 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.88 -52.98 62.17 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.975 0.91 . . . . 0.0 111.522 177.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -60.12 -27.89 67.41 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.0 t -58.55 -29.69 66.55 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.775 1.23 . . . . 0.0 113.064 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -70.47 -12.63 61.7 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.651 1.58 . . . . 0.0 114.387 174.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.53 -0.39 77.36 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.878 1.704 . . . . 0.0 114.998 -175.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -104.33 149.54 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.759 1.624 . . . . 0.0 109.89 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.85 160.17 20.23 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.775 1.63 . . . . 0.0 112.209 174.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.6 pt -71.84 129.05 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 124.284 1.034 . . . . 0.0 110.13 170.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -73.69 -38.29 64.93 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.907 1.283 . . . . 0.0 111.227 170.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.0 p -158.59 163.79 36.66 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.009 1.724 . . . . 0.0 112.359 168.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.47 154.94 34.27 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.569 1.548 . . . . 0.0 112.007 166.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.41 158.61 9.96 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 125.404 1.478 . . . . 0.0 112.022 -168.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.0 t -62.17 146.71 49.89 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.657 -0.907 . . . . 0.0 110.743 166.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -92.27 156.35 41.87 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -177.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.13 130.62 20.45 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.575 2.85 . . . . 0.0 111.751 177.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.8 m -71.09 -15.86 62.54 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.706 1.202 . . . . 0.0 113.521 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 160.1 -34.11 0.43 Allowed Glycine 0 CA--C 1.535 1.315 0 C-N-CA 126.607 2.051 . . . . 0.0 113.738 174.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 tt . . . . . 0 C--O 1.254 1.311 0 C-N-CA 127.149 2.18 . . . . 0.0 111.917 174.103 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 64.6 mttm . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -152.31 176.26 11.8 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.826 1.65 . . . . 0.0 112.468 178.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.2 m -59.01 101.48 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.907 2.083 . . . . 0.0 112.474 176.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 88.6 m -135.16 153.17 52.07 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.707 1.603 . . . . 0.0 111.448 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.66 94.25 6.26 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.11 1.364 . . . . 0.0 110.148 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 35.5 m -59.65 153.66 50.34 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 124.419 1.087 . . . . 0.0 112.304 175.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.67 159.14 53.72 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.588 2.859 . . . . 0.0 111.884 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -113.35 4.01 16.16 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.554 1.542 . . . . 0.0 114.024 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.2 mp -69.75 146.19 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.425 1.09 . . . . 0.0 109.914 175.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.7 tt -77.84 74.3 4.4 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.837 2.055 . . . . 0.0 109.672 176.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.4 mmmt -129.39 63.56 68.07 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 125.63 1.572 . . . . 0.0 111.851 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.65 166.22 28.19 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.27 2.647 . . . . 0.0 112.625 -176.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.0 m -146.98 143.02 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.348 1.859 . . . . 0.0 110.553 -172.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.7 t -79.77 111.64 16.28 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.72 153.84 39.02 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 119.233 0.924 . . . . 0.0 112.851 175.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 90.2 p -69.92 -9.8 56.29 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -69.86 -15.93 63.17 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.354 1.461 . . . . 0.0 113.779 169.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.42 15.65 22.56 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 124.675 1.131 . . . . 0.0 115.645 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 51.6 ttm-85 -136.08 168.08 20.04 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.237 1.815 . . . . 0.0 111.021 178.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.2 t -106.44 151.74 24.54 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.44 1.096 . . . . 0.0 111.697 172.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -121.36 175.74 6.0 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.569 1.947 . . . . 0.0 110.018 173.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.31 -25.74 61.69 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -171.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -160.66 -176.49 5.59 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.901 1.68 . . . . 0.0 111.487 174.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.4 p -72.77 -25.99 61.38 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 177.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.5 t -71.48 -43.78 65.95 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.698 1.599 . . . . 0.0 112.54 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.5 tp -68.75 -41.44 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.637 0.775 . . . . 0.0 111.12 176.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.54 -56.17 19.32 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.72 1.208 . . . . 0.0 111.844 173.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -61.71 -36.11 79.99 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 32.3 m -59.06 -33.76 71.16 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.428 0.691 . . . . 0.0 112.722 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -67.52 -9.92 46.89 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 173.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.82 10.38 72.64 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.762 1.172 . . . . 0.0 114.88 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 t -116.88 156.37 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.318 1.847 . . . . 0.0 109.085 176.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.2 t -107.42 167.63 9.8 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 122.515 1.15 . . . . 0.0 111.754 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.6 pt -77.49 123.81 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 126.009 1.723 . . . . 0.0 109.965 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.3 tttt -71.89 -40.76 68.65 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.168 0.987 . . . . 0.0 111.349 168.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.0 t -156.93 171.53 20.28 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.079 1.352 . . . . 0.0 112.871 172.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -75.54 148.16 39.14 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.014 2.126 . . . . 0.0 112.528 171.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.98 159.09 6.97 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.175 1.369 . . . . 0.0 112.594 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.7 m -58.69 138.66 56.89 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.748 0.819 . . . . 0.0 111.18 170.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.7 p -96.76 155.99 37.07 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -75.51 158.48 40.18 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 124.202 3.268 . . . . 0.0 112.077 173.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.14 -1.92 57.65 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.001 1.321 . . . . 0.0 113.27 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.68 9.91 53.63 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 126.338 1.923 . . . . 0.0 116.38 -172.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.203 0 C-N-CA 126.562 1.945 . . . . 0.0 112.203 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -133.85 -84.47 0.44 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 125.86 1.664 . . . . 0.0 111.34 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.8 p -70.14 -26.34 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.337 1.455 . . . . 0.0 113.492 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.8 t 64.51 -7.37 0.25 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 128.263 2.625 . . . . 0.0 115.961 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.98 120.33 21.25 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.683 1.993 . . . . 0.0 110.773 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.4 m -58.94 156.32 26.58 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 124.671 1.188 . . . . 0.0 112.317 173.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -74.64 168.37 24.97 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.57 2.847 . . . . 0.0 112.419 -175.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -114.19 8.7 16.95 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.18 2.192 . . . . 0.0 114.164 -177.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 26.6 mt -66.32 144.03 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.356 1.462 . . . . 0.0 109.854 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 tt -84.62 71.79 10.75 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.417 1.887 . . . . 0.0 110.001 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -135.03 67.13 69.41 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 125.135 1.374 . . . . 0.0 111.38 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.58 168.51 18.05 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.329 2.686 . . . . 0.0 112.792 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.3 m -145.82 162.63 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.444 1.898 . . . . 0.0 110.765 -174.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.0 t -102.81 121.84 43.31 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.957 0.903 . . . . 0.0 109.364 166.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.97 166.8 53.17 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 119.108 0.867 . . . . 0.0 112.951 174.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.0 m -65.32 -15.45 62.55 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -74.91 -6.61 50.11 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.451 1.1 . . . . 0.0 113.851 168.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.96 19.41 61.27 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.955 1.264 . . . . 0.0 114.56 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.46 153.8 24.53 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.384 1.874 . . . . 0.0 111.45 -174.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.8 m -102.9 117.96 35.77 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.956 1.702 . . . . 0.0 111.886 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -104.29 163.11 12.65 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 128.078 2.551 . . . . 0.0 110.949 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.78 -25.38 56.38 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -175.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -161.43 178.61 8.98 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.007 1.723 . . . . 0.0 111.432 173.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.9 m -63.96 -37.4 87.26 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 177.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.6 t -59.68 -45.18 92.85 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.872 1.669 . . . . 0.0 112.966 -177.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.8 tt -73.39 -40.1 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.566 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.06 -28.53 67.87 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 174.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -90.44 -27.29 19.37 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 174.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.3 t -55.26 -38.99 69.26 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.966 1.307 . . . . 0.0 113.044 -176.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -69.82 -10.66 59.26 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 126.17 1.788 . . . . 0.0 115.25 175.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.33 -8.2 52.31 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 126.377 1.941 . . . . 0.0 116.131 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 t -92.94 164.99 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 125.496 1.518 . . . . 0.0 110.203 177.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 p -98.16 165.89 11.67 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.806 2.042 . . . . 0.0 112.089 174.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 pt -75.67 128.35 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.182 0.993 . . . . 0.0 109.731 169.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -69.43 -44.15 71.91 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.46 1.104 . . . . 0.0 110.784 168.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.0 t -156.49 170.71 21.72 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.067 1.347 . . . . 0.0 112.072 170.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -77.4 153.03 34.06 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.46 1.904 . . . . 0.0 111.528 173.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.89 152.67 5.77 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.372 1.463 . . . . 0.0 112.45 -173.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 p -58.03 139.72 53.96 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.836 0.855 . . . . 0.0 111.675 167.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -90.86 155.63 45.14 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -175.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.82 143.27 50.05 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.687 2.925 . . . . 0.0 111.312 174.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.9 t -165.7 119.07 1.16 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.592 1.557 . . . . 0.0 110.321 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 158.18 -69.78 0.26 Allowed Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.67 1.605 . . . . 0.0 113.082 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 77.4 mt . . . . . 0 C--O 1.254 1.334 0 C-N-CA 126.306 1.843 . . . . 0.0 110.854 177.747 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 44.0 tptt . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.103 0.478 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -96.09 101.59 13.27 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.622 1.569 . . . . 0.0 110.473 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.5 p -62.58 142.88 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.801 0.841 . . . . 0.0 112.145 178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 81.7 m -114.92 -28.41 7.05 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.873 1.269 . . . . 0.0 113.768 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.93 99.06 2.93 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.543 1.537 . . . . 0.0 110.962 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.9 m -63.77 156.26 73.27 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 124.379 1.072 . . . . 0.0 112.716 173.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -81.77 173.67 11.03 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.492 2.795 . . . . 0.0 113.068 -173.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -124.09 15.04 9.16 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.324 1.85 . . . . 0.0 114.152 -171.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.3 pp -61.43 174.03 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 125.714 1.605 . . . . 0.0 112.575 165.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.4 mt -110.7 85.96 2.22 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.17 1.388 . . . . 0.0 109.489 171.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.09 69.9 41.54 Favored Pre-proline 0 N--CA 1.473 0.693 0 C-N-CA 123.989 0.916 . . . . 0.0 110.756 174.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.15 171.99 11.72 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.745 2.297 . . . . 0.0 112.376 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.7 m -141.59 163.58 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.228 1.811 . . . . 0.0 111.455 -173.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.5 t -104.25 115.45 30.41 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.001 0.92 . . . . 0.0 109.213 166.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.41 162.2 54.0 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 123.891 0.757 . . . . 0.0 114.14 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.9 t -59.11 -28.63 66.7 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.567 1.147 . . . . 0.0 114.036 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -79.64 -1.14 36.83 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 125.97 1.708 . . . . 0.0 113.861 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.62 5.63 86.47 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.172 1.367 . . . . 0.0 113.983 -171.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.59 163.86 15.37 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.637 1.975 . . . . 0.0 112.344 176.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 27.4 m -135.57 113.01 10.67 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.447 1.499 . . . . 0.0 109.659 170.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -105.55 157.26 17.51 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.7 1.2 . . . . 0.0 111.131 173.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.57 -36.03 73.29 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.386 1.474 . . . . 0.0 113.893 -176.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.59 171.62 16.82 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.43 0.692 . . . . 0.0 111.448 171.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.8 m -60.87 -40.71 94.02 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.9 t -53.57 -41.95 67.05 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.674 1.99 . . . . 0.0 112.89 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 44.9 mm -70.99 -46.87 65.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 114.191 -1.368 . . . . 0.0 111.09 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.05 -53.63 47.4 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 173.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -61.26 -37.52 83.41 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 177.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.9 t -61.71 -39.0 89.96 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.041 0.936 . . . . 0.0 112.343 176.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -72.53 -2.46 19.83 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.812 1.645 . . . . 0.0 114.376 172.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.03 4.93 64.48 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.03 1.3 . . . . 0.0 115.777 169.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 m -119.48 135.85 58.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 126.382 1.873 . . . . 0.0 111.271 -177.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -75.41 154.93 36.86 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.605 1.162 . . . . 0.0 112.231 176.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 pt -78.58 125.49 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.861 1.264 . . . . 0.0 109.557 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -78.67 -36.42 43.79 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.386 1.075 . . . . 0.0 111.829 172.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.8 t -153.83 168.84 24.97 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.672 1.189 . . . . 0.0 112.461 169.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -85.06 146.49 27.14 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.584 2.354 . . . . 0.0 110.807 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.64 149.22 5.2 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.67 1.128 . . . . 0.0 111.767 -170.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.0 p -59.1 135.57 57.68 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.569 -0.959 . . . . 0.0 111.287 168.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -82.23 155.87 69.32 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -177.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.39 154.61 60.85 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.536 2.824 . . . . 0.0 111.386 172.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.24 -1.95 32.19 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.882 1.273 . . . . 0.0 114.345 -176.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.6 16.91 78.55 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.02 1.295 . . . . 0.0 114.64 -176.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.7 tt . . . . . 0 C--O 1.253 1.26 0 C-N-CA 127.058 2.143 . . . . 0.0 113.759 179.922 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.428 0.156 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -76.56 70.43 3.09 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.467 1.907 . . . . 0.0 111.581 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.1 m -60.81 152.06 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.002 1.321 . . . . 0.0 112.258 175.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 52.4 t -133.73 -77.56 0.47 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.927 1.291 . . . . 0.0 110.695 -178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.48 82.97 4.71 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.112 0.965 . . . . 0.0 111.164 171.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.6 m -62.63 156.34 64.41 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 124.894 1.278 . . . . 0.0 111.899 172.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.34 160.24 35.87 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.535 2.823 . . . . 0.0 112.317 -172.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.85 4.09 13.86 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.194 1.797 . . . . 0.0 115.582 -172.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pp -71.59 168.81 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 126.897 2.079 . . . . 0.0 112.894 173.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.6 mt -96.33 89.93 5.26 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.426 1.49 . . . . 0.0 109.915 169.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -139.42 69.3 39.48 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 123.475 0.71 . . . . 0.0 110.976 169.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.45 167.16 17.48 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.046 2.497 . . . . 0.0 112.506 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.4 m -144.88 155.89 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.766 1.626 . . . . 0.0 110.678 -174.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.5 t -102.05 117.88 35.72 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.055 0.942 . . . . 0.0 109.666 172.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.55 165.99 53.12 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 121.51 -0.744 . . . . 0.0 113.659 175.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.7 p -61.63 -21.39 64.35 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -70.11 -12.77 61.84 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.559 1.543 . . . . 0.0 113.681 171.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.37 -0.85 75.47 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.935 1.731 . . . . 0.0 115.112 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -90.43 160.54 15.99 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.331 1.452 . . . . 0.0 111.512 176.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 40.4 m -109.26 131.65 54.87 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.279 1.431 . . . . 0.0 110.513 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -113.3 167.95 10.14 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.793 1.637 . . . . 0.0 110.481 173.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.73 -26.42 62.46 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -167.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -161.25 177.63 10.02 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.949 2.099 . . . . 0.0 110.681 174.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.8 p -62.17 -43.1 99.58 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 t -56.69 -37.98 71.62 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.471 1.908 . . . . 0.0 114.554 -176.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 tt -73.18 -52.75 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.844 0.858 . . . . 0.0 111.528 172.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.79 -56.05 6.87 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.799 1.24 . . . . 0.0 112.305 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.13 -27.69 69.25 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.205 1.802 . . . . 0.0 115.385 177.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 9.5 t -59.78 -33.29 71.52 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.361 1.064 . . . . 0.0 112.79 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -67.33 -17.83 64.92 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.171 1.389 . . . . 0.0 113.917 173.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.47 -9.95 57.6 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 126.594 2.045 . . . . 0.0 115.242 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.6 m -86.55 149.87 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 119.164 1.482 . . . . 0.0 111.516 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.01 156.18 20.55 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.921 1.289 . . . . 0.0 111.607 170.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.9 pt -71.2 129.02 35.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.195 0.998 . . . . 0.0 110.018 171.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.4 tptp -78.49 -35.32 46.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.449 1.099 . . . . 0.0 111.28 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.0 p -156.36 162.48 40.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.879 1.672 . . . . 0.0 112.503 172.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -84.84 157.2 21.0 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.119 0.968 . . . . 0.0 112.418 169.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.14 161.74 11.69 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.15 1.357 . . . . 0.0 111.975 -166.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.1 m -59.02 131.74 51.96 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.95 -0.735 . . . . 0.0 109.765 164.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -71.66 154.54 93.05 Favored Pre-proline 0 CA--C 1.545 0.774 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -177.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.78 155.08 58.77 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.377 2.718 . . . . 0.0 112.007 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.41 7.41 45.62 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.122 1.369 . . . . 0.0 113.2 -173.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.16 30.99 26.78 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.813 1.196 . . . . 0.0 114.021 -177.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.7 mt . . . . . 0 C--O 1.253 1.253 0 C-N-CA 127.173 2.189 . . . . 0.0 110.581 -176.455 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.65 115.1 14.24 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 120.503 1.502 . . . . 0.0 111.518 -178.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.7 m -66.3 132.35 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.029 1.331 . . . . 0.0 111.872 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 82.0 m -74.14 159.8 32.09 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.854 0.862 . . . . 0.0 112.219 175.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.12 91.08 4.37 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.932 1.293 . . . . 0.0 110.829 174.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 14.3 m -61.15 154.78 59.83 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.898 1.279 . . . . 0.0 112.393 173.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -77.97 166.96 24.33 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.238 2.625 . . . . 0.0 111.966 -176.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -119.74 15.33 12.68 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.763 2.025 . . . . 0.0 114.538 -170.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -60.64 170.29 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 126.736 2.014 . . . . 0.0 113.73 170.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.0 mt -104.83 80.1 1.6 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.565 1.546 . . . . 0.0 110.221 172.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.6 mmtt -138.92 66.24 39.46 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 125.132 1.373 . . . . 0.0 110.796 173.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.82 163.16 31.77 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.86 2.373 . . . . 0.0 111.944 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.0 m -146.51 160.75 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.561 1.544 . . . . 0.0 111.48 -170.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.5 t -96.28 116.88 29.72 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.012 1.325 . . . . 0.0 110.486 172.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.26 165.48 54.8 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 121.407 -0.808 . . . . 0.0 113.368 172.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.8 t -61.95 -26.93 68.49 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.35 1.06 . . . . 0.0 113.164 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -69.02 -8.01 40.96 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.603 1.961 . . . . 0.0 114.912 169.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.37 2.12 90.55 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.813 1.673 . . . . 0.0 115.3 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.2 mmt-85 -84.92 163.23 19.1 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.435 1.618 . . . . 0.0 111.615 173.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.3 m -118.42 117.59 29.45 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.589 1.555 . . . . 0.0 109.893 173.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -103.72 176.51 5.13 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.138 1.375 . . . . 0.0 110.298 170.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.87 -24.66 64.36 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -169.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.54 176.56 10.29 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.534 1.534 . . . . 0.0 110.869 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.7 p -62.24 -45.41 93.47 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 174.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.2 t -56.85 -44.26 81.97 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.404 1.882 . . . . 0.0 114.08 -177.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.44 -44.38 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.745 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.26 -49.56 77.38 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.022 0.929 . . . . 0.0 111.756 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -61.95 -28.65 69.69 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 174.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.9 t -61.29 -34.83 75.85 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.091 0.956 . . . . 0.0 112.844 176.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -72.47 -8.72 56.56 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.33 1.452 . . . . 0.0 114.144 170.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.93 -12.09 64.12 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.579 2.038 . . . . 0.0 115.335 174.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.6 m -79.97 141.18 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.266 1.426 . . . . 0.0 111.863 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.6 t -78.06 173.72 11.89 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.762 0.791 . . . . 0.0 112.036 171.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.0 mm -99.2 112.8 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 126.085 1.754 . . . . 0.0 110.196 -175.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -66.06 -38.6 88.73 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.533 0.733 . . . . 0.0 111.377 172.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.9 p -168.17 156.88 9.02 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.037 0.935 . . . . 0.0 112.949 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -82.11 153.87 25.85 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 122.304 1.05 . . . . 0.0 111.545 172.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.82 153.71 8.54 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.911 1.72 . . . . 0.0 111.618 -168.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.8 m -56.05 128.2 34.21 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.74 -0.859 . . . . 0.0 110.078 167.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -72.49 154.32 91.7 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -176.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.63 131.05 20.6 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.649 2.899 . . . . 0.0 112.026 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.65 -0.98 28.85 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.137 1.375 . . . . 0.0 113.39 -174.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.93 -18.88 71.45 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 124.8 1.19 . . . . 0.0 115.306 -176.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.4 mm . . . . . 0 C--O 1.253 1.25 0 C-N-CA 126.167 1.787 . . . . 0.0 110.685 174.741 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 20.8 tptp . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 110.631 -0.137 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -90.95 73.07 6.48 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.163 1.385 . . . . 0.0 111.912 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.6 m -75.65 -22.06 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.455 1.502 . . . . 0.0 113.635 170.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 71.8 m -71.99 177.67 4.2 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.379 1.072 . . . . 0.0 112.132 172.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 59.83 26.31 15.48 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.666 1.587 . . . . 0.0 115.254 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 27.2 m -52.4 151.21 7.72 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 125.625 1.57 . . . . 0.0 112.262 167.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.57 141.75 35.13 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.024 2.483 . . . . 0.0 111.441 -175.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -77.61 8.14 4.75 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.978 1.711 . . . . 0.0 114.868 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.4 tt -58.36 143.73 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 125.974 1.71 . . . . 0.0 112.702 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.5 tt -91.98 72.07 5.57 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.141 1.376 . . . . 0.0 109.573 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -138.24 72.45 45.51 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 125.415 1.486 . . . . 0.0 110.559 177.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -67.52 165.97 25.45 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.473 2.115 . . . . 0.0 112.037 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.7 m -141.35 156.68 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 126.238 1.815 . . . . 0.0 110.557 -175.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.4 t -91.95 117.0 29.4 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 165.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.18 162.18 45.93 Favored Glycine 0 CA--C 1.535 1.288 0 O-C-N 121.459 -0.776 . . . . 0.0 113.007 174.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.7 m -68.91 -14.27 62.94 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -176.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -74.31 -5.82 44.44 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.723 1.609 . . . . 0.0 113.27 169.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.82 21.08 54.43 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.787 1.184 . . . . 0.0 114.541 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -119.54 162.91 18.11 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.196 1.798 . . . . 0.0 111.788 -176.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.4 m -114.57 122.61 47.06 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.916 1.686 . . . . 0.0 110.133 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -115.34 169.07 9.42 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.635 1.574 . . . . 0.0 110.817 174.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.85 -30.35 66.73 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -166.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -164.51 170.3 16.06 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.28 1.432 . . . . 0.0 111.954 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.7 p -60.97 -39.85 91.16 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -171.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -54.08 -51.77 63.08 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.787 2.035 . . . . 0.0 112.997 176.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.6 tp -67.41 -40.43 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 121.387 -0.821 . . . . 0.0 110.865 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.97 -3.58 5.53 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.897 1.679 . . . . 0.0 114.905 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -116.09 -31.97 5.52 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.832 1.653 . . . . 0.0 114.489 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 56.4 m -60.41 -26.41 66.68 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.715 1.206 . . . . 0.0 113.633 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -72.94 -10.75 60.14 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 127.53 2.332 . . . . 0.0 115.472 170.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.27 1.17 59.43 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 125.642 1.591 . . . . 0.0 116.518 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 p -102.05 169.39 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-N 119.359 1.579 . . . . 0.0 111.064 172.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.1 149.79 29.53 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 127.115 2.166 . . . . 0.0 112.121 175.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -66.93 124.15 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 125.096 1.358 . . . . 0.0 110.089 176.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -78.98 -37.82 38.46 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.717 1.207 . . . . 0.0 111.523 174.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.8 p -160.03 162.13 34.15 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.472 1.509 . . . . 0.0 112.942 172.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -76.96 151.55 35.64 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.878 1.271 . . . . 0.0 112.615 171.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.54 156.94 8.48 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.097 1.332 . . . . 0.0 111.701 -169.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.2 p -60.1 146.08 44.4 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.71 -0.876 . . . . 0.0 111.837 167.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -93.98 155.04 40.61 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -179.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.03 157.05 55.21 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.831 3.021 . . . . 0.0 112.106 176.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 17.1 p -134.39 77.86 1.72 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.645 1.578 . . . . 0.0 111.428 -176.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.73 26.07 0.07 OUTLIER Glycine 0 CA--C 1.539 1.563 0 C-N-CA 124.413 1.006 . . . . 0.0 115.242 -175.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.4 tt . . . . . 0 C--O 1.253 1.283 0 C-N-CA 126.653 1.981 . . . . 0.0 112.491 -176.278 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -131.38 8.76 4.67 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.748 1.619 . . . . 0.0 114.758 -172.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.0 t -115.85 132.49 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 125.251 1.42 . . . . 0.0 110.774 -173.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 69.8 m -71.81 169.13 16.39 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.3 1.44 . . . . 0.0 113.193 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.24 -26.42 63.84 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 173.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.6 m -66.67 156.05 87.53 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 125.299 1.44 . . . . 0.0 112.969 174.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -79.61 173.71 12.69 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.973 3.116 . . . . 0.0 112.546 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -122.76 14.01 10.02 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.206 1.802 . . . . 0.0 114.065 -173.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.88 161.92 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 125.347 1.459 . . . . 0.0 112.52 172.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tt -98.25 75.94 2.3 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.765 1.226 . . . . 0.0 109.804 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -140.08 69.85 34.94 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 124.3 1.04 . . . . 0.0 111.428 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.88 168.04 24.17 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.176 2.584 . . . . 0.0 112.644 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.6 m -137.77 167.32 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 128.332 2.653 . . . . 0.0 111.518 -171.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.7 t -109.67 108.46 18.86 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.905 0.882 . . . . 0.0 109.569 167.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.13 156.17 53.55 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.008 0.813 . . . . 0.0 114.319 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.3 t -69.08 -14.26 62.91 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -78.3 -5.99 53.72 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.01 1.724 . . . . 0.0 113.86 168.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.23 4.43 74.3 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.752 1.644 . . . . 0.0 115.06 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -101.34 168.04 9.79 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.164 1.482 . . . . 0.0 111.727 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.2 m -121.27 135.51 55.11 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.733 1.613 . . . . 0.0 110.108 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -125.66 156.97 38.42 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.37 1.468 . . . . 0.0 110.863 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.84 -31.04 64.35 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.14 1.376 . . . . 0.0 114.108 -174.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -156.64 169.29 25.03 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.806 0.843 . . . . 0.0 111.605 175.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.1 t -60.61 -44.71 95.98 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.0 t -50.27 -44.19 53.65 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.113 1.765 . . . . 0.0 113.059 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.0 mm -64.03 -57.09 13.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.859 176.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.59 -52.87 16.31 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.396 0.678 . . . . 0.0 112.689 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -61.55 -38.19 86.56 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 30.6 t -63.16 -38.96 93.24 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.238 1.015 . . . . 0.0 112.138 176.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -67.51 -13.17 61.81 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.187 1.395 . . . . 0.0 113.463 173.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.12 -0.18 41.12 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 126.286 1.898 . . . . 0.0 115.529 172.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.2 m -112.91 134.07 56.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 126.229 1.812 . . . . 0.0 111.465 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 p -74.85 152.51 38.92 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.176 -0.953 . . . . 0.0 111.665 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.5 pt -73.49 127.47 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.114 0.965 . . . . 0.0 109.311 172.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -78.57 -37.05 43.56 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.838 -0.538 . . . . 0.0 111.269 171.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.0 p -152.74 162.39 41.33 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.588 1.555 . . . . 0.0 112.966 170.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -74.84 152.84 38.9 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.947 1.699 . . . . 0.0 111.22 169.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.54 152.63 6.32 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.215 1.388 . . . . 0.0 111.942 -175.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.5 t -58.33 147.39 31.17 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.783 -0.833 . . . . 0.0 110.871 167.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.8 p -102.23 157.51 33.56 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -73.69 161.33 42.1 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.673 2.915 . . . . 0.0 111.787 173.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.81 -0.21 12.75 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.914 1.686 . . . . 0.0 114.738 173.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.12 0.71 59.81 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 125.829 1.68 . . . . 0.0 114.713 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.9 mm . . . . . 0 C--O 1.254 1.311 0 C-N-CA 127.244 2.218 . . . . 0.0 110.361 176.975 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 63.5 mttm . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 120.349 0.119 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -134.7 163.25 30.19 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.902 2.081 . . . . 0.0 110.169 169.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.7 m -70.89 168.35 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.066 1.346 . . . . 0.0 112.533 175.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 76.7 m -63.38 -63.28 1.23 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.906 0.882 . . . . 0.0 111.737 174.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -161.36 124.79 3.25 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.025 1.73 . . . . 0.0 110.806 174.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 18.7 m -68.94 156.01 92.3 Favored Pre-proline 0 CA--C 1.549 0.917 0 O-C-N 121.434 -0.791 . . . . 0.0 111.855 168.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.38 166.22 26.38 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.632 2.888 . . . . 0.0 112.197 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -115.04 25.52 10.84 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.311 1.844 . . . . 0.0 113.408 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.3 pt -58.01 173.71 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 127.195 2.198 . . . . 0.0 112.726 169.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 tt -123.57 75.12 1.31 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.029 1.332 . . . . 0.0 109.237 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -141.99 71.76 23.49 Favored Pre-proline 0 N--CA 1.471 0.622 0 C-N-CA 124.305 1.042 . . . . 0.0 110.371 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.66 159.54 53.22 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.262 1.975 . . . . 0.0 112.079 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.4 m -145.82 147.33 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.149 1.38 . . . . 0.0 111.724 -169.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.2 t -90.55 116.81 28.74 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.665 1.186 . . . . 0.0 110.762 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.99 165.18 53.38 Favored Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.56 -0.712 . . . . 0.0 113.197 174.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.9 p -65.55 -17.25 64.43 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -68.84 -16.87 63.9 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.759 1.624 . . . . 0.0 113.589 168.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.07 -4.91 78.42 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.993 1.758 . . . . 0.0 114.961 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.7 ttt85 -83.77 161.82 20.85 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.356 1.462 . . . . 0.0 111.458 170.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 62.5 m -111.35 135.48 51.83 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.296 1.838 . . . . 0.0 110.952 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -119.87 165.52 14.5 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.739 1.616 . . . . 0.0 110.958 174.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.84 -30.45 70.63 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -167.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.44 173.88 15.53 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.282 1.833 . . . . 0.0 110.353 172.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.1 p -59.8 -41.72 91.83 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -56.36 -45.67 80.37 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.709 1.604 . . . . 0.0 113.301 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.7 tp -69.21 -41.82 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.931 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.66 -56.21 19.26 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.283 1.033 . . . . 0.0 111.32 174.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -59.32 -37.95 79.06 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 63.9 m -71.33 -23.85 62.0 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 175.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -74.1 -20.46 60.25 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.029 1.332 . . . . 0.0 112.934 172.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.68 7.66 17.48 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.851 1.691 . . . . 0.0 115.807 174.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 t -133.36 151.52 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.043 1.421 . . . . 0.0 110.545 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.8 t -92.99 158.46 15.78 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.169 0.985 . . . . 0.0 112.184 174.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.62 122.5 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 128.667 2.787 . . . . 0.0 108.51 171.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -79.22 -49.8 11.95 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.745 -0.597 . . . . 0.0 110.584 161.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.8 p -143.61 161.24 39.01 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.161 1.385 . . . . 0.0 113.227 -176.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.31 154.0 20.44 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.485 1.514 . . . . 0.0 112.597 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.17 160.9 19.98 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.03 1.3 . . . . 0.0 111.818 -169.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 m -61.37 126.95 29.2 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.783 -0.833 . . . . 0.0 109.564 164.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.99 155.1 94.04 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -173.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.81 153.58 64.05 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.47 2.78 . . . . 0.0 111.992 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.52 -4.59 43.54 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -173.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.19 -74.0 0.97 Allowed Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.78 1.657 . . . . 0.0 114.058 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 79.9 mt . . . . . 0 C--O 1.253 1.247 0 C-N-CA 125.974 1.71 . . . . 0.0 110.871 -179.424 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -139.88 -24.78 0.82 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.2 t -70.09 -48.79 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.828 1.251 . . . . 0.0 110.299 176.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.2 p -73.81 155.79 38.45 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.55 1.14 . . . . 0.0 111.872 165.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.53 96.96 2.77 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.586 1.554 . . . . 0.0 109.932 174.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.8 m -59.87 150.59 67.99 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.142 0.977 . . . . 0.0 112.462 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.63 168.51 24.24 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.261 2.641 . . . . 0.0 111.916 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -122.81 16.2 10.16 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.822 2.049 . . . . 0.0 114.497 -170.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.95 168.28 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 126.584 1.954 . . . . 0.0 112.925 170.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 tt -105.47 69.28 0.83 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.943 1.297 . . . . 0.0 110.583 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -137.31 72.13 52.52 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 124.822 1.249 . . . . 0.0 110.572 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.79 166.87 18.93 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.728 2.286 . . . . 0.0 111.937 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 m -142.99 150.98 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.81 1.644 . . . . 0.0 110.55 -176.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.5 t -87.98 114.49 24.64 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 169.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.56 159.68 53.75 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 119.409 1.004 . . . . 0.0 112.364 171.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t -65.2 -20.13 66.29 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 121.271 -1.135 . . . . 0.0 114.024 -177.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.67 -17.15 64.39 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.057 1.743 . . . . 0.0 113.859 168.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.68 -6.63 62.84 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 126.44 1.971 . . . . 0.0 114.826 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -77.9 164.67 24.93 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 118.712 1.256 . . . . 0.0 111.859 173.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 60.5 m -117.93 133.7 55.67 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.422 1.489 . . . . 0.0 110.027 169.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -121.81 170.19 10.01 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.857 1.663 . . . . 0.0 110.565 172.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.04 -30.64 71.21 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -165.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -163.36 172.77 14.13 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.833 1.253 . . . . 0.0 111.609 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.5 m -59.8 -39.18 84.12 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -173.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.6 t -58.92 -44.55 91.32 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.529 1.931 . . . . 0.0 113.479 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.89 -40.34 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.317 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.67 -53.22 60.85 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.634 0.774 . . . . 0.0 111.292 174.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -61.58 -29.02 69.76 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 176.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 10.8 t -60.12 -35.13 74.58 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.102 0.961 . . . . 0.0 112.705 176.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -75.37 -3.67 34.95 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.872 1.669 . . . . 0.0 114.068 172.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.71 -10.55 73.27 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 126.528 2.013 . . . . 0.0 115.173 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.5 m -85.08 138.02 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.81 1.644 . . . . 0.0 111.637 176.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -76.96 154.67 33.35 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.396 1.079 . . . . 0.0 112.238 169.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 pp -74.05 123.15 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.384 1.474 . . . . 0.0 109.744 174.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -75.4 -42.59 53.41 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.806 1.242 . . . . 0.0 111.57 173.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.4 t -158.09 169.4 24.63 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.093 1.357 . . . . 0.0 112.209 173.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -79.93 152.2 29.69 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.756 2.022 . . . . 0.0 113.012 174.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.46 163.96 13.46 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.476 1.512 . . . . 0.0 112.309 -173.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 m -59.47 128.66 38.17 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.602 0.761 . . . . 0.0 109.563 164.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.83 154.36 94.32 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -176.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.89 144.92 49.25 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.297 2.664 . . . . 0.0 111.633 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.3 m -76.09 -10.57 59.52 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -176.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.23 -11.22 56.41 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.621 1.581 . . . . 0.0 116.169 -172.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.1 mt . . . . . 0 N--CA 1.483 1.19 0 C-N-CA 126.088 1.755 . . . . 0.0 110.149 -179.952 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 45.3 m . . . . . 0 CA--C 1.549 0.911 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.87 154.98 43.55 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.371 2.714 . . . . 0.0 111.482 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -104.58 5.42 33.78 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.911 2.084 . . . . 0.0 114.135 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 9.1 mt -70.16 143.07 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.897 1.679 . . . . 0.0 110.102 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.6 tt -80.75 74.99 7.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.558 1.943 . . . . 0.0 110.293 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -133.58 68.23 76.1 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 125.391 1.476 . . . . 0.0 111.509 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -67.6 165.95 25.66 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.024 2.483 . . . . 0.0 112.54 -176.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.6 m -142.94 152.23 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.973 1.709 . . . . 0.0 110.694 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.5 t -90.59 118.15 29.82 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 167.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.57 165.02 54.3 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-N 119.177 0.898 . . . . 0.0 112.799 172.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.7 p -67.42 -16.0 63.99 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.34 -9.28 58.53 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.227 1.411 . . . . 0.0 114.053 167.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.59 -1.58 88.21 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.609 1.576 . . . . 0.0 114.931 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.5 mmt-85 -72.28 159.44 34.06 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.011 1.324 . . . . 0.0 111.277 168.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 59.4 m -114.56 131.24 56.73 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.176 1.39 . . . . 0.0 109.564 169.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.406 ' HB3' HG23 ' A' ' 26' ' ' ILE . 16.3 m-85 -118.11 166.62 12.34 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.688 1.595 . . . . 0.0 109.916 175.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.73 -24.21 62.58 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -167.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -165.09 176.33 8.62 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.727 2.011 . . . . 0.0 111.12 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.1 m -65.26 -34.58 78.69 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.7 t -62.32 -45.65 92.25 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.953 1.701 . . . . 0.0 113.244 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.406 HG23 ' HB3' ' A' ' 21' ' ' TYR . 10.8 tp -69.96 -39.36 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.194 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.04 -54.87 37.51 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.102 0.961 . . . . 0.0 111.685 170.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -63.18 -32.22 73.56 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.9 m -62.82 -20.23 64.84 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -80.93 -2.81 49.21 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.526 1.13 . . . . 0.0 113.673 169.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.75 16.32 58.43 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.418 1.485 . . . . 0.0 114.774 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 t -129.8 148.99 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.332 1.453 . . . . 0.0 111.277 -172.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.1 p -85.25 158.31 20.36 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.929 1.692 . . . . 0.0 112.721 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.66 124.77 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 125.578 1.551 . . . . 0.0 109.606 172.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -76.15 -39.86 54.02 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.879 1.272 . . . . 0.0 111.317 172.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.3 p -158.98 162.91 36.84 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.54 1.536 . . . . 0.0 112.785 172.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -74.89 152.41 38.88 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.025 1.33 . . . . 0.0 112.539 170.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.24 162.42 20.09 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.597 1.57 . . . . 0.0 112.538 -172.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.4 t -59.93 148.04 36.51 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.987 -0.713 . . . . 0.0 110.87 164.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 CA--C 1.544 0.714 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -177.982 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 13.7 m . . . . . 0 CA--C 1.552 1.047 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -76.62 171.74 17.49 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.952 3.101 . . . . 0.0 112.211 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.1 tttm -119.37 9.41 11.62 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.97 1.708 . . . . 0.0 114.581 -174.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.5 mt -63.11 143.66 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.182 1.393 . . . . 0.0 110.069 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 71.6 mt -75.01 70.61 2.03 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.054 1.741 . . . . 0.0 111.108 173.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -132.92 63.38 66.94 Favored Pre-proline 0 N--CA 1.471 0.622 0 C-N-CA 125.374 1.469 . . . . 0.0 109.934 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.26 160.25 48.46 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.987 2.458 . . . . 0.0 111.455 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.7 m -144.71 162.39 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.833 1.253 . . . . 0.0 111.639 -172.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.4 t -98.45 113.81 25.95 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.171 1.388 . . . . 0.0 110.201 173.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.37 166.37 54.71 Favored Glycine 0 CA--C 1.535 1.34 0 O-C-N 121.604 -0.685 . . . . 0.0 113.425 172.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.1 t -60.13 -25.1 65.21 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.071 1.349 . . . . 0.0 113.717 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -68.08 -14.12 62.73 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.918 1.287 . . . . 0.0 113.827 172.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.84 -4.04 84.87 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 126.088 1.804 . . . . 0.0 114.634 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -78.13 159.87 28.38 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.782 1.233 . . . . 0.0 111.685 173.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 59.6 m -109.91 131.56 54.95 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.519 1.528 . . . . 0.0 109.793 170.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -119.72 167.95 11.55 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.66 1.184 . . . . 0.0 110.756 171.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.63 -25.24 59.86 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -175.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -167.34 177.24 6.18 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.569 1.548 . . . . 0.0 111.329 174.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.0 p -60.49 -47.1 87.61 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 176.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.5 t -55.69 -42.06 74.64 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.503 1.921 . . . . 0.0 113.424 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.43 -52.71 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 125.38 1.472 . . . . 0.0 111.032 175.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.58 -46.93 83.4 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.36 0.664 . . . . 0.0 111.96 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -65.77 -28.86 69.34 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.3 t -59.46 -33.98 71.97 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.248 1.019 . . . . 0.0 112.69 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -72.44 -3.63 25.4 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.145 1.778 . . . . 0.0 113.998 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.92 -12.29 65.77 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 126.807 2.146 . . . . 0.0 115.334 172.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.5 m -88.22 135.71 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.836 1.654 . . . . 0.0 111.855 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.3 p -68.62 164.66 20.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.928 1.291 . . . . 0.0 112.726 173.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.3 mm -90.79 110.8 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 123.996 0.918 . . . . 0.0 110.263 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -45.97 90.78 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.256 1.022 . . . . 0.0 110.97 172.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.7 t -164.18 166.06 21.49 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.727 0.775 . . . . 0.0 112.777 173.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -86.78 154.99 20.5 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.628 1.971 . . . . 0.0 112.719 176.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.06 157.56 11.6 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.958 1.266 . . . . 0.0 111.806 -168.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.3 m -59.45 126.95 29.68 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.784 -0.833 . . . . 0.0 109.958 168.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.544 0.739 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -176.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.1 m . . . . . 0 CA--C 1.55 0.955 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.98 158.2 38.43 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.35 2.7 . . . . 0.0 112.106 -174.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -100.14 4.37 44.45 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.573 1.949 . . . . 0.0 114.435 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.7 mt -68.29 143.2 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.744 1.618 . . . . 0.0 109.905 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.89 79.58 9.58 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.129 1.772 . . . . 0.0 110.199 173.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -131.64 63.07 67.98 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 125.605 1.562 . . . . 0.0 111.721 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.33 166.12 24.57 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.309 2.672 . . . . 0.0 112.714 -173.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.6 m -142.55 152.54 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.835 1.654 . . . . 0.0 110.904 -175.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.8 t -89.42 113.55 24.9 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 166.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.87 162.56 52.96 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-N 118.906 0.776 . . . . 0.0 112.939 175.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 t -67.05 -14.08 62.55 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -72.53 -14.2 61.59 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.942 1.297 . . . . 0.0 113.479 168.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.55 -6.86 77.77 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 126.245 1.878 . . . . 0.0 114.706 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.2 mmt85 -74.29 161.99 29.35 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.776 1.631 . . . . 0.0 112.006 170.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.5 m -115.05 137.47 51.97 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.456 1.502 . . . . 0.0 109.763 167.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -127.18 166.84 16.95 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.894 1.678 . . . . 0.0 110.622 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.09 -23.75 64.05 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -165.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -164.42 -176.53 4.42 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.703 2.001 . . . . 0.0 111.353 172.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 54.8 m -67.17 -34.62 77.93 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 176.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.2 t -65.91 -38.1 87.83 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.796 1.638 . . . . 0.0 113.48 -175.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.0 tp -70.9 -50.22 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.843 170.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.53 -51.06 64.07 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.139 1.376 . . . . 0.0 112.882 -177.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.42 -34.82 72.96 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.044 1.337 . . . . 0.0 113.543 175.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.8 t -63.87 -30.92 71.96 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.504 1.122 . . . . 0.0 113.075 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -67.8 -8.15 33.52 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.059 1.344 . . . . 0.0 114.045 173.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.34 11.91 60.48 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.994 1.283 . . . . 0.0 115.086 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -128.74 151.26 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.538 1.535 . . . . 0.0 110.321 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 p -82.29 160.36 22.93 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.319 1.848 . . . . 0.0 112.847 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -73.09 126.04 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 125.75 1.62 . . . . 0.0 109.495 171.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -81.41 -38.21 26.88 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.557 1.143 . . . . 0.0 111.617 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.6 p -157.57 162.7 38.78 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.337 1.455 . . . . 0.0 112.788 169.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -75.1 150.25 38.87 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.238 1.415 . . . . 0.0 112.445 171.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.77 161.29 19.56 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.554 1.549 . . . . 0.0 112.403 -171.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.0 t -58.97 148.55 30.2 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 122.012 -0.699 . . . . 0.0 111.024 165.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 CA--C 1.542 0.65 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 179.807 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 43.0 m . . . . . 0 CA--C 1.548 0.892 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.1 146.8 41.81 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.272 2.648 . . . . 0.0 110.981 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -80.26 6.57 11.55 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.944 1.698 . . . . 0.0 115.006 176.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.7 tt -57.91 139.63 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 126.291 1.837 . . . . 0.0 113.186 -173.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.8 mt -84.9 72.01 10.83 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.11 1.364 . . . . 0.0 110.683 175.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -139.16 71.48 40.29 Favored Pre-proline 0 N--CA 1.47 0.54 0 C-N-CA 125.243 1.417 . . . . 0.0 109.944 173.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -66.64 166.64 21.42 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.367 2.045 . . . . 0.0 112.179 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.8 m -144.71 154.43 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.112 1.765 . . . . 0.0 111.027 -172.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 t -94.23 115.18 27.4 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.522 0.729 . . . . 0.0 109.186 167.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.9 160.66 53.58 Favored Glycine 0 CA--C 1.536 1.369 0 O-C-N 121.336 -0.853 . . . . 0.0 113.085 173.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.1 t -64.56 -20.62 66.34 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -70.79 -6.18 35.76 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.084 1.353 . . . . 0.0 114.364 170.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.48 19.97 55.52 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.71 1.148 . . . . 0.0 114.833 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -118.25 162.89 17.51 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.448 1.899 . . . . 0.0 111.332 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.1 m -116.53 129.62 56.29 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.237 1.415 . . . . 0.0 110.748 -175.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -123.9 165.86 16.65 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.721 1.608 . . . . 0.0 110.767 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.8 -29.96 70.53 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -167.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -166.41 171.06 12.34 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.908 1.683 . . . . 0.0 111.358 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.3 m -59.16 -42.78 91.55 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -171.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.2 t -56.08 -43.56 78.12 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.236 1.814 . . . . 0.0 113.264 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.5 tp -72.8 -38.77 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.899 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.33 -52.61 64.54 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.926 0.89 . . . . 0.0 111.766 174.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -60.05 -28.45 67.79 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.8 t -58.04 -31.51 67.08 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.118 1.367 . . . . 0.0 113.413 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -73.75 -3.97 31.7 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.238 1.415 . . . . 0.0 114.31 173.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.11 11.46 63.07 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.214 1.388 . . . . 0.0 114.908 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.35 146.83 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 126.076 1.75 . . . . 0.0 110.57 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 p -79.87 162.45 25.01 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.868 1.667 . . . . 0.0 113.111 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.3 pp -72.11 123.04 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.371 1.468 . . . . 0.0 109.611 170.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -68.66 -41.47 79.26 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.915 1.286 . . . . 0.0 111.173 170.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.9 p -156.98 158.17 36.1 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.17 1.788 . . . . 0.0 112.362 174.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -72.69 149.78 43.51 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.099 1.36 . . . . 0.0 110.653 171.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.32 158.46 20.77 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.922 1.249 . . . . 0.0 112.057 -174.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.3 t -59.87 145.02 47.2 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.739 -0.86 . . . . 0.0 110.912 167.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.542 0.64 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -178.147 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 16.6 m . . . . . 0 CA--C 1.551 1.005 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -73.85 171.78 17.19 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.819 3.013 . . . . 0.0 111.449 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.75 17.8 10.27 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.877 1.671 . . . . 0.0 113.978 -173.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.9 mt -63.84 141.56 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.505 1.522 . . . . 0.0 109.814 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.4 mt -79.59 70.47 6.07 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.732 1.213 . . . . 0.0 110.584 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -134.9 72.16 68.65 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 124.941 1.296 . . . . 0.0 109.866 172.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.17 164.03 33.79 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.109 1.873 . . . . 0.0 111.745 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.7 m -144.48 140.69 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.884 1.673 . . . . 0.0 110.58 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 t -79.14 114.78 18.35 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.85 163.09 45.44 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 121.546 -0.721 . . . . 0.0 113.159 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.1 m -68.11 -11.91 59.92 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -77.23 -10.52 59.47 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.929 1.692 . . . . 0.0 114.192 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.05 13.98 35.07 Favored Glycine 0 CA--C 1.539 1.541 0 N-CA-C 115.894 1.118 . . . . 0.0 115.894 175.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -137.05 168.24 19.97 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.317 1.847 . . . . 0.0 110.944 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.0 t -105.47 150.31 25.42 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.61 1.164 . . . . 0.0 111.699 175.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -124.19 170.28 10.89 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.233 1.813 . . . . 0.0 110.39 173.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.04 -35.17 77.8 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -167.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -163.16 168.04 21.32 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.474 1.51 . . . . 0.0 112.077 175.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.2 m -60.13 -32.11 70.7 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -167.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.7 t -61.22 -43.94 98.07 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.905 1.682 . . . . 0.0 113.514 176.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.9 tp -72.44 -39.59 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.747 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.48 -28.64 69.97 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.451 1.1 . . . . 0.0 113.418 176.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -88.04 -30.13 20.16 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.141 1.376 . . . . 0.0 114.377 173.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 37.5 t -55.09 -39.82 69.73 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.99 1.316 . . . . 0.0 113.13 -174.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -70.26 -11.34 60.83 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 126.076 1.75 . . . . 0.0 115.164 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.91 -8.29 42.45 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 126.488 1.994 . . . . 0.0 116.247 175.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.5 t -93.58 168.99 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 125.507 1.523 . . . . 0.0 110.654 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.6 p -112.24 155.9 23.27 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 127.477 2.311 . . . . 0.0 112.37 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -67.64 123.17 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.623 1.569 . . . . 0.0 110.075 176.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -77.34 -42.23 37.4 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.507 1.123 . . . . 0.0 110.832 172.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.0 p -153.75 157.93 40.2 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.461 1.504 . . . . 0.0 112.508 174.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -82.74 149.25 27.38 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.721 1.208 . . . . 0.0 111.269 177.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.81 162.04 24.34 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.54 1.066 . . . . 0.0 111.676 -169.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.1 t -60.33 148.27 37.59 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 122.125 -0.633 . . . . 0.0 110.942 167.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -179.58 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 18.6 m . . . . . 0 CA--C 1.549 0.932 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.48 147.26 31.97 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.354 2.702 . . . . 0.0 111.664 -176.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.61 3.63 55.2 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.263 1.825 . . . . 0.0 114.645 177.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.2 mt -65.06 140.6 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.207 1.403 . . . . 0.0 109.995 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tt -80.75 74.2 7.7 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.981 1.712 . . . . 0.0 109.357 175.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.23 69.73 77.87 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 124.424 1.09 . . . . 0.0 110.474 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.29 167.28 18.85 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.835 2.356 . . . . 0.0 112.5 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.6 m -144.84 153.18 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 126.006 1.722 . . . . 0.0 110.358 -173.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.5 t -98.53 113.62 25.72 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.181 0.992 . . . . 0.0 108.766 171.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.63 159.16 53.53 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 118.773 0.715 . . . . 0.0 113.296 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.3 t -59.83 -24.09 63.89 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -67.57 -13.7 62.29 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 125.227 1.411 . . . . 0.0 114.017 171.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.97 -3.29 64.62 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 126.439 1.971 . . . . 0.0 114.697 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -84.11 164.64 19.08 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.941 1.696 . . . . 0.0 111.937 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.6 m -114.76 138.68 50.44 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.997 1.319 . . . . 0.0 110.508 171.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -124.92 166.87 15.53 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.981 1.712 . . . . 0.0 110.624 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.48 -24.23 61.96 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -167.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -164.18 179.28 6.99 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.158 2.183 . . . . 0.0 110.629 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.5 p -65.24 -42.47 93.32 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.8 t -57.17 -41.52 79.38 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.522 1.929 . . . . 0.0 113.972 -176.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.6 tt -70.59 -48.38 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.948 1.299 . . . . 0.0 111.966 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.54 -52.94 42.86 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.183 0.993 . . . . 0.0 112.051 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -62.75 -27.64 69.42 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 178.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.9 t -61.93 -31.69 72.03 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.562 1.145 . . . . 0.0 112.786 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -73.84 -4.16 33.15 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.625 1.57 . . . . 0.0 114.178 171.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.82 -7.02 83.09 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 126.207 1.861 . . . . 0.0 115.072 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.7 m -93.31 146.0 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 126.341 1.857 . . . . 0.0 111.581 176.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.2 p -84.99 160.95 19.95 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.074 1.35 . . . . 0.0 112.0 171.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.4 pt -73.24 128.02 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.48 1.112 . . . . 0.0 110.031 172.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -77.54 -39.48 45.84 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.058 0.943 . . . . 0.0 111.494 169.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.4 t -154.76 170.59 21.25 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.474 1.109 . . . . 0.0 113.071 173.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -85.06 151.57 24.06 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.433 2.293 . . . . 0.0 112.684 174.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.29 162.5 10.65 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.475 1.512 . . . . 0.0 112.286 -170.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.7 m -59.39 130.0 44.75 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.85 -0.794 . . . . 0.0 109.588 163.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.542 0.666 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.0 m . . . . . 0 CA--C 1.549 0.914 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.56 167.87 26.13 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.691 2.927 . . . . 0.0 112.027 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.69 8.24 13.73 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.345 2.258 . . . . 0.0 114.008 -173.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.9 mt -68.8 140.74 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.3 1.44 . . . . 0.0 109.785 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tt -82.01 72.93 9.07 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.166 1.787 . . . . 0.0 110.584 -176.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -134.73 68.67 71.82 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 125.554 1.541 . . . . 0.0 111.406 -175.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.27 162.2 43.26 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.0 2.466 . . . . 0.0 112.914 -175.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.8 m -144.85 163.73 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 127.045 2.138 . . . . 0.0 111.244 -172.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.2 t -94.41 122.46 37.0 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.523 0.729 . . . . 0.0 110.39 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.46 161.39 53.56 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.079 0.847 . . . . 0.0 113.61 172.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.0 t -61.73 -27.48 68.75 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.239 1.016 . . . . 0.0 113.567 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -82.86 -5.92 59.21 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.311 1.844 . . . . 0.0 114.488 174.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.17 2.04 66.47 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.556 1.55 . . . . 0.0 115.956 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -73.38 166.03 23.95 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 119.814 1.807 . . . . 0.0 111.622 170.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.5 m -121.54 123.7 42.62 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.814 1.646 . . . . 0.0 109.203 172.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.403 ' HB3' ' CG2' ' A' ' 26' ' ' ILE . 35.4 m-85 -113.21 170.58 8.11 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.763 1.625 . . . . 0.0 110.812 174.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.29 -31.85 71.58 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -168.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.09 170.32 19.39 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.634 1.574 . . . . 0.0 110.96 176.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.3 m -59.74 -40.8 89.33 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -172.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.9 t -55.89 -45.71 78.54 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.079 1.752 . . . . 0.0 113.203 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.403 ' CG2' ' HB3' ' A' ' 21' ' ' TYR . 2.2 tp -72.27 -36.25 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.183 -177.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.04 -55.24 37.44 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.395 0.678 . . . . 0.0 111.299 169.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -63.91 -26.75 68.74 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.3 t -57.6 -34.62 69.45 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.585 1.154 . . . . 0.0 112.909 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -74.23 -4.35 35.48 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.699 1.6 . . . . 0.0 114.435 173.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.87 -11.28 72.55 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 126.39 1.947 . . . . 0.0 115.263 175.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 m -83.07 151.43 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.811 1.644 . . . . 0.0 111.495 173.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.7 t -80.55 176.02 10.15 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.937 0.875 . . . . 0.0 111.634 167.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 pp -101.2 119.95 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 128.307 2.643 . . . . 0.0 109.661 174.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -59.94 -44.8 94.14 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.542 0.737 . . . . 0.0 111.552 176.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.1 t -161.49 171.01 18.86 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.42 1.488 . . . . 0.0 112.129 170.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -72.83 152.85 41.33 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.258 1.823 . . . . 0.0 112.641 171.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.51 146.15 4.42 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.858 1.218 . . . . 0.0 112.248 -175.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 p -59.37 133.75 56.38 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.528 -0.983 . . . . 0.0 111.569 171.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.541 0.601 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -172.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 33.2 m . . . . . 0 CA--C 1.546 0.826 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.59 140.06 23.48 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.054 2.502 . . . . 0.0 111.242 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -75.16 -1.98 25.65 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.8 mt -66.36 140.79 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.637 1.575 . . . . 0.0 109.724 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.1 mt -89.1 80.11 7.06 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.159 1.784 . . . . 0.0 110.085 175.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -127.66 68.56 74.61 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 124.003 0.921 . . . . 0.0 110.593 176.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.6 163.34 27.69 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.95 2.434 . . . . 0.0 112.453 -173.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.1 m -145.24 157.01 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.889 1.676 . . . . 0.0 110.7 -171.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.6 t -101.18 110.34 22.35 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.987 0.915 . . . . 0.0 109.424 170.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.74 158.21 52.17 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-N 118.981 0.81 . . . . 0.0 112.905 173.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.5 p -70.09 -9.19 54.68 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -64.32 -14.59 57.03 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.37 1.468 . . . . 0.0 113.45 163.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.17 19.58 45.71 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.324 1.44 . . . . 0.0 114.085 -177.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.9 ttm-85 -119.24 160.27 22.5 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.528 1.931 . . . . 0.0 111.682 -174.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.9 m -116.61 131.52 56.93 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.386 1.475 . . . . 0.0 110.683 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -125.23 169.97 11.73 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.621 1.568 . . . . 0.0 110.925 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.87 -21.6 61.63 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -165.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -161.01 -174.54 4.44 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.987 2.115 . . . . 0.0 109.815 174.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.7 p -72.64 -38.34 67.74 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.1 t -58.2 -41.81 84.78 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.777 1.631 . . . . 0.0 113.953 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 tp -72.1 -43.75 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.836 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.61 -49.49 76.25 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.288 1.035 . . . . 0.0 112.106 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -60.97 -25.45 66.85 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.0 t -59.27 -31.26 68.94 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.92 1.288 . . . . 0.0 113.146 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -74.73 -2.83 28.15 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.362 1.465 . . . . 0.0 114.211 172.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.61 15.08 62.32 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.089 1.328 . . . . 0.0 114.951 177.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 t -128.46 149.04 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.559 1.544 . . . . 0.0 110.856 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 p -87.81 162.8 16.78 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 126.53 1.932 . . . . 0.0 112.43 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.4 pt -73.47 126.54 34.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.708 1.203 . . . . 0.0 110.113 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -75.35 -40.53 58.09 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.641 1.177 . . . . 0.0 111.032 169.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.7 p -150.33 161.4 42.54 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.585 1.554 . . . . 0.0 112.751 171.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.17 153.49 25.97 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.286 1.434 . . . . 0.0 111.034 170.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.41 160.17 12.2 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.172 1.368 . . . . 0.0 112.073 -169.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.2 m -59.51 130.61 47.74 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.729 -0.865 . . . . 0.0 109.981 165.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.546 0.792 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -176.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.8 m . . . . . 0 CA--C 1.548 0.866 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.21 166.93 27.93 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.403 2.735 . . . . 0.0 111.265 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -109.86 10.79 24.43 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.35 1.46 . . . . 0.0 114.36 -173.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.7 mt -58.66 139.16 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.27 1.428 . . . . 0.0 110.217 -176.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.1 mt -80.94 71.9 7.93 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.461 1.505 . . . . 0.0 110.055 172.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -135.62 71.21 65.41 Favored Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 124.718 1.207 . . . . 0.0 109.136 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -68.83 159.07 55.32 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.141 1.894 . . . . 0.0 111.599 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 m -144.85 146.93 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.1 1.36 . . . . 0.0 111.52 -169.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.9 t -89.65 115.24 26.89 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.752 1.221 . . . . 0.0 110.583 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.59 164.61 50.82 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 121.78 -0.575 . . . . 0.0 113.905 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.2 m -62.27 -20.08 63.9 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.56 -8.82 57.58 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.407 1.483 . . . . 0.0 113.571 171.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.36 -2.64 85.16 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.949 1.737 . . . . 0.0 114.929 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -86.18 165.07 16.84 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.019 1.328 . . . . 0.0 111.884 172.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 65.2 m -115.13 138.37 50.97 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.13 1.372 . . . . 0.0 110.455 175.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -121.63 164.32 17.51 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.42 1.888 . . . . 0.0 110.08 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.18 -26.94 67.64 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -168.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -167.12 172.51 9.96 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.382 1.873 . . . . 0.0 111.031 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 t -60.21 -43.57 95.86 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -176.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.4 t -57.8 -44.19 86.16 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.654 1.582 . . . . 0.0 113.41 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.4 tp -70.41 -38.41 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.05 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.08 -55.12 39.04 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.417 1.087 . . . . 0.0 111.279 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -60.1 -37.96 81.53 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.606 0.762 . . . . 0.0 112.865 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 23.6 t -65.16 -38.68 91.34 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.097 0.959 . . . . 0.0 112.817 174.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.12 -21.85 66.46 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.225 1.41 . . . . 0.0 113.866 173.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.34 8.8 18.82 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.088 1.328 . . . . 0.0 115.618 174.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.84 149.05 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 119.301 1.55 . . . . 0.0 110.937 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.57 151.1 29.28 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.225 1.41 . . . . 0.0 111.394 172.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.13 126.75 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 126.849 2.06 . . . . 0.0 107.985 165.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -85.47 -48.21 9.19 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.18 0.592 . . . . 0.0 111.337 162.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.5 m -138.53 156.58 47.37 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.022 1.329 . . . . 0.0 112.501 -176.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -82.62 155.05 24.63 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.855 1.262 . . . . 0.0 112.483 172.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.25 159.42 13.14 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.042 1.306 . . . . 0.0 112.012 -172.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 m -60.18 128.02 34.69 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 121.956 -0.732 . . . . 0.0 109.673 164.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.546 0.802 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -175.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.6 m . . . . . 0 CA--C 1.548 0.886 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -73.38 142.24 33.08 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.217 2.611 . . . . 0.0 110.986 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -78.45 6.4 8.58 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.998 1.719 . . . . 0.0 114.877 176.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.3 tt -58.47 143.4 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 126.117 1.767 . . . . 0.0 112.723 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 tt -92.85 70.11 4.69 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.047 1.339 . . . . 0.0 109.643 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -135.4 72.6 64.81 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 125.603 1.561 . . . . 0.0 110.358 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.65 166.21 26.77 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.565 2.177 . . . . 0.0 112.24 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.8 m -141.26 156.27 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.356 1.863 . . . . 0.0 110.515 -176.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.2 t -90.13 113.87 25.71 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 164.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.32 160.05 47.37 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 121.454 -0.779 . . . . 0.0 113.263 176.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.7 t -62.11 -22.65 65.99 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.563 1.145 . . . . 0.0 113.603 -178.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -68.87 -13.15 62.24 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.434 1.494 . . . . 0.0 114.239 172.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.0 9.84 65.29 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.079 1.324 . . . . 0.0 114.53 -175.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -103.45 163.26 12.4 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.316 1.846 . . . . 0.0 111.409 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.5 m -115.29 129.02 56.5 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.19 1.796 . . . . 0.0 109.747 175.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -120.31 169.57 10.15 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.95 1.7 . . . . 0.0 110.72 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.77 -28.44 65.77 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -171.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.5 172.19 17.66 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.537 1.535 . . . . 0.0 111.093 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.9 p -63.04 -40.27 97.23 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.5 t -56.89 -46.88 81.6 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.23 1.812 . . . . 0.0 113.439 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.2 tp -70.68 -36.82 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.841 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.79 -55.42 35.15 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.694 0.798 . . . . 0.0 111.605 170.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -60.69 -28.6 68.75 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.158 1.169 . . . . 0.0 114.158 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.6 m -63.25 -20.36 65.38 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 174.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -84.91 -6.42 59.34 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.756 1.222 . . . . 0.0 113.787 167.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.43 -10.84 63.26 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 126.705 2.098 . . . . 0.0 115.157 177.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.0 m -99.02 142.56 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 126.39 1.876 . . . . 0.0 111.771 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.6 t -91.31 169.18 11.03 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.307 1.051 . . . . 0.0 112.584 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -72.16 132.04 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 127.58 2.352 . . . . 0.0 110.246 176.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -91.35 -36.6 13.74 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.049 1.34 . . . . 0.0 112.209 173.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.5 p -157.09 160.56 39.0 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.219 1.407 . . . . 0.0 112.75 171.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -73.35 146.91 44.87 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.065 1.346 . . . . 0.0 112.454 172.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.98 153.01 6.05 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.165 1.364 . . . . 0.0 111.871 -172.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.1 p -59.32 142.88 50.97 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.731 -0.864 . . . . 0.0 112.036 169.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.541 0.627 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -178.036 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.5 m . . . . . 0 CA--C 1.55 0.959 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -72.91 144.34 38.34 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 123.368 2.712 . . . . 0.0 111.767 -175.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -75.39 5.96 5.12 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.293 1.837 . . . . 0.0 115.18 175.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.8 tt -61.8 149.91 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.987 1.715 . . . . 0.0 112.829 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 tt -102.81 75.0 1.37 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.167 1.787 . . . . 0.0 109.512 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -142.69 73.88 19.38 Favored Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 124.791 1.236 . . . . 0.0 110.593 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.77 167.29 17.8 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.056 2.504 . . . . 0.0 112.743 -176.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.9 m -141.93 158.97 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.839 1.655 . . . . 0.0 110.789 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.9 t -99.81 118.3 35.98 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.928 0.891 . . . . 0.0 109.116 166.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.17 163.57 54.55 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 118.963 0.801 . . . . 0.0 113.268 172.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.5 t -63.43 -20.95 66.0 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -67.35 -14.29 62.78 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.37 1.468 . . . . 0.0 113.784 169.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.55 1.49 71.31 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 126.028 1.775 . . . . 0.0 114.666 -178.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -87.03 160.74 18.51 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.043 1.737 . . . . 0.0 111.591 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 91.1 m -109.79 136.37 49.23 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.303 1.441 . . . . 0.0 110.517 175.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -126.75 168.44 14.39 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.48 1.512 . . . . 0.0 111.603 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.46 -23.79 61.89 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -166.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -162.18 -179.64 7.21 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.218 1.807 . . . . 0.0 111.239 171.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 61.0 p -63.89 -40.96 97.73 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 175.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.2 t -59.18 -44.34 92.17 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.077 1.751 . . . . 0.0 113.57 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.4 tp -70.33 -42.93 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.054 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.88 -52.98 62.17 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.975 0.91 . . . . 0.0 111.522 177.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -60.12 -27.89 67.41 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.0 t -58.55 -29.69 66.55 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.775 1.23 . . . . 0.0 113.064 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -70.47 -12.63 61.7 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.651 1.58 . . . . 0.0 114.387 174.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.53 -0.39 77.36 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.878 1.704 . . . . 0.0 114.998 -175.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -104.33 149.54 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.759 1.624 . . . . 0.0 109.89 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.85 160.17 20.23 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.775 1.63 . . . . 0.0 112.209 174.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.6 pt -71.84 129.05 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 124.284 1.034 . . . . 0.0 110.13 170.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -73.69 -38.29 64.93 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.907 1.283 . . . . 0.0 111.227 170.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.0 p -158.59 163.79 36.66 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.009 1.724 . . . . 0.0 112.359 168.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.47 154.94 34.27 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.569 1.548 . . . . 0.0 112.007 166.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.41 158.61 9.96 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 125.404 1.478 . . . . 0.0 112.022 -168.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.0 t -62.17 146.71 49.89 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.657 -0.907 . . . . 0.0 110.743 166.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.541 0.605 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -177.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 35.5 m . . . . . 0 CA--C 1.549 0.909 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.67 159.14 53.72 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.588 2.859 . . . . 0.0 111.884 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -113.35 4.01 16.16 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.554 1.542 . . . . 0.0 114.024 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.51 ' H ' HD12 ' A' ' 9' ' ' ILE . 4.2 mp -69.75 146.19 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.425 1.09 . . . . 0.0 109.914 175.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.7 tt -77.84 74.3 4.4 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.837 2.055 . . . . 0.0 109.672 176.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.4 mmmt -129.39 63.56 68.07 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 125.63 1.572 . . . . 0.0 111.851 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.65 166.22 28.19 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.27 2.647 . . . . 0.0 112.625 -176.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.0 m -146.98 143.02 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.348 1.859 . . . . 0.0 110.553 -172.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.7 t -79.77 111.64 16.28 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.72 153.84 39.02 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 119.233 0.924 . . . . 0.0 112.851 175.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 90.2 p -69.92 -9.8 56.29 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -69.86 -15.93 63.17 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.354 1.461 . . . . 0.0 113.779 169.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.42 15.65 22.56 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 124.675 1.131 . . . . 0.0 115.645 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 51.6 ttm-85 -136.08 168.08 20.04 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.237 1.815 . . . . 0.0 111.021 178.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.2 t -106.44 151.74 24.54 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.44 1.096 . . . . 0.0 111.697 172.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -121.36 175.74 6.0 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.569 1.947 . . . . 0.0 110.018 173.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.31 -25.74 61.69 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -171.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -160.66 -176.49 5.59 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.901 1.68 . . . . 0.0 111.487 174.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.4 p -72.77 -25.99 61.38 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 177.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.5 t -71.48 -43.78 65.95 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.698 1.599 . . . . 0.0 112.54 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.5 tp -68.75 -41.44 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.637 0.775 . . . . 0.0 111.12 176.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.54 -56.17 19.32 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.72 1.208 . . . . 0.0 111.844 173.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -61.71 -36.11 79.99 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 32.3 m -59.06 -33.76 71.16 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.428 0.691 . . . . 0.0 112.722 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -67.52 -9.92 46.89 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 173.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.82 10.38 72.64 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.762 1.172 . . . . 0.0 114.88 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 t -116.88 156.37 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.318 1.847 . . . . 0.0 109.085 176.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.2 t -107.42 167.63 9.8 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 122.515 1.15 . . . . 0.0 111.754 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.6 pt -77.49 123.81 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 126.009 1.723 . . . . 0.0 109.965 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.3 tttt -71.89 -40.76 68.65 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.168 0.987 . . . . 0.0 111.349 168.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.0 t -156.93 171.53 20.28 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.079 1.352 . . . . 0.0 112.871 172.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -75.54 148.16 39.14 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.014 2.126 . . . . 0.0 112.528 171.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.98 159.09 6.97 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.175 1.369 . . . . 0.0 112.594 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.7 m -58.69 138.66 56.89 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.748 0.819 . . . . 0.0 111.18 170.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 CA--C 1.54 0.567 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -179.709 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.4 m . . . . . 0 CA--C 1.55 0.965 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -74.64 168.37 24.97 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.57 2.847 . . . . 0.0 112.419 -175.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -114.19 8.7 16.95 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.18 2.192 . . . . 0.0 114.164 -177.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 26.6 mt -66.32 144.03 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.356 1.462 . . . . 0.0 109.854 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 tt -84.62 71.79 10.75 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.417 1.887 . . . . 0.0 110.001 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -135.03 67.13 69.41 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 125.135 1.374 . . . . 0.0 111.38 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.58 168.51 18.05 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.329 2.686 . . . . 0.0 112.792 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.3 m -145.82 162.63 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.444 1.898 . . . . 0.0 110.765 -174.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.0 t -102.81 121.84 43.31 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.957 0.903 . . . . 0.0 109.364 166.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.97 166.8 53.17 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 119.108 0.867 . . . . 0.0 112.951 174.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.0 m -65.32 -15.45 62.55 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -74.91 -6.61 50.11 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.451 1.1 . . . . 0.0 113.851 168.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.96 19.41 61.27 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.955 1.264 . . . . 0.0 114.56 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.46 153.8 24.53 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.384 1.874 . . . . 0.0 111.45 -174.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.8 m -102.9 117.96 35.77 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.956 1.702 . . . . 0.0 111.886 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -104.29 163.11 12.65 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 128.078 2.551 . . . . 0.0 110.949 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.78 -25.38 56.38 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -175.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -161.43 178.61 8.98 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.007 1.723 . . . . 0.0 111.432 173.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.9 m -63.96 -37.4 87.26 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 177.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.6 t -59.68 -45.18 92.85 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.872 1.669 . . . . 0.0 112.966 -177.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.8 tt -73.39 -40.1 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.566 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.06 -28.53 67.87 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 174.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -90.44 -27.29 19.37 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 174.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.3 t -55.26 -38.99 69.26 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.966 1.307 . . . . 0.0 113.044 -176.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -69.82 -10.66 59.26 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 126.17 1.788 . . . . 0.0 115.25 175.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.33 -8.2 52.31 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 126.377 1.941 . . . . 0.0 116.131 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 t -92.94 164.99 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 125.496 1.518 . . . . 0.0 110.203 177.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 p -98.16 165.89 11.67 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.806 2.042 . . . . 0.0 112.089 174.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 pt -75.67 128.35 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.182 0.993 . . . . 0.0 109.731 169.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -69.43 -44.15 71.91 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.46 1.104 . . . . 0.0 110.784 168.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.0 t -156.49 170.71 21.72 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.067 1.347 . . . . 0.0 112.072 170.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -77.4 153.03 34.06 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.46 1.904 . . . . 0.0 111.528 173.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.89 152.67 5.77 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.372 1.463 . . . . 0.0 112.45 -173.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 p -58.03 139.72 53.96 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.836 0.855 . . . . 0.0 111.675 167.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.542 0.657 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -175.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.9 m . . . . . 0 CA--C 1.551 0.99 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -81.77 173.67 11.03 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.492 2.795 . . . . 0.0 113.068 -173.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -124.09 15.04 9.16 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.324 1.85 . . . . 0.0 114.152 -171.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.3 pp -61.43 174.03 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 125.714 1.605 . . . . 0.0 112.575 165.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.4 mt -110.7 85.96 2.22 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.17 1.388 . . . . 0.0 109.489 171.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.09 69.9 41.54 Favored Pre-proline 0 N--CA 1.473 0.693 0 C-N-CA 123.989 0.916 . . . . 0.0 110.756 174.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.15 171.99 11.72 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.745 2.297 . . . . 0.0 112.376 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.7 m -141.59 163.58 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.228 1.811 . . . . 0.0 111.455 -173.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.5 t -104.25 115.45 30.41 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.001 0.92 . . . . 0.0 109.213 166.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.41 162.2 54.0 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 123.891 0.757 . . . . 0.0 114.14 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.9 t -59.11 -28.63 66.7 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.567 1.147 . . . . 0.0 114.036 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -79.64 -1.14 36.83 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 125.97 1.708 . . . . 0.0 113.861 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.62 5.63 86.47 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.172 1.367 . . . . 0.0 113.983 -171.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.59 163.86 15.37 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.637 1.975 . . . . 0.0 112.344 176.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 27.4 m -135.57 113.01 10.67 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.447 1.499 . . . . 0.0 109.659 170.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -105.55 157.26 17.51 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.7 1.2 . . . . 0.0 111.131 173.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.57 -36.03 73.29 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.386 1.474 . . . . 0.0 113.893 -176.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.59 171.62 16.82 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.43 0.692 . . . . 0.0 111.448 171.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.8 m -60.87 -40.71 94.02 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.9 t -53.57 -41.95 67.05 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.674 1.99 . . . . 0.0 112.89 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 44.9 mm -70.99 -46.87 65.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 114.191 -1.368 . . . . 0.0 111.09 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.05 -53.63 47.4 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 173.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -61.26 -37.52 83.41 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 177.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.9 t -61.71 -39.0 89.96 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.041 0.936 . . . . 0.0 112.343 176.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -72.53 -2.46 19.83 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.812 1.645 . . . . 0.0 114.376 172.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.03 4.93 64.48 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.03 1.3 . . . . 0.0 115.777 169.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 m -119.48 135.85 58.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 126.382 1.873 . . . . 0.0 111.271 -177.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -75.41 154.93 36.86 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.605 1.162 . . . . 0.0 112.231 176.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 pt -78.58 125.49 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.861 1.264 . . . . 0.0 109.557 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -78.67 -36.42 43.79 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.386 1.075 . . . . 0.0 111.829 172.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.8 t -153.83 168.84 24.97 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.672 1.189 . . . . 0.0 112.461 169.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -85.06 146.49 27.14 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.584 2.354 . . . . 0.0 110.807 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.64 149.22 5.2 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.67 1.128 . . . . 0.0 111.767 -170.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.0 p -59.1 135.57 57.68 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.569 -0.959 . . . . 0.0 111.287 168.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -177.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.6 m . . . . . 0 CA--C 1.551 0.993 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.34 160.24 35.87 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.535 2.823 . . . . 0.0 112.317 -172.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.85 4.09 13.86 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.194 1.797 . . . . 0.0 115.582 -172.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pp -71.59 168.81 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 126.897 2.079 . . . . 0.0 112.894 173.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.6 mt -96.33 89.93 5.26 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.426 1.49 . . . . 0.0 109.915 169.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -139.42 69.3 39.48 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 123.475 0.71 . . . . 0.0 110.976 169.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.45 167.16 17.48 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.046 2.497 . . . . 0.0 112.506 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.4 m -144.88 155.89 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.766 1.626 . . . . 0.0 110.678 -174.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.5 t -102.05 117.88 35.72 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.055 0.942 . . . . 0.0 109.666 172.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.55 165.99 53.12 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 121.51 -0.744 . . . . 0.0 113.659 175.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.7 p -61.63 -21.39 64.35 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -70.11 -12.77 61.84 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.559 1.543 . . . . 0.0 113.681 171.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.37 -0.85 75.47 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.935 1.731 . . . . 0.0 115.112 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -90.43 160.54 15.99 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.331 1.452 . . . . 0.0 111.512 176.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 40.4 m -109.26 131.65 54.87 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.279 1.431 . . . . 0.0 110.513 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -113.3 167.95 10.14 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.793 1.637 . . . . 0.0 110.481 173.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.73 -26.42 62.46 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -167.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -161.25 177.63 10.02 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.949 2.099 . . . . 0.0 110.681 174.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.8 p -62.17 -43.1 99.58 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 t -56.69 -37.98 71.62 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.471 1.908 . . . . 0.0 114.554 -176.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 tt -73.18 -52.75 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.844 0.858 . . . . 0.0 111.528 172.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.79 -56.05 6.87 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.799 1.24 . . . . 0.0 112.305 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.13 -27.69 69.25 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.205 1.802 . . . . 0.0 115.385 177.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 9.5 t -59.78 -33.29 71.52 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.361 1.064 . . . . 0.0 112.79 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -67.33 -17.83 64.92 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.171 1.389 . . . . 0.0 113.917 173.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.47 -9.95 57.6 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 126.594 2.045 . . . . 0.0 115.242 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.6 m -86.55 149.87 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 119.164 1.482 . . . . 0.0 111.516 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.01 156.18 20.55 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.921 1.289 . . . . 0.0 111.607 170.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.9 pt -71.2 129.02 35.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.195 0.998 . . . . 0.0 110.018 171.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.4 tptp -78.49 -35.32 46.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.449 1.099 . . . . 0.0 111.28 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.0 p -156.36 162.48 40.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.879 1.672 . . . . 0.0 112.503 172.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -84.84 157.2 21.0 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.119 0.968 . . . . 0.0 112.418 169.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.14 161.74 11.69 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.15 1.357 . . . . 0.0 111.975 -166.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.1 m -59.02 131.74 51.96 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.95 -0.735 . . . . 0.0 109.765 164.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.545 0.774 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 14.3 m . . . . . 0 CA--C 1.547 0.862 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -77.97 166.96 24.33 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.238 2.625 . . . . 0.0 111.966 -176.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -119.74 15.33 12.68 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.763 2.025 . . . . 0.0 114.538 -170.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -60.64 170.29 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 126.736 2.014 . . . . 0.0 113.73 170.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.0 mt -104.83 80.1 1.6 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.565 1.546 . . . . 0.0 110.221 172.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.6 mmtt -138.92 66.24 39.46 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 125.132 1.373 . . . . 0.0 110.796 173.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.82 163.16 31.77 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.86 2.373 . . . . 0.0 111.944 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.0 m -146.51 160.75 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.561 1.544 . . . . 0.0 111.48 -170.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.5 t -96.28 116.88 29.72 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.012 1.325 . . . . 0.0 110.486 172.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.26 165.48 54.8 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 121.407 -0.808 . . . . 0.0 113.368 172.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.8 t -61.95 -26.93 68.49 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.35 1.06 . . . . 0.0 113.164 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -69.02 -8.01 40.96 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.603 1.961 . . . . 0.0 114.912 169.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.37 2.12 90.55 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.813 1.673 . . . . 0.0 115.3 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.2 mmt-85 -84.92 163.23 19.1 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.435 1.618 . . . . 0.0 111.615 173.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.3 m -118.42 117.59 29.45 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.589 1.555 . . . . 0.0 109.893 173.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -103.72 176.51 5.13 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.138 1.375 . . . . 0.0 110.298 170.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.87 -24.66 64.36 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -169.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.54 176.56 10.29 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.534 1.534 . . . . 0.0 110.869 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.7 p -62.24 -45.41 93.47 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 174.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.2 t -56.85 -44.26 81.97 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.404 1.882 . . . . 0.0 114.08 -177.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.44 -44.38 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.745 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.26 -49.56 77.38 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.022 0.929 . . . . 0.0 111.756 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -61.95 -28.65 69.69 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 174.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.9 t -61.29 -34.83 75.85 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.091 0.956 . . . . 0.0 112.844 176.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -72.47 -8.72 56.56 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.33 1.452 . . . . 0.0 114.144 170.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.93 -12.09 64.12 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.579 2.038 . . . . 0.0 115.335 174.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.6 m -79.97 141.18 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.266 1.426 . . . . 0.0 111.863 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.6 t -78.06 173.72 11.89 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.762 0.791 . . . . 0.0 112.036 171.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.0 mm -99.2 112.8 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 126.085 1.754 . . . . 0.0 110.196 -175.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -66.06 -38.6 88.73 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.533 0.733 . . . . 0.0 111.377 172.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.9 p -168.17 156.88 9.02 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.037 0.935 . . . . 0.0 112.949 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -82.11 153.87 25.85 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 122.304 1.05 . . . . 0.0 111.545 172.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.82 153.71 8.54 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.911 1.72 . . . . 0.0 111.618 -168.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.8 m -56.05 128.2 34.21 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.74 -0.859 . . . . 0.0 110.078 167.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.546 0.824 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -176.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 27.2 m . . . . . 0 CA--C 1.551 1.004 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.57 141.75 35.13 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.024 2.483 . . . . 0.0 111.441 -175.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -77.61 8.14 4.75 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.978 1.711 . . . . 0.0 114.868 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.4 tt -58.36 143.73 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 125.974 1.71 . . . . 0.0 112.702 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.5 tt -91.98 72.07 5.57 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.141 1.376 . . . . 0.0 109.573 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -138.24 72.45 45.51 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 125.415 1.486 . . . . 0.0 110.559 177.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -67.52 165.97 25.45 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.473 2.115 . . . . 0.0 112.037 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.7 m -141.35 156.68 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 126.238 1.815 . . . . 0.0 110.557 -175.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.4 t -91.95 117.0 29.4 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 165.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.18 162.18 45.93 Favored Glycine 0 CA--C 1.535 1.288 0 O-C-N 121.459 -0.776 . . . . 0.0 113.007 174.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.7 m -68.91 -14.27 62.94 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -176.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -74.31 -5.82 44.44 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.723 1.609 . . . . 0.0 113.27 169.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.82 21.08 54.43 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.787 1.184 . . . . 0.0 114.541 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -119.54 162.91 18.11 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.196 1.798 . . . . 0.0 111.788 -176.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.4 m -114.57 122.61 47.06 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.916 1.686 . . . . 0.0 110.133 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -115.34 169.07 9.42 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.635 1.574 . . . . 0.0 110.817 174.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.85 -30.35 66.73 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -166.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -164.51 170.3 16.06 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.28 1.432 . . . . 0.0 111.954 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.7 p -60.97 -39.85 91.16 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -171.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -54.08 -51.77 63.08 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.787 2.035 . . . . 0.0 112.997 176.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.6 tp -67.41 -40.43 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 121.387 -0.821 . . . . 0.0 110.865 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.97 -3.58 5.53 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.897 1.679 . . . . 0.0 114.905 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -116.09 -31.97 5.52 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.832 1.653 . . . . 0.0 114.489 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 56.4 m -60.41 -26.41 66.68 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.715 1.206 . . . . 0.0 113.633 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -72.94 -10.75 60.14 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 127.53 2.332 . . . . 0.0 115.472 170.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.27 1.17 59.43 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 125.642 1.591 . . . . 0.0 116.518 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 p -102.05 169.39 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-N 119.359 1.579 . . . . 0.0 111.064 172.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.1 149.79 29.53 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 127.115 2.166 . . . . 0.0 112.121 175.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -66.93 124.15 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 125.096 1.358 . . . . 0.0 110.089 176.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -78.98 -37.82 38.46 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.717 1.207 . . . . 0.0 111.523 174.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.8 p -160.03 162.13 34.15 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.472 1.509 . . . . 0.0 112.942 172.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -76.96 151.55 35.64 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.878 1.271 . . . . 0.0 112.615 171.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.54 156.94 8.48 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.097 1.332 . . . . 0.0 111.701 -169.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.2 p -60.1 146.08 44.4 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.71 -0.876 . . . . 0.0 111.837 167.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.542 0.652 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.6 m . . . . . 0 CA--C 1.55 0.944 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -79.61 173.71 12.69 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.973 3.116 . . . . 0.0 112.546 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -122.76 14.01 10.02 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.206 1.802 . . . . 0.0 114.065 -173.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.88 161.92 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 125.347 1.459 . . . . 0.0 112.52 172.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tt -98.25 75.94 2.3 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.765 1.226 . . . . 0.0 109.804 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -140.08 69.85 34.94 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 124.3 1.04 . . . . 0.0 111.428 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.88 168.04 24.17 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.176 2.584 . . . . 0.0 112.644 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.6 m -137.77 167.32 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 128.332 2.653 . . . . 0.0 111.518 -171.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.7 t -109.67 108.46 18.86 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.905 0.882 . . . . 0.0 109.569 167.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.13 156.17 53.55 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.008 0.813 . . . . 0.0 114.319 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.3 t -69.08 -14.26 62.91 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -78.3 -5.99 53.72 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.01 1.724 . . . . 0.0 113.86 168.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.23 4.43 74.3 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.752 1.644 . . . . 0.0 115.06 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -101.34 168.04 9.79 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.164 1.482 . . . . 0.0 111.727 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.2 m -121.27 135.51 55.11 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.733 1.613 . . . . 0.0 110.108 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -125.66 156.97 38.42 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.37 1.468 . . . . 0.0 110.863 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.84 -31.04 64.35 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.14 1.376 . . . . 0.0 114.108 -174.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -156.64 169.29 25.03 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.806 0.843 . . . . 0.0 111.605 175.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.1 t -60.61 -44.71 95.98 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.0 t -50.27 -44.19 53.65 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.113 1.765 . . . . 0.0 113.059 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.0 mm -64.03 -57.09 13.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.859 176.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.59 -52.87 16.31 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.396 0.678 . . . . 0.0 112.689 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -61.55 -38.19 86.56 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 30.6 t -63.16 -38.96 93.24 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.238 1.015 . . . . 0.0 112.138 176.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -67.51 -13.17 61.81 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.187 1.395 . . . . 0.0 113.463 173.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.12 -0.18 41.12 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 126.286 1.898 . . . . 0.0 115.529 172.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.2 m -112.91 134.07 56.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 126.229 1.812 . . . . 0.0 111.465 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 p -74.85 152.51 38.92 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.176 -0.953 . . . . 0.0 111.665 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.5 pt -73.49 127.47 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.114 0.965 . . . . 0.0 109.311 172.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -78.57 -37.05 43.56 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.838 -0.538 . . . . 0.0 111.269 171.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.0 p -152.74 162.39 41.33 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.588 1.555 . . . . 0.0 112.966 170.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -74.84 152.84 38.9 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.947 1.699 . . . . 0.0 111.22 169.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.54 152.63 6.32 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.215 1.388 . . . . 0.0 111.942 -175.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.5 t -58.33 147.39 31.17 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.783 -0.833 . . . . 0.0 110.871 167.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 CA--C 1.54 0.585 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -178.055 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 18.7 m . . . . . 0 CA--C 1.549 0.917 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.38 166.22 26.38 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.632 2.888 . . . . 0.0 112.197 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -115.04 25.52 10.84 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.311 1.844 . . . . 0.0 113.408 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.3 pt -58.01 173.71 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 127.195 2.198 . . . . 0.0 112.726 169.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 tt -123.57 75.12 1.31 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.029 1.332 . . . . 0.0 109.237 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -141.99 71.76 23.49 Favored Pre-proline 0 N--CA 1.471 0.622 0 C-N-CA 124.305 1.042 . . . . 0.0 110.371 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.66 159.54 53.22 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.262 1.975 . . . . 0.0 112.079 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.4 m -145.82 147.33 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.149 1.38 . . . . 0.0 111.724 -169.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.2 t -90.55 116.81 28.74 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.665 1.186 . . . . 0.0 110.762 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.99 165.18 53.38 Favored Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.56 -0.712 . . . . 0.0 113.197 174.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.9 p -65.55 -17.25 64.43 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -68.84 -16.87 63.9 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.759 1.624 . . . . 0.0 113.589 168.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.07 -4.91 78.42 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.993 1.758 . . . . 0.0 114.961 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.7 ttt85 -83.77 161.82 20.85 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.356 1.462 . . . . 0.0 111.458 170.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 62.5 m -111.35 135.48 51.83 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.296 1.838 . . . . 0.0 110.952 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -119.87 165.52 14.5 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.739 1.616 . . . . 0.0 110.958 174.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.84 -30.45 70.63 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -167.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.44 173.88 15.53 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.282 1.833 . . . . 0.0 110.353 172.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.1 p -59.8 -41.72 91.83 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -56.36 -45.67 80.37 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.709 1.604 . . . . 0.0 113.301 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.7 tp -69.21 -41.82 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.931 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.66 -56.21 19.26 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.283 1.033 . . . . 0.0 111.32 174.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -59.32 -37.95 79.06 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 63.9 m -71.33 -23.85 62.0 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 175.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -74.1 -20.46 60.25 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.029 1.332 . . . . 0.0 112.934 172.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.68 7.66 17.48 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.851 1.691 . . . . 0.0 115.807 174.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 t -133.36 151.52 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.043 1.421 . . . . 0.0 110.545 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.8 t -92.99 158.46 15.78 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.169 0.985 . . . . 0.0 112.184 174.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.62 122.5 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 128.667 2.787 . . . . 0.0 108.51 171.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -79.22 -49.8 11.95 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.745 -0.597 . . . . 0.0 110.584 161.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.8 p -143.61 161.24 39.01 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.161 1.385 . . . . 0.0 113.227 -176.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.31 154.0 20.44 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.485 1.514 . . . . 0.0 112.597 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.17 160.9 19.98 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.03 1.3 . . . . 0.0 111.818 -169.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 m -61.37 126.95 29.2 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.783 -0.833 . . . . 0.0 109.564 164.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -173.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.8 m . . . . . 0 CA--C 1.547 0.847 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.63 168.51 24.24 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.261 2.641 . . . . 0.0 111.916 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -122.81 16.2 10.16 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.822 2.049 . . . . 0.0 114.497 -170.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.95 168.28 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 126.584 1.954 . . . . 0.0 112.925 170.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 tt -105.47 69.28 0.83 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.943 1.297 . . . . 0.0 110.583 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -137.31 72.13 52.52 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 124.822 1.249 . . . . 0.0 110.572 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.79 166.87 18.93 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.728 2.286 . . . . 0.0 111.937 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 m -142.99 150.98 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.81 1.644 . . . . 0.0 110.55 -176.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.5 t -87.98 114.49 24.64 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 169.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.56 159.68 53.75 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 119.409 1.004 . . . . 0.0 112.364 171.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t -65.2 -20.13 66.29 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 121.271 -1.135 . . . . 0.0 114.024 -177.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.67 -17.15 64.39 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.057 1.743 . . . . 0.0 113.859 168.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.68 -6.63 62.84 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 126.44 1.971 . . . . 0.0 114.826 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -77.9 164.67 24.93 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 118.712 1.256 . . . . 0.0 111.859 173.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 60.5 m -117.93 133.7 55.67 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.422 1.489 . . . . 0.0 110.027 169.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -121.81 170.19 10.01 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.857 1.663 . . . . 0.0 110.565 172.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.04 -30.64 71.21 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -165.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -163.36 172.77 14.13 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.833 1.253 . . . . 0.0 111.609 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.5 m -59.8 -39.18 84.12 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -173.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.6 t -58.92 -44.55 91.32 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.529 1.931 . . . . 0.0 113.479 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.89 -40.34 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.317 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.67 -53.22 60.85 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.634 0.774 . . . . 0.0 111.292 174.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -61.58 -29.02 69.76 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 176.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 10.8 t -60.12 -35.13 74.58 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.102 0.961 . . . . 0.0 112.705 176.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -75.37 -3.67 34.95 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.872 1.669 . . . . 0.0 114.068 172.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.71 -10.55 73.27 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 126.528 2.013 . . . . 0.0 115.173 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.5 m -85.08 138.02 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.81 1.644 . . . . 0.0 111.637 176.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -76.96 154.67 33.35 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.396 1.079 . . . . 0.0 112.238 169.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 pp -74.05 123.15 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.384 1.474 . . . . 0.0 109.744 174.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -75.4 -42.59 53.41 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.806 1.242 . . . . 0.0 111.57 173.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.4 t -158.09 169.4 24.63 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.093 1.357 . . . . 0.0 112.209 173.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -79.93 152.2 29.69 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.756 2.022 . . . . 0.0 113.012 174.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.46 163.96 13.46 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.476 1.512 . . . . 0.0 112.309 -173.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 m -59.47 128.66 38.17 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.602 0.761 . . . . 0.0 109.563 164.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.544 0.739 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -176.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 120.497 0.189 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.0 mtpp -143.1 159.66 41.85 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.301 1.841 . . . . 0.0 110.754 173.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.4 m -74.9 -28.36 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.854 1.262 . . . . 0.0 113.206 173.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 86.3 m -82.59 152.49 25.92 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.874 1.27 . . . . 0.0 111.715 173.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -146.76 131.71 18.16 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.278 1.431 . . . . 0.0 110.525 173.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 45.3 m -64.56 154.76 83.62 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.426 1.091 . . . . 0.0 112.052 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.87 154.98 43.55 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.371 2.714 . . . . 0.0 111.482 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -104.58 5.42 33.78 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.911 2.084 . . . . 0.0 114.135 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 9.1 mt -70.16 143.07 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.897 1.679 . . . . 0.0 110.102 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.6 tt -80.75 74.99 7.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.558 1.943 . . . . 0.0 110.293 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -133.58 68.23 76.1 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 125.391 1.476 . . . . 0.0 111.509 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -67.6 165.95 25.66 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.024 2.483 . . . . 0.0 112.54 -176.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.6 m -142.94 152.23 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.973 1.709 . . . . 0.0 110.694 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.5 t -90.59 118.15 29.82 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 167.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.57 165.02 54.3 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-N 119.177 0.898 . . . . 0.0 112.799 172.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.7 p -67.42 -16.0 63.99 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.34 -9.28 58.53 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.227 1.411 . . . . 0.0 114.053 167.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.59 -1.58 88.21 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.609 1.576 . . . . 0.0 114.931 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.5 mmt-85 -72.28 159.44 34.06 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.011 1.324 . . . . 0.0 111.277 168.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 59.4 m -114.56 131.24 56.73 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.176 1.39 . . . . 0.0 109.564 169.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.406 ' HB3' HG23 ' A' ' 26' ' ' ILE . 16.3 m-85 -118.11 166.62 12.34 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.688 1.595 . . . . 0.0 109.916 175.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.73 -24.21 62.58 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -167.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -165.09 176.33 8.62 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.727 2.011 . . . . 0.0 111.12 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.1 m -65.26 -34.58 78.69 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.7 t -62.32 -45.65 92.25 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.953 1.701 . . . . 0.0 113.244 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.406 HG23 ' HB3' ' A' ' 21' ' ' TYR . 10.8 tp -69.96 -39.36 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.194 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.04 -54.87 37.51 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.102 0.961 . . . . 0.0 111.685 170.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -63.18 -32.22 73.56 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.9 m -62.82 -20.23 64.84 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -80.93 -2.81 49.21 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.526 1.13 . . . . 0.0 113.673 169.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.75 16.32 58.43 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.418 1.485 . . . . 0.0 114.774 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 t -129.8 148.99 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.332 1.453 . . . . 0.0 111.277 -172.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.1 p -85.25 158.31 20.36 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.929 1.692 . . . . 0.0 112.721 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.66 124.77 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 125.578 1.551 . . . . 0.0 109.606 172.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -76.15 -39.86 54.02 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.879 1.272 . . . . 0.0 111.317 172.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.3 p -158.98 162.91 36.84 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.54 1.536 . . . . 0.0 112.785 172.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -74.89 152.41 38.88 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.025 1.33 . . . . 0.0 112.539 170.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.24 162.42 20.09 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.597 1.57 . . . . 0.0 112.538 -172.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.4 t -59.93 148.04 36.51 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.987 -0.713 . . . . 0.0 110.87 164.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.6 p -100.6 153.35 37.79 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.59 122.56 8.7 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 124.03 3.153 . . . . 0.0 112.475 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.3 m -72.36 -12.29 61.06 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.937 1.295 . . . . 0.0 113.615 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -83.15 2.06 87.64 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 126.347 1.927 . . . . 0.0 115.742 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 52.9 mt . . . . . 0 C--O 1.253 1.247 0 C-N-CA 126.634 1.974 . . . . 0.0 110.278 -178.386 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 120.712 0.291 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -141.27 28.87 1.83 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 126.116 1.766 . . . . 0.0 113.297 -169.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.9 t -56.01 120.18 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 125.225 1.41 . . . . 0.0 111.96 -175.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 77.1 m -87.75 -35.72 17.73 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.101 1.36 . . . . 0.0 112.84 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.36 112.6 5.53 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.035 1.734 . . . . 0.0 110.731 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 13.7 m -63.47 159.26 52.33 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 125.027 1.331 . . . . 0.0 112.984 174.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -76.62 171.74 17.49 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.952 3.101 . . . . 0.0 112.211 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.1 tttm -119.37 9.41 11.62 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.97 1.708 . . . . 0.0 114.581 -174.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.5 mt -63.11 143.66 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.182 1.393 . . . . 0.0 110.069 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 71.6 mt -75.01 70.61 2.03 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.054 1.741 . . . . 0.0 111.108 173.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -132.92 63.38 66.94 Favored Pre-proline 0 N--CA 1.471 0.622 0 C-N-CA 125.374 1.469 . . . . 0.0 109.934 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.26 160.25 48.46 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.987 2.458 . . . . 0.0 111.455 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.7 m -144.71 162.39 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.833 1.253 . . . . 0.0 111.639 -172.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.4 t -98.45 113.81 25.95 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.171 1.388 . . . . 0.0 110.201 173.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.37 166.37 54.71 Favored Glycine 0 CA--C 1.535 1.34 0 O-C-N 121.604 -0.685 . . . . 0.0 113.425 172.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.1 t -60.13 -25.1 65.21 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.071 1.349 . . . . 0.0 113.717 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -68.08 -14.12 62.73 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.918 1.287 . . . . 0.0 113.827 172.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.84 -4.04 84.87 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 126.088 1.804 . . . . 0.0 114.634 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -78.13 159.87 28.38 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.782 1.233 . . . . 0.0 111.685 173.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 59.6 m -109.91 131.56 54.95 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.519 1.528 . . . . 0.0 109.793 170.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -119.72 167.95 11.55 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.66 1.184 . . . . 0.0 110.756 171.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.63 -25.24 59.86 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -175.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -167.34 177.24 6.18 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.569 1.548 . . . . 0.0 111.329 174.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.0 p -60.49 -47.1 87.61 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 176.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.5 t -55.69 -42.06 74.64 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.503 1.921 . . . . 0.0 113.424 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.43 -52.71 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 125.38 1.472 . . . . 0.0 111.032 175.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.58 -46.93 83.4 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.36 0.664 . . . . 0.0 111.96 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -65.77 -28.86 69.34 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.3 t -59.46 -33.98 71.97 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.248 1.019 . . . . 0.0 112.69 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -72.44 -3.63 25.4 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.145 1.778 . . . . 0.0 113.998 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.92 -12.29 65.77 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 126.807 2.146 . . . . 0.0 115.334 172.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.5 m -88.22 135.71 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.836 1.654 . . . . 0.0 111.855 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.3 p -68.62 164.66 20.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.928 1.291 . . . . 0.0 112.726 173.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.3 mm -90.79 110.8 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 123.996 0.918 . . . . 0.0 110.263 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -45.97 90.78 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.256 1.022 . . . . 0.0 110.97 172.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.7 t -164.18 166.06 21.49 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.727 0.775 . . . . 0.0 112.777 173.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -86.78 154.99 20.5 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.628 1.971 . . . . 0.0 112.719 176.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.06 157.56 11.6 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.958 1.266 . . . . 0.0 111.806 -168.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.3 m -59.45 126.95 29.68 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.784 -0.833 . . . . 0.0 109.958 168.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -72.99 156.96 89.27 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -176.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -66.19 140.62 59.82 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.451 2.768 . . . . 0.0 111.742 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.5 t -160.99 113.96 1.96 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.544 1.538 . . . . 0.0 110.594 -177.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 157.08 -27.5 0.51 Allowed Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.37 1.462 . . . . 0.0 115.227 171.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.7 tp . . . . . 0 C--O 1.253 1.264 0 C-N-CA 126.636 1.974 . . . . 0.0 111.999 176.005 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -131.49 72.61 1.5 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.814 1.646 . . . . 0.0 113.242 -173.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.2 t -89.52 -31.27 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.759 1.224 . . . . 0.0 112.385 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.8 p -115.45 -55.98 2.39 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.775 1.63 . . . . 0.0 112.362 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.91 84.75 3.46 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.73 1.212 . . . . 0.0 111.708 174.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.1 m -61.84 157.52 49.19 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.389 1.476 . . . . 0.0 112.198 171.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.98 158.2 38.43 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.35 2.7 . . . . 0.0 112.106 -174.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -100.14 4.37 44.45 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.573 1.949 . . . . 0.0 114.435 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.7 mt -68.29 143.2 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.744 1.618 . . . . 0.0 109.905 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.89 79.58 9.58 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.129 1.772 . . . . 0.0 110.199 173.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -131.64 63.07 67.98 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 125.605 1.562 . . . . 0.0 111.721 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.33 166.12 24.57 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.309 2.672 . . . . 0.0 112.714 -173.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.6 m -142.55 152.54 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.835 1.654 . . . . 0.0 110.904 -175.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.8 t -89.42 113.55 24.9 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 166.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.87 162.56 52.96 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-N 118.906 0.776 . . . . 0.0 112.939 175.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 t -67.05 -14.08 62.55 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -72.53 -14.2 61.59 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.942 1.297 . . . . 0.0 113.479 168.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.55 -6.86 77.77 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 126.245 1.878 . . . . 0.0 114.706 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.2 mmt85 -74.29 161.99 29.35 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.776 1.631 . . . . 0.0 112.006 170.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.5 m -115.05 137.47 51.97 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.456 1.502 . . . . 0.0 109.763 167.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -127.18 166.84 16.95 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.894 1.678 . . . . 0.0 110.622 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.09 -23.75 64.05 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -165.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -164.42 -176.53 4.42 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.703 2.001 . . . . 0.0 111.353 172.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 54.8 m -67.17 -34.62 77.93 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 176.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.2 t -65.91 -38.1 87.83 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.796 1.638 . . . . 0.0 113.48 -175.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.0 tp -70.9 -50.22 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.843 170.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.53 -51.06 64.07 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.139 1.376 . . . . 0.0 112.882 -177.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.42 -34.82 72.96 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.044 1.337 . . . . 0.0 113.543 175.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.8 t -63.87 -30.92 71.96 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.504 1.122 . . . . 0.0 113.075 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -67.8 -8.15 33.52 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.059 1.344 . . . . 0.0 114.045 173.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.34 11.91 60.48 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.994 1.283 . . . . 0.0 115.086 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -128.74 151.26 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.538 1.535 . . . . 0.0 110.321 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 p -82.29 160.36 22.93 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.319 1.848 . . . . 0.0 112.847 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -73.09 126.04 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 125.75 1.62 . . . . 0.0 109.495 171.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -81.41 -38.21 26.88 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.557 1.143 . . . . 0.0 111.617 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.6 p -157.57 162.7 38.78 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.337 1.455 . . . . 0.0 112.788 169.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -75.1 150.25 38.87 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.238 1.415 . . . . 0.0 112.445 171.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.77 161.29 19.56 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.554 1.549 . . . . 0.0 112.403 -171.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.0 t -58.97 148.55 30.2 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 122.012 -0.699 . . . . 0.0 111.024 165.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.7 p -101.36 152.96 38.08 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.0 131.63 18.47 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.901 3.067 . . . . 0.0 111.936 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.21 -3.58 37.17 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.322 1.449 . . . . 0.0 114.278 -176.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.89 -14.53 82.08 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 125.209 1.385 . . . . 0.0 116.468 -169.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mp . . . . . 0 C--O 1.253 1.257 0 C-N-CA 125.982 1.713 . . . . 0.0 109.934 177.546 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -143.03 116.52 9.12 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 126.156 1.782 . . . . 0.0 110.611 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.8 m -65.13 133.69 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.379 1.072 . . . . 0.0 112.115 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.1 t -78.64 -27.68 45.39 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.196 0.998 . . . . 0.0 112.842 175.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.99 96.71 5.28 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.178 1.791 . . . . 0.0 111.034 -176.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 43.0 m -60.7 156.17 46.56 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 125.568 1.547 . . . . 0.0 113.049 173.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.1 146.8 41.81 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.272 2.648 . . . . 0.0 110.981 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -80.26 6.57 11.55 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.944 1.698 . . . . 0.0 115.006 176.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.7 tt -57.91 139.63 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 126.291 1.837 . . . . 0.0 113.186 -173.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.8 mt -84.9 72.01 10.83 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.11 1.364 . . . . 0.0 110.683 175.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -139.16 71.48 40.29 Favored Pre-proline 0 N--CA 1.47 0.54 0 C-N-CA 125.243 1.417 . . . . 0.0 109.944 173.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -66.64 166.64 21.42 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.367 2.045 . . . . 0.0 112.179 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.8 m -144.71 154.43 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.112 1.765 . . . . 0.0 111.027 -172.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 t -94.23 115.18 27.4 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.522 0.729 . . . . 0.0 109.186 167.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.9 160.66 53.58 Favored Glycine 0 CA--C 1.536 1.369 0 O-C-N 121.336 -0.853 . . . . 0.0 113.085 173.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.1 t -64.56 -20.62 66.34 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -70.79 -6.18 35.76 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.084 1.353 . . . . 0.0 114.364 170.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.48 19.97 55.52 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.71 1.148 . . . . 0.0 114.833 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -118.25 162.89 17.51 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.448 1.899 . . . . 0.0 111.332 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.1 m -116.53 129.62 56.29 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.237 1.415 . . . . 0.0 110.748 -175.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -123.9 165.86 16.65 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.721 1.608 . . . . 0.0 110.767 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.8 -29.96 70.53 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -167.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -166.41 171.06 12.34 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.908 1.683 . . . . 0.0 111.358 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.3 m -59.16 -42.78 91.55 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -171.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.2 t -56.08 -43.56 78.12 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.236 1.814 . . . . 0.0 113.264 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.5 tp -72.8 -38.77 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.899 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.33 -52.61 64.54 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.926 0.89 . . . . 0.0 111.766 174.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -60.05 -28.45 67.79 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.8 t -58.04 -31.51 67.08 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.118 1.367 . . . . 0.0 113.413 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -73.75 -3.97 31.7 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.238 1.415 . . . . 0.0 114.31 173.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.11 11.46 63.07 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.214 1.388 . . . . 0.0 114.908 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.35 146.83 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 126.076 1.75 . . . . 0.0 110.57 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 p -79.87 162.45 25.01 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.868 1.667 . . . . 0.0 113.111 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.3 pp -72.11 123.04 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.371 1.468 . . . . 0.0 109.611 170.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -68.66 -41.47 79.26 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.915 1.286 . . . . 0.0 111.173 170.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.9 p -156.98 158.17 36.1 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.17 1.788 . . . . 0.0 112.362 174.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -72.69 149.78 43.51 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.099 1.36 . . . . 0.0 110.653 171.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.32 158.46 20.77 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.922 1.249 . . . . 0.0 112.057 -174.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.3 t -59.87 145.02 47.2 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.739 -0.86 . . . . 0.0 110.912 167.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.2 p -93.6 155.41 40.66 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -70.11 143.73 50.05 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.527 2.818 . . . . 0.0 111.92 177.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.04 5.87 9.05 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.957 1.703 . . . . 0.0 113.956 -177.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.99 20.77 17.49 Favored Glycine 0 CA--C 1.54 1.616 0 C-N-CA 125.387 1.47 . . . . 0.0 114.224 -173.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.9 pt . . . . . 0 C--O 1.252 1.23 0 C-N-CA 127.19 2.196 . . . . 0.0 114.279 178.929 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.39 153.68 42.2 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.425 1.49 . . . . 0.0 112.273 173.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.4 t -85.12 129.11 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.283 1.433 . . . . 0.0 110.396 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 84.1 m -73.67 -32.55 64.03 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.222 1.009 . . . . 0.0 113.603 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.56 94.0 2.68 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.174 1.789 . . . . 0.0 110.77 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 16.6 m -60.14 155.86 42.38 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 125.045 1.338 . . . . 0.0 112.847 176.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -73.85 171.78 17.19 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.819 3.013 . . . . 0.0 111.449 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.75 17.8 10.27 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.877 1.671 . . . . 0.0 113.978 -173.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.9 mt -63.84 141.56 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.505 1.522 . . . . 0.0 109.814 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.4 mt -79.59 70.47 6.07 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.732 1.213 . . . . 0.0 110.584 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -134.9 72.16 68.65 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 124.941 1.296 . . . . 0.0 109.866 172.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.17 164.03 33.79 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.109 1.873 . . . . 0.0 111.745 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.7 m -144.48 140.69 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.884 1.673 . . . . 0.0 110.58 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 t -79.14 114.78 18.35 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.85 163.09 45.44 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 121.546 -0.721 . . . . 0.0 113.159 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.1 m -68.11 -11.91 59.92 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -77.23 -10.52 59.47 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.929 1.692 . . . . 0.0 114.192 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.05 13.98 35.07 Favored Glycine 0 CA--C 1.539 1.541 0 N-CA-C 115.894 1.118 . . . . 0.0 115.894 175.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -137.05 168.24 19.97 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.317 1.847 . . . . 0.0 110.944 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.0 t -105.47 150.31 25.42 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.61 1.164 . . . . 0.0 111.699 175.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -124.19 170.28 10.89 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.233 1.813 . . . . 0.0 110.39 173.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.04 -35.17 77.8 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -167.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -163.16 168.04 21.32 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.474 1.51 . . . . 0.0 112.077 175.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.2 m -60.13 -32.11 70.7 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -167.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.7 t -61.22 -43.94 98.07 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.905 1.682 . . . . 0.0 113.514 176.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.9 tp -72.44 -39.59 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.747 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.48 -28.64 69.97 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.451 1.1 . . . . 0.0 113.418 176.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -88.04 -30.13 20.16 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.141 1.376 . . . . 0.0 114.377 173.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 37.5 t -55.09 -39.82 69.73 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.99 1.316 . . . . 0.0 113.13 -174.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -70.26 -11.34 60.83 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 126.076 1.75 . . . . 0.0 115.164 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.91 -8.29 42.45 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 126.488 1.994 . . . . 0.0 116.247 175.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.5 t -93.58 168.99 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 125.507 1.523 . . . . 0.0 110.654 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.6 p -112.24 155.9 23.27 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 127.477 2.311 . . . . 0.0 112.37 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -67.64 123.17 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.623 1.569 . . . . 0.0 110.075 176.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -77.34 -42.23 37.4 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.507 1.123 . . . . 0.0 110.832 172.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.0 p -153.75 157.93 40.2 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.461 1.504 . . . . 0.0 112.508 174.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -82.74 149.25 27.38 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.721 1.208 . . . . 0.0 111.269 177.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.81 162.04 24.34 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.54 1.066 . . . . 0.0 111.676 -169.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.1 t -60.33 148.27 37.59 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 122.125 -0.633 . . . . 0.0 110.942 167.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.2 p -98.48 157.47 34.28 Favored Pre-proline 0 CA--C 1.541 0.63 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -72.62 162.44 41.3 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.828 3.019 . . . . 0.0 112.038 173.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.9 p -133.36 80.13 1.86 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.604 1.562 . . . . 0.0 111.38 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.69 -18.38 6.1 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 125.14 1.352 . . . . 0.0 115.442 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.213 0 C-N-CA 126.69 1.996 . . . . 0.0 110.608 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 21.2 tptp . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 120.518 0.199 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -130.03 -18.59 3.33 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -172.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.9 m -71.94 -20.7 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.942 1.297 . . . . 0.0 113.895 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.4 p -67.85 137.76 55.56 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.441 1.096 . . . . 0.0 111.951 174.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.18 87.61 2.67 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.197 1.399 . . . . 0.0 110.333 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 18.6 m -60.15 154.95 48.29 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.856 1.263 . . . . 0.0 111.916 173.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.48 147.26 31.97 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.354 2.702 . . . . 0.0 111.664 -176.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.61 3.63 55.2 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.263 1.825 . . . . 0.0 114.645 177.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.2 mt -65.06 140.6 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.207 1.403 . . . . 0.0 109.995 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tt -80.75 74.2 7.7 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.981 1.712 . . . . 0.0 109.357 175.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.23 69.73 77.87 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 124.424 1.09 . . . . 0.0 110.474 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.29 167.28 18.85 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.835 2.356 . . . . 0.0 112.5 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.6 m -144.84 153.18 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 126.006 1.722 . . . . 0.0 110.358 -173.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.5 t -98.53 113.62 25.72 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.181 0.992 . . . . 0.0 108.766 171.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.63 159.16 53.53 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 118.773 0.715 . . . . 0.0 113.296 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.3 t -59.83 -24.09 63.89 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -67.57 -13.7 62.29 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 125.227 1.411 . . . . 0.0 114.017 171.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.97 -3.29 64.62 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 126.439 1.971 . . . . 0.0 114.697 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -84.11 164.64 19.08 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.941 1.696 . . . . 0.0 111.937 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.6 m -114.76 138.68 50.44 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.997 1.319 . . . . 0.0 110.508 171.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -124.92 166.87 15.53 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.981 1.712 . . . . 0.0 110.624 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.48 -24.23 61.96 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -167.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -164.18 179.28 6.99 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.158 2.183 . . . . 0.0 110.629 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.5 p -65.24 -42.47 93.32 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.8 t -57.17 -41.52 79.38 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.522 1.929 . . . . 0.0 113.972 -176.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.6 tt -70.59 -48.38 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.948 1.299 . . . . 0.0 111.966 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.54 -52.94 42.86 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.183 0.993 . . . . 0.0 112.051 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -62.75 -27.64 69.42 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 178.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.9 t -61.93 -31.69 72.03 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.562 1.145 . . . . 0.0 112.786 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -73.84 -4.16 33.15 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.625 1.57 . . . . 0.0 114.178 171.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.82 -7.02 83.09 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 126.207 1.861 . . . . 0.0 115.072 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.7 m -93.31 146.0 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 126.341 1.857 . . . . 0.0 111.581 176.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.2 p -84.99 160.95 19.95 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.074 1.35 . . . . 0.0 112.0 171.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.4 pt -73.24 128.02 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.48 1.112 . . . . 0.0 110.031 172.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -77.54 -39.48 45.84 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.058 0.943 . . . . 0.0 111.494 169.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.4 t -154.76 170.59 21.25 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.474 1.109 . . . . 0.0 113.071 173.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -85.06 151.57 24.06 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.433 2.293 . . . . 0.0 112.684 174.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.29 162.5 10.65 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.475 1.512 . . . . 0.0 112.286 -170.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.7 m -59.39 130.0 44.75 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.85 -0.794 . . . . 0.0 109.588 163.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.75 153.15 89.32 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -175.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -65.56 122.43 10.08 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.597 2.865 . . . . 0.0 110.755 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.9 m 55.1 28.58 11.12 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.531 1.533 . . . . 0.0 112.85 -172.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.89 -11.56 69.85 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 125.497 1.522 . . . . 0.0 115.733 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.2 mm . . . . . 0 C--O 1.254 1.315 0 C-N-CA 126.404 1.882 . . . . 0.0 110.44 173.397 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.34 -5.37 12.93 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 125.44 1.496 . . . . 0.0 114.446 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 t -78.09 138.89 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.211 1.404 . . . . 0.0 110.658 176.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 80.4 m -108.19 -37.51 6.01 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.758 1.223 . . . . 0.0 113.6 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.3 130.18 41.32 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.402 1.081 . . . . 0.0 111.849 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.0 m -63.06 152.92 82.87 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.772 0.829 . . . . 0.0 112.547 173.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.56 167.87 26.13 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.691 2.927 . . . . 0.0 112.027 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.69 8.24 13.73 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.345 2.258 . . . . 0.0 114.008 -173.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.9 mt -68.8 140.74 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.3 1.44 . . . . 0.0 109.785 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tt -82.01 72.93 9.07 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.166 1.787 . . . . 0.0 110.584 -176.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -134.73 68.67 71.82 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 125.554 1.541 . . . . 0.0 111.406 -175.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.27 162.2 43.26 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.0 2.466 . . . . 0.0 112.914 -175.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.8 m -144.85 163.73 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 127.045 2.138 . . . . 0.0 111.244 -172.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.2 t -94.41 122.46 37.0 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.523 0.729 . . . . 0.0 110.39 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.46 161.39 53.56 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.079 0.847 . . . . 0.0 113.61 172.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.0 t -61.73 -27.48 68.75 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.239 1.016 . . . . 0.0 113.567 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -82.86 -5.92 59.21 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.311 1.844 . . . . 0.0 114.488 174.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.17 2.04 66.47 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.556 1.55 . . . . 0.0 115.956 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -73.38 166.03 23.95 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 119.814 1.807 . . . . 0.0 111.622 170.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.5 m -121.54 123.7 42.62 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.814 1.646 . . . . 0.0 109.203 172.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.403 ' HB3' ' CG2' ' A' ' 26' ' ' ILE . 35.4 m-85 -113.21 170.58 8.11 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.763 1.625 . . . . 0.0 110.812 174.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.29 -31.85 71.58 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -168.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.09 170.32 19.39 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.634 1.574 . . . . 0.0 110.96 176.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.3 m -59.74 -40.8 89.33 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -172.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.9 t -55.89 -45.71 78.54 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.079 1.752 . . . . 0.0 113.203 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.403 ' CG2' ' HB3' ' A' ' 21' ' ' TYR . 2.2 tp -72.27 -36.25 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.183 -177.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.04 -55.24 37.44 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.395 0.678 . . . . 0.0 111.299 169.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -63.91 -26.75 68.74 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.3 t -57.6 -34.62 69.45 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.585 1.154 . . . . 0.0 112.909 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -74.23 -4.35 35.48 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.699 1.6 . . . . 0.0 114.435 173.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.87 -11.28 72.55 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 126.39 1.947 . . . . 0.0 115.263 175.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 m -83.07 151.43 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.811 1.644 . . . . 0.0 111.495 173.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.7 t -80.55 176.02 10.15 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.937 0.875 . . . . 0.0 111.634 167.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 pp -101.2 119.95 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 128.307 2.643 . . . . 0.0 109.661 174.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -59.94 -44.8 94.14 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.542 0.737 . . . . 0.0 111.552 176.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.1 t -161.49 171.01 18.86 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.42 1.488 . . . . 0.0 112.129 170.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -72.83 152.85 41.33 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.258 1.823 . . . . 0.0 112.641 171.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.51 146.15 4.42 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.858 1.218 . . . . 0.0 112.248 -175.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 p -59.37 133.75 56.38 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.528 -0.983 . . . . 0.0 111.569 171.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -88.41 156.36 50.99 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -172.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.49 153.17 78.99 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.272 2.648 . . . . 0.0 110.758 170.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.1 m 63.54 1.18 0.97 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.853 1.661 . . . . 0.0 114.593 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.21 -12.9 34.93 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.49 1.519 . . . . 0.0 115.054 -177.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.7 pt . . . . . 0 C--O 1.253 1.241 0 C-N-CA 126.237 1.815 . . . . 0.0 113.309 175.429 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.3 mmtp -140.81 146.64 37.86 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.328 1.851 . . . . 0.0 111.418 177.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.9 t -93.25 -31.2 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.975 1.31 . . . . 0.0 111.814 174.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.4 t -145.9 159.79 42.73 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.004 1.722 . . . . 0.0 111.845 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.96 -26.85 54.45 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.632 1.173 . . . . 0.0 113.946 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 33.2 m -65.8 159.33 69.95 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.484 1.514 . . . . 0.0 113.401 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.59 140.06 23.48 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.054 2.502 . . . . 0.0 111.242 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -75.16 -1.98 25.65 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.8 mt -66.36 140.79 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.637 1.575 . . . . 0.0 109.724 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.1 mt -89.1 80.11 7.06 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.159 1.784 . . . . 0.0 110.085 175.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -127.66 68.56 74.61 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 124.003 0.921 . . . . 0.0 110.593 176.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.6 163.34 27.69 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.95 2.434 . . . . 0.0 112.453 -173.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.1 m -145.24 157.01 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.889 1.676 . . . . 0.0 110.7 -171.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.6 t -101.18 110.34 22.35 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.987 0.915 . . . . 0.0 109.424 170.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.74 158.21 52.17 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-N 118.981 0.81 . . . . 0.0 112.905 173.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.5 p -70.09 -9.19 54.68 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -64.32 -14.59 57.03 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.37 1.468 . . . . 0.0 113.45 163.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.17 19.58 45.71 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.324 1.44 . . . . 0.0 114.085 -177.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.9 ttm-85 -119.24 160.27 22.5 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.528 1.931 . . . . 0.0 111.682 -174.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.9 m -116.61 131.52 56.93 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.386 1.475 . . . . 0.0 110.683 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -125.23 169.97 11.73 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.621 1.568 . . . . 0.0 110.925 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.87 -21.6 61.63 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -165.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -161.01 -174.54 4.44 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.987 2.115 . . . . 0.0 109.815 174.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.7 p -72.64 -38.34 67.74 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.1 t -58.2 -41.81 84.78 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.777 1.631 . . . . 0.0 113.953 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 tp -72.1 -43.75 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.836 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.61 -49.49 76.25 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.288 1.035 . . . . 0.0 112.106 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -60.97 -25.45 66.85 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.0 t -59.27 -31.26 68.94 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.92 1.288 . . . . 0.0 113.146 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -74.73 -2.83 28.15 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.362 1.465 . . . . 0.0 114.211 172.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.61 15.08 62.32 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.089 1.328 . . . . 0.0 114.951 177.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 t -128.46 149.04 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.559 1.544 . . . . 0.0 110.856 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 p -87.81 162.8 16.78 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 126.53 1.932 . . . . 0.0 112.43 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.4 pt -73.47 126.54 34.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.708 1.203 . . . . 0.0 110.113 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -75.35 -40.53 58.09 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.641 1.177 . . . . 0.0 111.032 169.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.7 p -150.33 161.4 42.54 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.585 1.554 . . . . 0.0 112.751 171.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.17 153.49 25.97 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.286 1.434 . . . . 0.0 111.034 170.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.41 160.17 12.2 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.172 1.368 . . . . 0.0 112.073 -169.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.2 m -59.51 130.61 47.74 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.729 -0.865 . . . . 0.0 109.981 165.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -71.73 153.78 93.19 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -176.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -71.43 140.14 36.01 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.568 2.846 . . . . 0.0 112.004 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -5.49 49.27 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.932 1.693 . . . . 0.0 114.993 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.03 -36.82 50.94 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.877 1.227 . . . . 0.0 115.563 -171.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.4 mp . . . . . 0 C--O 1.253 1.263 0 C-N-CA 126.436 1.895 . . . . 0.0 110.014 -178.692 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? . . . . . 0 N--CA 1.493 1.718 0 N-CA-C 110.48 -0.192 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -83.49 -34.25 25.39 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.5 m -61.77 142.74 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.756 1.222 . . . . 0.0 112.235 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.7 p -144.69 -39.72 0.26 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.879 1.271 . . . . 0.0 113.362 -177.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.03 87.19 0.74 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.094 1.357 . . . . 0.0 111.706 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.8 m -62.29 153.8 73.97 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 125.577 1.551 . . . . 0.0 112.693 176.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.21 166.93 27.93 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.403 2.735 . . . . 0.0 111.265 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -109.86 10.79 24.43 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.35 1.46 . . . . 0.0 114.36 -173.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.7 mt -58.66 139.16 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.27 1.428 . . . . 0.0 110.217 -176.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.1 mt -80.94 71.9 7.93 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.461 1.505 . . . . 0.0 110.055 172.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -135.62 71.21 65.41 Favored Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 124.718 1.207 . . . . 0.0 109.136 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -68.83 159.07 55.32 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.141 1.894 . . . . 0.0 111.599 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 m -144.85 146.93 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.1 1.36 . . . . 0.0 111.52 -169.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.9 t -89.65 115.24 26.89 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.752 1.221 . . . . 0.0 110.583 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.59 164.61 50.82 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 121.78 -0.575 . . . . 0.0 113.905 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.2 m -62.27 -20.08 63.9 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.56 -8.82 57.58 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.407 1.483 . . . . 0.0 113.571 171.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.36 -2.64 85.16 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.949 1.737 . . . . 0.0 114.929 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -86.18 165.07 16.84 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.019 1.328 . . . . 0.0 111.884 172.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 65.2 m -115.13 138.37 50.97 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.13 1.372 . . . . 0.0 110.455 175.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -121.63 164.32 17.51 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.42 1.888 . . . . 0.0 110.08 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.18 -26.94 67.64 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -168.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -167.12 172.51 9.96 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.382 1.873 . . . . 0.0 111.031 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 t -60.21 -43.57 95.86 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -176.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.4 t -57.8 -44.19 86.16 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.654 1.582 . . . . 0.0 113.41 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.4 tp -70.41 -38.41 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.05 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.08 -55.12 39.04 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.417 1.087 . . . . 0.0 111.279 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -60.1 -37.96 81.53 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.606 0.762 . . . . 0.0 112.865 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 23.6 t -65.16 -38.68 91.34 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.097 0.959 . . . . 0.0 112.817 174.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.12 -21.85 66.46 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.225 1.41 . . . . 0.0 113.866 173.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.34 8.8 18.82 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.088 1.328 . . . . 0.0 115.618 174.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.84 149.05 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 119.301 1.55 . . . . 0.0 110.937 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.57 151.1 29.28 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.225 1.41 . . . . 0.0 111.394 172.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.13 126.75 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 126.849 2.06 . . . . 0.0 107.985 165.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -85.47 -48.21 9.19 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.18 0.592 . . . . 0.0 111.337 162.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.5 m -138.53 156.58 47.37 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.022 1.329 . . . . 0.0 112.501 -176.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -82.62 155.05 24.63 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.855 1.262 . . . . 0.0 112.483 172.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.25 159.42 13.14 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.042 1.306 . . . . 0.0 112.012 -172.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 m -60.18 128.02 34.69 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 121.956 -0.732 . . . . 0.0 109.673 164.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.99 157.4 89.85 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -175.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.7 166.55 28.38 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.596 2.864 . . . . 0.0 112.116 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.67 1.88 32.47 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.746 1.218 . . . . 0.0 113.069 -173.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.53 56.39 0.56 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.606 1.574 . . . . 0.0 113.682 -173.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.526 ' H ' HD12 ' A' ' 44' ' ' ILE . 5.4 mp . . . . . 0 C--O 1.254 1.312 0 C-N-CA 125.798 1.639 . . . . 0.0 110.696 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 61.1 mttp . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 120.196 0.046 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -104.09 57.86 0.72 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.397 1.879 . . . . 0.0 111.427 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.0 t -67.21 127.48 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.899 0.88 . . . . 0.0 111.091 -176.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 78.7 m -102.37 -22.49 14.09 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.931 1.292 . . . . 0.0 113.719 177.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.3 94.91 2.46 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.618 1.567 . . . . 0.0 111.186 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.6 m -62.6 155.82 67.02 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.722 1.209 . . . . 0.0 112.209 171.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -73.38 142.24 33.08 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.217 2.611 . . . . 0.0 110.986 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -78.45 6.4 8.58 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.998 1.719 . . . . 0.0 114.877 176.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.3 tt -58.47 143.4 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 126.117 1.767 . . . . 0.0 112.723 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 tt -92.85 70.11 4.69 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.047 1.339 . . . . 0.0 109.643 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -135.4 72.6 64.81 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 125.603 1.561 . . . . 0.0 110.358 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.65 166.21 26.77 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.565 2.177 . . . . 0.0 112.24 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.8 m -141.26 156.27 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.356 1.863 . . . . 0.0 110.515 -176.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.2 t -90.13 113.87 25.71 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 164.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.32 160.05 47.37 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 121.454 -0.779 . . . . 0.0 113.263 176.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.7 t -62.11 -22.65 65.99 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.563 1.145 . . . . 0.0 113.603 -178.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -68.87 -13.15 62.24 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.434 1.494 . . . . 0.0 114.239 172.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.0 9.84 65.29 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.079 1.324 . . . . 0.0 114.53 -175.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -103.45 163.26 12.4 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.316 1.846 . . . . 0.0 111.409 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.5 m -115.29 129.02 56.5 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.19 1.796 . . . . 0.0 109.747 175.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -120.31 169.57 10.15 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.95 1.7 . . . . 0.0 110.72 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.77 -28.44 65.77 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -171.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.5 172.19 17.66 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.537 1.535 . . . . 0.0 111.093 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.9 p -63.04 -40.27 97.23 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.5 t -56.89 -46.88 81.6 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.23 1.812 . . . . 0.0 113.439 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.2 tp -70.68 -36.82 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.841 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.79 -55.42 35.15 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.694 0.798 . . . . 0.0 111.605 170.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -60.69 -28.6 68.75 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.158 1.169 . . . . 0.0 114.158 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.6 m -63.25 -20.36 65.38 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 174.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -84.91 -6.42 59.34 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.756 1.222 . . . . 0.0 113.787 167.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.43 -10.84 63.26 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 126.705 2.098 . . . . 0.0 115.157 177.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.0 m -99.02 142.56 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 126.39 1.876 . . . . 0.0 111.771 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.6 t -91.31 169.18 11.03 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.307 1.051 . . . . 0.0 112.584 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -72.16 132.04 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 127.58 2.352 . . . . 0.0 110.246 176.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -91.35 -36.6 13.74 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.049 1.34 . . . . 0.0 112.209 173.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.5 p -157.09 160.56 39.0 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.219 1.407 . . . . 0.0 112.75 171.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -73.35 146.91 44.87 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.065 1.346 . . . . 0.0 112.454 172.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.98 153.01 6.05 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.165 1.364 . . . . 0.0 111.871 -172.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.1 p -59.32 142.88 50.97 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.731 -0.864 . . . . 0.0 112.036 169.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.2 p -92.05 155.07 43.33 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.83 144.61 43.92 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.795 2.997 . . . . 0.0 111.757 175.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.2 t -80.75 -15.27 56.91 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.74 -16.53 1.8 Allowed Glycine 0 CA--C 1.538 1.481 0 C-N-CA 126.663 2.078 . . . . 0.0 115.021 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.2 mt . . . . . 0 C--O 1.252 1.221 0 C-N-CA 127.15 2.18 . . . . 0.0 109.615 176.032 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 48.8 tptt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -142.4 131.36 23.04 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.632 1.573 . . . . 0.0 110.611 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.0 m -67.26 143.73 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.787 1.235 . . . . 0.0 112.539 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.6 m -138.93 -62.48 0.55 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.462 1.505 . . . . 0.0 111.039 177.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.25 112.92 5.44 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.882 1.273 . . . . 0.0 111.785 174.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.5 m -62.39 156.28 62.43 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.79 1.236 . . . . 0.0 112.31 170.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -72.91 144.34 38.34 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 123.368 2.712 . . . . 0.0 111.767 -175.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -75.39 5.96 5.12 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.293 1.837 . . . . 0.0 115.18 175.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.8 tt -61.8 149.91 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.987 1.715 . . . . 0.0 112.829 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 tt -102.81 75.0 1.37 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.167 1.787 . . . . 0.0 109.512 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -142.69 73.88 19.38 Favored Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 124.791 1.236 . . . . 0.0 110.593 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.77 167.29 17.8 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.056 2.504 . . . . 0.0 112.743 -176.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.9 m -141.93 158.97 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.839 1.655 . . . . 0.0 110.789 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.9 t -99.81 118.3 35.98 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.928 0.891 . . . . 0.0 109.116 166.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.17 163.57 54.55 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 118.963 0.801 . . . . 0.0 113.268 172.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.5 t -63.43 -20.95 66.0 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -67.35 -14.29 62.78 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.37 1.468 . . . . 0.0 113.784 169.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.55 1.49 71.31 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 126.028 1.775 . . . . 0.0 114.666 -178.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -87.03 160.74 18.51 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.043 1.737 . . . . 0.0 111.591 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 91.1 m -109.79 136.37 49.23 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.303 1.441 . . . . 0.0 110.517 175.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -126.75 168.44 14.39 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.48 1.512 . . . . 0.0 111.603 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.46 -23.79 61.89 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -166.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -162.18 -179.64 7.21 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.218 1.807 . . . . 0.0 111.239 171.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 61.0 p -63.89 -40.96 97.73 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 175.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.2 t -59.18 -44.34 92.17 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.077 1.751 . . . . 0.0 113.57 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.4 tp -70.33 -42.93 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.054 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.88 -52.98 62.17 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.975 0.91 . . . . 0.0 111.522 177.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -60.12 -27.89 67.41 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.0 t -58.55 -29.69 66.55 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.775 1.23 . . . . 0.0 113.064 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -70.47 -12.63 61.7 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.651 1.58 . . . . 0.0 114.387 174.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.53 -0.39 77.36 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.878 1.704 . . . . 0.0 114.998 -175.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -104.33 149.54 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.759 1.624 . . . . 0.0 109.89 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.85 160.17 20.23 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.775 1.63 . . . . 0.0 112.209 174.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.6 pt -71.84 129.05 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 124.284 1.034 . . . . 0.0 110.13 170.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -73.69 -38.29 64.93 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.907 1.283 . . . . 0.0 111.227 170.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.0 p -158.59 163.79 36.66 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.009 1.724 . . . . 0.0 112.359 168.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.47 154.94 34.27 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.569 1.548 . . . . 0.0 112.007 166.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.41 158.61 9.96 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 125.404 1.478 . . . . 0.0 112.022 -168.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.0 t -62.17 146.71 49.89 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.657 -0.907 . . . . 0.0 110.743 166.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -92.27 156.35 41.87 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -177.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.13 130.62 20.45 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.575 2.85 . . . . 0.0 111.751 177.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.8 m -71.09 -15.86 62.54 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.706 1.202 . . . . 0.0 113.521 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 160.1 -34.11 0.43 Allowed Glycine 0 CA--C 1.535 1.315 0 C-N-CA 126.607 2.051 . . . . 0.0 113.738 174.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 tt . . . . . 0 C--O 1.254 1.311 0 C-N-CA 127.149 2.18 . . . . 0.0 111.917 174.103 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 64.6 mttm . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -152.31 176.26 11.8 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.826 1.65 . . . . 0.0 112.468 178.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.2 m -59.01 101.48 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.907 2.083 . . . . 0.0 112.474 176.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 88.6 m -135.16 153.17 52.07 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.707 1.603 . . . . 0.0 111.448 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.66 94.25 6.26 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.11 1.364 . . . . 0.0 110.148 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 35.5 m -59.65 153.66 50.34 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 124.419 1.087 . . . . 0.0 112.304 175.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.67 159.14 53.72 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.588 2.859 . . . . 0.0 111.884 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -113.35 4.01 16.16 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.554 1.542 . . . . 0.0 114.024 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.51 ' H ' HD12 ' A' ' 9' ' ' ILE . 4.2 mp -69.75 146.19 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.425 1.09 . . . . 0.0 109.914 175.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.7 tt -77.84 74.3 4.4 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.837 2.055 . . . . 0.0 109.672 176.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.4 mmmt -129.39 63.56 68.07 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 125.63 1.572 . . . . 0.0 111.851 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.65 166.22 28.19 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.27 2.647 . . . . 0.0 112.625 -176.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.0 m -146.98 143.02 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.348 1.859 . . . . 0.0 110.553 -172.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.7 t -79.77 111.64 16.28 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.72 153.84 39.02 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 119.233 0.924 . . . . 0.0 112.851 175.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 90.2 p -69.92 -9.8 56.29 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -69.86 -15.93 63.17 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.354 1.461 . . . . 0.0 113.779 169.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.42 15.65 22.56 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 124.675 1.131 . . . . 0.0 115.645 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 51.6 ttm-85 -136.08 168.08 20.04 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.237 1.815 . . . . 0.0 111.021 178.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.2 t -106.44 151.74 24.54 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.44 1.096 . . . . 0.0 111.697 172.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -121.36 175.74 6.0 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.569 1.947 . . . . 0.0 110.018 173.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.31 -25.74 61.69 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -171.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -160.66 -176.49 5.59 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.901 1.68 . . . . 0.0 111.487 174.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.4 p -72.77 -25.99 61.38 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 177.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.5 t -71.48 -43.78 65.95 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.698 1.599 . . . . 0.0 112.54 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.5 tp -68.75 -41.44 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.637 0.775 . . . . 0.0 111.12 176.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.54 -56.17 19.32 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.72 1.208 . . . . 0.0 111.844 173.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -61.71 -36.11 79.99 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 32.3 m -59.06 -33.76 71.16 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.428 0.691 . . . . 0.0 112.722 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -67.52 -9.92 46.89 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 173.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.82 10.38 72.64 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.762 1.172 . . . . 0.0 114.88 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 t -116.88 156.37 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.318 1.847 . . . . 0.0 109.085 176.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.2 t -107.42 167.63 9.8 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 122.515 1.15 . . . . 0.0 111.754 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.6 pt -77.49 123.81 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 126.009 1.723 . . . . 0.0 109.965 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.3 tttt -71.89 -40.76 68.65 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.168 0.987 . . . . 0.0 111.349 168.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.0 t -156.93 171.53 20.28 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.079 1.352 . . . . 0.0 112.871 172.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -75.54 148.16 39.14 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.014 2.126 . . . . 0.0 112.528 171.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.98 159.09 6.97 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.175 1.369 . . . . 0.0 112.594 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.7 m -58.69 138.66 56.89 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.748 0.819 . . . . 0.0 111.18 170.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.7 p -96.76 155.99 37.07 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -75.51 158.48 40.18 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 124.202 3.268 . . . . 0.0 112.077 173.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.14 -1.92 57.65 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.001 1.321 . . . . 0.0 113.27 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.68 9.91 53.63 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 126.338 1.923 . . . . 0.0 116.38 -172.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.203 0 C-N-CA 126.562 1.945 . . . . 0.0 112.203 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -133.85 -84.47 0.44 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 125.86 1.664 . . . . 0.0 111.34 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.8 p -70.14 -26.34 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.337 1.455 . . . . 0.0 113.492 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.8 t 64.51 -7.37 0.25 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 128.263 2.625 . . . . 0.0 115.961 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.98 120.33 21.25 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.683 1.993 . . . . 0.0 110.773 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.4 m -58.94 156.32 26.58 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 124.671 1.188 . . . . 0.0 112.317 173.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -74.64 168.37 24.97 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.57 2.847 . . . . 0.0 112.419 -175.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -114.19 8.7 16.95 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.18 2.192 . . . . 0.0 114.164 -177.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 26.6 mt -66.32 144.03 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.356 1.462 . . . . 0.0 109.854 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 tt -84.62 71.79 10.75 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.417 1.887 . . . . 0.0 110.001 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -135.03 67.13 69.41 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 125.135 1.374 . . . . 0.0 111.38 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.58 168.51 18.05 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.329 2.686 . . . . 0.0 112.792 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.3 m -145.82 162.63 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.444 1.898 . . . . 0.0 110.765 -174.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.0 t -102.81 121.84 43.31 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.957 0.903 . . . . 0.0 109.364 166.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.97 166.8 53.17 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 119.108 0.867 . . . . 0.0 112.951 174.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.0 m -65.32 -15.45 62.55 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -74.91 -6.61 50.11 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.451 1.1 . . . . 0.0 113.851 168.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.96 19.41 61.27 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.955 1.264 . . . . 0.0 114.56 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.46 153.8 24.53 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.384 1.874 . . . . 0.0 111.45 -174.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.8 m -102.9 117.96 35.77 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.956 1.702 . . . . 0.0 111.886 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -104.29 163.11 12.65 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 128.078 2.551 . . . . 0.0 110.949 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.78 -25.38 56.38 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -175.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -161.43 178.61 8.98 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.007 1.723 . . . . 0.0 111.432 173.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.9 m -63.96 -37.4 87.26 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 177.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.6 t -59.68 -45.18 92.85 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.872 1.669 . . . . 0.0 112.966 -177.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.8 tt -73.39 -40.1 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.566 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.06 -28.53 67.87 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 174.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -90.44 -27.29 19.37 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 174.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.3 t -55.26 -38.99 69.26 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.966 1.307 . . . . 0.0 113.044 -176.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -69.82 -10.66 59.26 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 126.17 1.788 . . . . 0.0 115.25 175.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.33 -8.2 52.31 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 126.377 1.941 . . . . 0.0 116.131 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 t -92.94 164.99 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 125.496 1.518 . . . . 0.0 110.203 177.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 p -98.16 165.89 11.67 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.806 2.042 . . . . 0.0 112.089 174.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 pt -75.67 128.35 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.182 0.993 . . . . 0.0 109.731 169.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -69.43 -44.15 71.91 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.46 1.104 . . . . 0.0 110.784 168.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.0 t -156.49 170.71 21.72 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.067 1.347 . . . . 0.0 112.072 170.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -77.4 153.03 34.06 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.46 1.904 . . . . 0.0 111.528 173.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.89 152.67 5.77 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.372 1.463 . . . . 0.0 112.45 -173.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 p -58.03 139.72 53.96 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.836 0.855 . . . . 0.0 111.675 167.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -90.86 155.63 45.14 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -175.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.82 143.27 50.05 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.687 2.925 . . . . 0.0 111.312 174.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.9 t -165.7 119.07 1.16 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.592 1.557 . . . . 0.0 110.321 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 158.18 -69.78 0.26 Allowed Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.67 1.605 . . . . 0.0 113.082 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 77.4 mt . . . . . 0 C--O 1.254 1.334 0 C-N-CA 126.306 1.843 . . . . 0.0 110.854 177.747 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 44.0 tptt . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.103 0.478 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -96.09 101.59 13.27 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.622 1.569 . . . . 0.0 110.473 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.5 p -62.58 142.88 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.801 0.841 . . . . 0.0 112.145 178.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 81.7 m -114.92 -28.41 7.05 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.873 1.269 . . . . 0.0 113.768 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.93 99.06 2.93 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.543 1.537 . . . . 0.0 110.962 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.9 m -63.77 156.26 73.27 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 124.379 1.072 . . . . 0.0 112.716 173.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -81.77 173.67 11.03 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.492 2.795 . . . . 0.0 113.068 -173.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -124.09 15.04 9.16 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.324 1.85 . . . . 0.0 114.152 -171.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.3 pp -61.43 174.03 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 125.714 1.605 . . . . 0.0 112.575 165.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.4 mt -110.7 85.96 2.22 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.17 1.388 . . . . 0.0 109.489 171.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.09 69.9 41.54 Favored Pre-proline 0 N--CA 1.473 0.693 0 C-N-CA 123.989 0.916 . . . . 0.0 110.756 174.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.15 171.99 11.72 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.745 2.297 . . . . 0.0 112.376 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.7 m -141.59 163.58 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.228 1.811 . . . . 0.0 111.455 -173.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.5 t -104.25 115.45 30.41 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.001 0.92 . . . . 0.0 109.213 166.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.41 162.2 54.0 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 123.891 0.757 . . . . 0.0 114.14 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.9 t -59.11 -28.63 66.7 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.567 1.147 . . . . 0.0 114.036 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -79.64 -1.14 36.83 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 125.97 1.708 . . . . 0.0 113.861 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.62 5.63 86.47 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.172 1.367 . . . . 0.0 113.983 -171.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.59 163.86 15.37 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.637 1.975 . . . . 0.0 112.344 176.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 27.4 m -135.57 113.01 10.67 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.447 1.499 . . . . 0.0 109.659 170.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -105.55 157.26 17.51 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.7 1.2 . . . . 0.0 111.131 173.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.57 -36.03 73.29 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.386 1.474 . . . . 0.0 113.893 -176.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.59 171.62 16.82 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.43 0.692 . . . . 0.0 111.448 171.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.8 m -60.87 -40.71 94.02 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.9 t -53.57 -41.95 67.05 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.674 1.99 . . . . 0.0 112.89 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 44.9 mm -70.99 -46.87 65.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 114.191 -1.368 . . . . 0.0 111.09 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.05 -53.63 47.4 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 173.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -61.26 -37.52 83.41 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 177.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.9 t -61.71 -39.0 89.96 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.041 0.936 . . . . 0.0 112.343 176.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -72.53 -2.46 19.83 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.812 1.645 . . . . 0.0 114.376 172.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.03 4.93 64.48 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.03 1.3 . . . . 0.0 115.777 169.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 m -119.48 135.85 58.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 126.382 1.873 . . . . 0.0 111.271 -177.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -75.41 154.93 36.86 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.605 1.162 . . . . 0.0 112.231 176.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 pt -78.58 125.49 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.861 1.264 . . . . 0.0 109.557 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -78.67 -36.42 43.79 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.386 1.075 . . . . 0.0 111.829 172.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.8 t -153.83 168.84 24.97 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.672 1.189 . . . . 0.0 112.461 169.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -85.06 146.49 27.14 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.584 2.354 . . . . 0.0 110.807 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.64 149.22 5.2 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.67 1.128 . . . . 0.0 111.767 -170.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.0 p -59.1 135.57 57.68 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.569 -0.959 . . . . 0.0 111.287 168.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -82.23 155.87 69.32 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -177.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.39 154.61 60.85 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.536 2.824 . . . . 0.0 111.386 172.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.24 -1.95 32.19 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.882 1.273 . . . . 0.0 114.345 -176.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.6 16.91 78.55 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.02 1.295 . . . . 0.0 114.64 -176.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.7 tt . . . . . 0 C--O 1.253 1.26 0 C-N-CA 127.058 2.143 . . . . 0.0 113.759 179.922 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.428 0.156 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -76.56 70.43 3.09 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.467 1.907 . . . . 0.0 111.581 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.1 m -60.81 152.06 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.002 1.321 . . . . 0.0 112.258 175.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 52.4 t -133.73 -77.56 0.47 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.927 1.291 . . . . 0.0 110.695 -178.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.48 82.97 4.71 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.112 0.965 . . . . 0.0 111.164 171.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.6 m -62.63 156.34 64.41 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 124.894 1.278 . . . . 0.0 111.899 172.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.34 160.24 35.87 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.535 2.823 . . . . 0.0 112.317 -172.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.85 4.09 13.86 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.194 1.797 . . . . 0.0 115.582 -172.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pp -71.59 168.81 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 126.897 2.079 . . . . 0.0 112.894 173.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.6 mt -96.33 89.93 5.26 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.426 1.49 . . . . 0.0 109.915 169.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -139.42 69.3 39.48 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 123.475 0.71 . . . . 0.0 110.976 169.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.45 167.16 17.48 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.046 2.497 . . . . 0.0 112.506 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.4 m -144.88 155.89 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.766 1.626 . . . . 0.0 110.678 -174.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.5 t -102.05 117.88 35.72 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.055 0.942 . . . . 0.0 109.666 172.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.55 165.99 53.12 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 121.51 -0.744 . . . . 0.0 113.659 175.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.7 p -61.63 -21.39 64.35 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -70.11 -12.77 61.84 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.559 1.543 . . . . 0.0 113.681 171.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.37 -0.85 75.47 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.935 1.731 . . . . 0.0 115.112 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -90.43 160.54 15.99 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.331 1.452 . . . . 0.0 111.512 176.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 40.4 m -109.26 131.65 54.87 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.279 1.431 . . . . 0.0 110.513 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -113.3 167.95 10.14 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.793 1.637 . . . . 0.0 110.481 173.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.73 -26.42 62.46 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -167.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -161.25 177.63 10.02 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.949 2.099 . . . . 0.0 110.681 174.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.8 p -62.17 -43.1 99.58 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 t -56.69 -37.98 71.62 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.471 1.908 . . . . 0.0 114.554 -176.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 tt -73.18 -52.75 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.844 0.858 . . . . 0.0 111.528 172.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.79 -56.05 6.87 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.799 1.24 . . . . 0.0 112.305 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.13 -27.69 69.25 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.205 1.802 . . . . 0.0 115.385 177.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 9.5 t -59.78 -33.29 71.52 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.361 1.064 . . . . 0.0 112.79 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -67.33 -17.83 64.92 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.171 1.389 . . . . 0.0 113.917 173.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.47 -9.95 57.6 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 126.594 2.045 . . . . 0.0 115.242 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.6 m -86.55 149.87 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 119.164 1.482 . . . . 0.0 111.516 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.01 156.18 20.55 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.921 1.289 . . . . 0.0 111.607 170.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.9 pt -71.2 129.02 35.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.195 0.998 . . . . 0.0 110.018 171.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.4 tptp -78.49 -35.32 46.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.449 1.099 . . . . 0.0 111.28 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.0 p -156.36 162.48 40.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.879 1.672 . . . . 0.0 112.503 172.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -84.84 157.2 21.0 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.119 0.968 . . . . 0.0 112.418 169.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.14 161.74 11.69 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.15 1.357 . . . . 0.0 111.975 -166.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.1 m -59.02 131.74 51.96 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.95 -0.735 . . . . 0.0 109.765 164.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -71.66 154.54 93.05 Favored Pre-proline 0 CA--C 1.545 0.774 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -177.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.78 155.08 58.77 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.377 2.718 . . . . 0.0 112.007 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.41 7.41 45.62 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.122 1.369 . . . . 0.0 113.2 -173.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.16 30.99 26.78 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.813 1.196 . . . . 0.0 114.021 -177.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.7 mt . . . . . 0 C--O 1.253 1.253 0 C-N-CA 127.173 2.189 . . . . 0.0 110.581 -176.455 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.65 115.1 14.24 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 120.503 1.502 . . . . 0.0 111.518 -178.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.7 m -66.3 132.35 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.029 1.331 . . . . 0.0 111.872 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 82.0 m -74.14 159.8 32.09 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.854 0.862 . . . . 0.0 112.219 175.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.12 91.08 4.37 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.932 1.293 . . . . 0.0 110.829 174.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 14.3 m -61.15 154.78 59.83 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.898 1.279 . . . . 0.0 112.393 173.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -77.97 166.96 24.33 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.238 2.625 . . . . 0.0 111.966 -176.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -119.74 15.33 12.68 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.763 2.025 . . . . 0.0 114.538 -170.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -60.64 170.29 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 126.736 2.014 . . . . 0.0 113.73 170.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.0 mt -104.83 80.1 1.6 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.565 1.546 . . . . 0.0 110.221 172.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.6 mmtt -138.92 66.24 39.46 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 125.132 1.373 . . . . 0.0 110.796 173.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.82 163.16 31.77 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.86 2.373 . . . . 0.0 111.944 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.0 m -146.51 160.75 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.561 1.544 . . . . 0.0 111.48 -170.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.5 t -96.28 116.88 29.72 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.012 1.325 . . . . 0.0 110.486 172.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.26 165.48 54.8 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 121.407 -0.808 . . . . 0.0 113.368 172.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.8 t -61.95 -26.93 68.49 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.35 1.06 . . . . 0.0 113.164 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -69.02 -8.01 40.96 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.603 1.961 . . . . 0.0 114.912 169.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.37 2.12 90.55 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.813 1.673 . . . . 0.0 115.3 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.2 mmt-85 -84.92 163.23 19.1 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.435 1.618 . . . . 0.0 111.615 173.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.3 m -118.42 117.59 29.45 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.589 1.555 . . . . 0.0 109.893 173.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -103.72 176.51 5.13 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.138 1.375 . . . . 0.0 110.298 170.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.87 -24.66 64.36 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -169.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.54 176.56 10.29 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.534 1.534 . . . . 0.0 110.869 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.7 p -62.24 -45.41 93.47 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 174.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.2 t -56.85 -44.26 81.97 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.404 1.882 . . . . 0.0 114.08 -177.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.44 -44.38 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.745 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.26 -49.56 77.38 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.022 0.929 . . . . 0.0 111.756 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -61.95 -28.65 69.69 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 174.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.9 t -61.29 -34.83 75.85 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.091 0.956 . . . . 0.0 112.844 176.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -72.47 -8.72 56.56 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.33 1.452 . . . . 0.0 114.144 170.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.93 -12.09 64.12 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.579 2.038 . . . . 0.0 115.335 174.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.6 m -79.97 141.18 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.266 1.426 . . . . 0.0 111.863 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.6 t -78.06 173.72 11.89 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.762 0.791 . . . . 0.0 112.036 171.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.0 mm -99.2 112.8 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 126.085 1.754 . . . . 0.0 110.196 -175.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -66.06 -38.6 88.73 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.533 0.733 . . . . 0.0 111.377 172.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.9 p -168.17 156.88 9.02 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.037 0.935 . . . . 0.0 112.949 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -82.11 153.87 25.85 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 122.304 1.05 . . . . 0.0 111.545 172.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.82 153.71 8.54 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.911 1.72 . . . . 0.0 111.618 -168.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.8 m -56.05 128.2 34.21 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.74 -0.859 . . . . 0.0 110.078 167.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -72.49 154.32 91.7 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -176.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.63 131.05 20.6 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.649 2.899 . . . . 0.0 112.026 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.65 -0.98 28.85 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.137 1.375 . . . . 0.0 113.39 -174.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.93 -18.88 71.45 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 124.8 1.19 . . . . 0.0 115.306 -176.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.4 mm . . . . . 0 C--O 1.253 1.25 0 C-N-CA 126.167 1.787 . . . . 0.0 110.685 174.741 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 20.8 tptp . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 110.631 -0.137 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -90.95 73.07 6.48 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.163 1.385 . . . . 0.0 111.912 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.6 m -75.65 -22.06 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.455 1.502 . . . . 0.0 113.635 170.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 71.8 m -71.99 177.67 4.2 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.379 1.072 . . . . 0.0 112.132 172.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 59.83 26.31 15.48 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.666 1.587 . . . . 0.0 115.254 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 27.2 m -52.4 151.21 7.72 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 125.625 1.57 . . . . 0.0 112.262 167.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.57 141.75 35.13 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.024 2.483 . . . . 0.0 111.441 -175.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -77.61 8.14 4.75 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.978 1.711 . . . . 0.0 114.868 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.4 tt -58.36 143.73 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 125.974 1.71 . . . . 0.0 112.702 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.5 tt -91.98 72.07 5.57 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.141 1.376 . . . . 0.0 109.573 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -138.24 72.45 45.51 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 125.415 1.486 . . . . 0.0 110.559 177.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -67.52 165.97 25.45 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.473 2.115 . . . . 0.0 112.037 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.7 m -141.35 156.68 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 126.238 1.815 . . . . 0.0 110.557 -175.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.4 t -91.95 117.0 29.4 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 165.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.18 162.18 45.93 Favored Glycine 0 CA--C 1.535 1.288 0 O-C-N 121.459 -0.776 . . . . 0.0 113.007 174.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.7 m -68.91 -14.27 62.94 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -176.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -74.31 -5.82 44.44 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.723 1.609 . . . . 0.0 113.27 169.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.82 21.08 54.43 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.787 1.184 . . . . 0.0 114.541 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -119.54 162.91 18.11 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.196 1.798 . . . . 0.0 111.788 -176.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.4 m -114.57 122.61 47.06 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.916 1.686 . . . . 0.0 110.133 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -115.34 169.07 9.42 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.635 1.574 . . . . 0.0 110.817 174.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.85 -30.35 66.73 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -166.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -164.51 170.3 16.06 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.28 1.432 . . . . 0.0 111.954 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.7 p -60.97 -39.85 91.16 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -171.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -54.08 -51.77 63.08 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.787 2.035 . . . . 0.0 112.997 176.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.6 tp -67.41 -40.43 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 121.387 -0.821 . . . . 0.0 110.865 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.97 -3.58 5.53 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.897 1.679 . . . . 0.0 114.905 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -116.09 -31.97 5.52 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.832 1.653 . . . . 0.0 114.489 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 56.4 m -60.41 -26.41 66.68 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.715 1.206 . . . . 0.0 113.633 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -72.94 -10.75 60.14 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 127.53 2.332 . . . . 0.0 115.472 170.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.27 1.17 59.43 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 125.642 1.591 . . . . 0.0 116.518 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 p -102.05 169.39 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-N 119.359 1.579 . . . . 0.0 111.064 172.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.1 149.79 29.53 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 127.115 2.166 . . . . 0.0 112.121 175.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -66.93 124.15 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 125.096 1.358 . . . . 0.0 110.089 176.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -78.98 -37.82 38.46 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.717 1.207 . . . . 0.0 111.523 174.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.8 p -160.03 162.13 34.15 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.472 1.509 . . . . 0.0 112.942 172.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -76.96 151.55 35.64 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.878 1.271 . . . . 0.0 112.615 171.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.54 156.94 8.48 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.097 1.332 . . . . 0.0 111.701 -169.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.2 p -60.1 146.08 44.4 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.71 -0.876 . . . . 0.0 111.837 167.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -93.98 155.04 40.61 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -179.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.03 157.05 55.21 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.831 3.021 . . . . 0.0 112.106 176.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 17.1 p -134.39 77.86 1.72 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.645 1.578 . . . . 0.0 111.428 -176.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.73 26.07 0.07 OUTLIER Glycine 0 CA--C 1.539 1.563 0 C-N-CA 124.413 1.006 . . . . 0.0 115.242 -175.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.4 tt . . . . . 0 C--O 1.253 1.283 0 C-N-CA 126.653 1.981 . . . . 0.0 112.491 -176.278 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -131.38 8.76 4.67 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.748 1.619 . . . . 0.0 114.758 -172.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.0 t -115.85 132.49 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 125.251 1.42 . . . . 0.0 110.774 -173.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 69.8 m -71.81 169.13 16.39 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.3 1.44 . . . . 0.0 113.193 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.24 -26.42 63.84 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 173.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.6 m -66.67 156.05 87.53 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 125.299 1.44 . . . . 0.0 112.969 174.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -79.61 173.71 12.69 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.973 3.116 . . . . 0.0 112.546 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -122.76 14.01 10.02 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.206 1.802 . . . . 0.0 114.065 -173.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.88 161.92 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 125.347 1.459 . . . . 0.0 112.52 172.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tt -98.25 75.94 2.3 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.765 1.226 . . . . 0.0 109.804 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -140.08 69.85 34.94 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 124.3 1.04 . . . . 0.0 111.428 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.88 168.04 24.17 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.176 2.584 . . . . 0.0 112.644 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.6 m -137.77 167.32 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 128.332 2.653 . . . . 0.0 111.518 -171.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.7 t -109.67 108.46 18.86 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.905 0.882 . . . . 0.0 109.569 167.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.13 156.17 53.55 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.008 0.813 . . . . 0.0 114.319 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.3 t -69.08 -14.26 62.91 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -78.3 -5.99 53.72 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.01 1.724 . . . . 0.0 113.86 168.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.23 4.43 74.3 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.752 1.644 . . . . 0.0 115.06 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -101.34 168.04 9.79 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.164 1.482 . . . . 0.0 111.727 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.2 m -121.27 135.51 55.11 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.733 1.613 . . . . 0.0 110.108 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -125.66 156.97 38.42 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.37 1.468 . . . . 0.0 110.863 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.84 -31.04 64.35 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.14 1.376 . . . . 0.0 114.108 -174.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -156.64 169.29 25.03 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.806 0.843 . . . . 0.0 111.605 175.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.1 t -60.61 -44.71 95.98 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.0 t -50.27 -44.19 53.65 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.113 1.765 . . . . 0.0 113.059 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.0 mm -64.03 -57.09 13.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.859 176.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.59 -52.87 16.31 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.396 0.678 . . . . 0.0 112.689 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -61.55 -38.19 86.56 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 30.6 t -63.16 -38.96 93.24 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.238 1.015 . . . . 0.0 112.138 176.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -67.51 -13.17 61.81 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.187 1.395 . . . . 0.0 113.463 173.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.12 -0.18 41.12 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 126.286 1.898 . . . . 0.0 115.529 172.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.2 m -112.91 134.07 56.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 126.229 1.812 . . . . 0.0 111.465 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 p -74.85 152.51 38.92 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.176 -0.953 . . . . 0.0 111.665 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.5 pt -73.49 127.47 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.114 0.965 . . . . 0.0 109.311 172.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -78.57 -37.05 43.56 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.838 -0.538 . . . . 0.0 111.269 171.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.0 p -152.74 162.39 41.33 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.588 1.555 . . . . 0.0 112.966 170.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -74.84 152.84 38.9 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.947 1.699 . . . . 0.0 111.22 169.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.54 152.63 6.32 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.215 1.388 . . . . 0.0 111.942 -175.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.5 t -58.33 147.39 31.17 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.783 -0.833 . . . . 0.0 110.871 167.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.8 p -102.23 157.51 33.56 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -73.69 161.33 42.1 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.673 2.915 . . . . 0.0 111.787 173.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.81 -0.21 12.75 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.914 1.686 . . . . 0.0 114.738 173.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.12 0.71 59.81 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 125.829 1.68 . . . . 0.0 114.713 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.9 mm . . . . . 0 C--O 1.254 1.311 0 C-N-CA 127.244 2.218 . . . . 0.0 110.361 176.975 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 63.5 mttm . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 120.349 0.119 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -134.7 163.25 30.19 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.902 2.081 . . . . 0.0 110.169 169.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.7 m -70.89 168.35 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.066 1.346 . . . . 0.0 112.533 175.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 76.7 m -63.38 -63.28 1.23 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.906 0.882 . . . . 0.0 111.737 174.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -161.36 124.79 3.25 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.025 1.73 . . . . 0.0 110.806 174.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 18.7 m -68.94 156.01 92.3 Favored Pre-proline 0 CA--C 1.549 0.917 0 O-C-N 121.434 -0.791 . . . . 0.0 111.855 168.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.38 166.22 26.38 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.632 2.888 . . . . 0.0 112.197 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -115.04 25.52 10.84 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.311 1.844 . . . . 0.0 113.408 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.3 pt -58.01 173.71 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 127.195 2.198 . . . . 0.0 112.726 169.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 tt -123.57 75.12 1.31 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.029 1.332 . . . . 0.0 109.237 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -141.99 71.76 23.49 Favored Pre-proline 0 N--CA 1.471 0.622 0 C-N-CA 124.305 1.042 . . . . 0.0 110.371 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.66 159.54 53.22 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.262 1.975 . . . . 0.0 112.079 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.4 m -145.82 147.33 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.149 1.38 . . . . 0.0 111.724 -169.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.2 t -90.55 116.81 28.74 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.665 1.186 . . . . 0.0 110.762 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.99 165.18 53.38 Favored Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.56 -0.712 . . . . 0.0 113.197 174.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.9 p -65.55 -17.25 64.43 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -68.84 -16.87 63.9 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.759 1.624 . . . . 0.0 113.589 168.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.07 -4.91 78.42 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.993 1.758 . . . . 0.0 114.961 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.7 ttt85 -83.77 161.82 20.85 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.356 1.462 . . . . 0.0 111.458 170.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 62.5 m -111.35 135.48 51.83 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.296 1.838 . . . . 0.0 110.952 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -119.87 165.52 14.5 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.739 1.616 . . . . 0.0 110.958 174.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.84 -30.45 70.63 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -167.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.44 173.88 15.53 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.282 1.833 . . . . 0.0 110.353 172.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.1 p -59.8 -41.72 91.83 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -56.36 -45.67 80.37 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.709 1.604 . . . . 0.0 113.301 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.7 tp -69.21 -41.82 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.931 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.66 -56.21 19.26 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.283 1.033 . . . . 0.0 111.32 174.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -59.32 -37.95 79.06 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 63.9 m -71.33 -23.85 62.0 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 175.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -74.1 -20.46 60.25 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.029 1.332 . . . . 0.0 112.934 172.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.68 7.66 17.48 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.851 1.691 . . . . 0.0 115.807 174.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 t -133.36 151.52 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.043 1.421 . . . . 0.0 110.545 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.8 t -92.99 158.46 15.78 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.169 0.985 . . . . 0.0 112.184 174.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.62 122.5 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 128.667 2.787 . . . . 0.0 108.51 171.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -79.22 -49.8 11.95 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.745 -0.597 . . . . 0.0 110.584 161.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.8 p -143.61 161.24 39.01 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.161 1.385 . . . . 0.0 113.227 -176.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.31 154.0 20.44 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.485 1.514 . . . . 0.0 112.597 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.17 160.9 19.98 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.03 1.3 . . . . 0.0 111.818 -169.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 m -61.37 126.95 29.2 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.783 -0.833 . . . . 0.0 109.564 164.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.99 155.1 94.04 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -173.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.81 153.58 64.05 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.47 2.78 . . . . 0.0 111.992 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.52 -4.59 43.54 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -173.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.19 -74.0 0.97 Allowed Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.78 1.657 . . . . 0.0 114.058 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 79.9 mt . . . . . 0 C--O 1.253 1.247 0 C-N-CA 125.974 1.71 . . . . 0.0 110.871 -179.424 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -139.88 -24.78 0.82 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.2 t -70.09 -48.79 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.828 1.251 . . . . 0.0 110.299 176.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.2 p -73.81 155.79 38.45 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.55 1.14 . . . . 0.0 111.872 165.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.53 96.96 2.77 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.586 1.554 . . . . 0.0 109.932 174.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.8 m -59.87 150.59 67.99 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.142 0.977 . . . . 0.0 112.462 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.63 168.51 24.24 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.261 2.641 . . . . 0.0 111.916 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -122.81 16.2 10.16 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.822 2.049 . . . . 0.0 114.497 -170.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.95 168.28 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 126.584 1.954 . . . . 0.0 112.925 170.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 tt -105.47 69.28 0.83 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.943 1.297 . . . . 0.0 110.583 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -137.31 72.13 52.52 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 124.822 1.249 . . . . 0.0 110.572 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.79 166.87 18.93 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.728 2.286 . . . . 0.0 111.937 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 m -142.99 150.98 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.81 1.644 . . . . 0.0 110.55 -176.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.5 t -87.98 114.49 24.64 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 169.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.56 159.68 53.75 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 119.409 1.004 . . . . 0.0 112.364 171.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t -65.2 -20.13 66.29 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 121.271 -1.135 . . . . 0.0 114.024 -177.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.67 -17.15 64.39 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.057 1.743 . . . . 0.0 113.859 168.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.68 -6.63 62.84 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 126.44 1.971 . . . . 0.0 114.826 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -77.9 164.67 24.93 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 118.712 1.256 . . . . 0.0 111.859 173.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 60.5 m -117.93 133.7 55.67 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.422 1.489 . . . . 0.0 110.027 169.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -121.81 170.19 10.01 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.857 1.663 . . . . 0.0 110.565 172.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.04 -30.64 71.21 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -165.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -163.36 172.77 14.13 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.833 1.253 . . . . 0.0 111.609 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.5 m -59.8 -39.18 84.12 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -173.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.6 t -58.92 -44.55 91.32 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.529 1.931 . . . . 0.0 113.479 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.89 -40.34 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.317 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.67 -53.22 60.85 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.634 0.774 . . . . 0.0 111.292 174.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -61.58 -29.02 69.76 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 176.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 10.8 t -60.12 -35.13 74.58 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.102 0.961 . . . . 0.0 112.705 176.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -75.37 -3.67 34.95 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.872 1.669 . . . . 0.0 114.068 172.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.71 -10.55 73.27 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 126.528 2.013 . . . . 0.0 115.173 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.5 m -85.08 138.02 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.81 1.644 . . . . 0.0 111.637 176.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -76.96 154.67 33.35 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.396 1.079 . . . . 0.0 112.238 169.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 pp -74.05 123.15 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.384 1.474 . . . . 0.0 109.744 174.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -75.4 -42.59 53.41 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.806 1.242 . . . . 0.0 111.57 173.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.4 t -158.09 169.4 24.63 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.093 1.357 . . . . 0.0 112.209 173.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -79.93 152.2 29.69 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.756 2.022 . . . . 0.0 113.012 174.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.46 163.96 13.46 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.476 1.512 . . . . 0.0 112.309 -173.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 m -59.47 128.66 38.17 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.602 0.761 . . . . 0.0 109.563 164.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.83 154.36 94.32 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -176.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.89 144.92 49.25 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.297 2.664 . . . . 0.0 111.633 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.3 m -76.09 -10.57 59.52 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -176.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.23 -11.22 56.41 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.621 1.581 . . . . 0.0 116.169 -172.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.1 mt . . . . . 0 N--CA 1.483 1.19 0 C-N-CA 126.088 1.755 . . . . 0.0 110.149 -179.952 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 45.3 m . . . . . 0 CA--C 1.549 0.911 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.87 154.98 43.55 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.371 2.714 . . . . 0.0 111.482 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -104.58 5.42 33.78 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.911 2.084 . . . . 0.0 114.135 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 9.1 mt -70.16 143.07 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.897 1.679 . . . . 0.0 110.102 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.6 tt -80.75 74.99 7.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.558 1.943 . . . . 0.0 110.293 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -133.58 68.23 76.1 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 125.391 1.476 . . . . 0.0 111.509 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -67.6 165.95 25.66 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.024 2.483 . . . . 0.0 112.54 -176.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.6 m -142.94 152.23 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.973 1.709 . . . . 0.0 110.694 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.5 t -90.59 118.15 29.82 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 167.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.57 165.02 54.3 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-N 119.177 0.898 . . . . 0.0 112.799 172.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.7 p -67.42 -16.0 63.99 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.34 -9.28 58.53 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.227 1.411 . . . . 0.0 114.053 167.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.59 -1.58 88.21 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.609 1.576 . . . . 0.0 114.931 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.5 mmt-85 -72.28 159.44 34.06 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.011 1.324 . . . . 0.0 111.277 168.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 59.4 m -114.56 131.24 56.73 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.176 1.39 . . . . 0.0 109.564 169.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.406 ' HB3' HG23 ' A' ' 26' ' ' ILE . 16.3 m-85 -118.11 166.62 12.34 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.688 1.595 . . . . 0.0 109.916 175.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.73 -24.21 62.58 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -167.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -165.09 176.33 8.62 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.727 2.011 . . . . 0.0 111.12 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.1 m -65.26 -34.58 78.69 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.7 t -62.32 -45.65 92.25 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.953 1.701 . . . . 0.0 113.244 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.406 HG23 ' HB3' ' A' ' 21' ' ' TYR . 10.8 tp -69.96 -39.36 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.194 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.04 -54.87 37.51 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.102 0.961 . . . . 0.0 111.685 170.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -63.18 -32.22 73.56 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.9 m -62.82 -20.23 64.84 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -80.93 -2.81 49.21 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.526 1.13 . . . . 0.0 113.673 169.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.75 16.32 58.43 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.418 1.485 . . . . 0.0 114.774 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 t -129.8 148.99 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.332 1.453 . . . . 0.0 111.277 -172.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.1 p -85.25 158.31 20.36 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.929 1.692 . . . . 0.0 112.721 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.66 124.77 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 125.578 1.551 . . . . 0.0 109.606 172.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -76.15 -39.86 54.02 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.879 1.272 . . . . 0.0 111.317 172.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.3 p -158.98 162.91 36.84 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.54 1.536 . . . . 0.0 112.785 172.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -74.89 152.41 38.88 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.025 1.33 . . . . 0.0 112.539 170.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.24 162.42 20.09 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.597 1.57 . . . . 0.0 112.538 -172.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.4 t -59.93 148.04 36.51 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.987 -0.713 . . . . 0.0 110.87 164.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 CA--C 1.544 0.714 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -177.982 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 13.7 m . . . . . 0 CA--C 1.552 1.047 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -76.62 171.74 17.49 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.952 3.101 . . . . 0.0 112.211 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.1 tttm -119.37 9.41 11.62 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.97 1.708 . . . . 0.0 114.581 -174.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.5 mt -63.11 143.66 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.182 1.393 . . . . 0.0 110.069 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 71.6 mt -75.01 70.61 2.03 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.054 1.741 . . . . 0.0 111.108 173.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -132.92 63.38 66.94 Favored Pre-proline 0 N--CA 1.471 0.622 0 C-N-CA 125.374 1.469 . . . . 0.0 109.934 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.26 160.25 48.46 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.987 2.458 . . . . 0.0 111.455 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.7 m -144.71 162.39 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.833 1.253 . . . . 0.0 111.639 -172.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.4 t -98.45 113.81 25.95 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.171 1.388 . . . . 0.0 110.201 173.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.37 166.37 54.71 Favored Glycine 0 CA--C 1.535 1.34 0 O-C-N 121.604 -0.685 . . . . 0.0 113.425 172.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.1 t -60.13 -25.1 65.21 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.071 1.349 . . . . 0.0 113.717 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -68.08 -14.12 62.73 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.918 1.287 . . . . 0.0 113.827 172.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.84 -4.04 84.87 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 126.088 1.804 . . . . 0.0 114.634 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -78.13 159.87 28.38 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.782 1.233 . . . . 0.0 111.685 173.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 59.6 m -109.91 131.56 54.95 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.519 1.528 . . . . 0.0 109.793 170.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -119.72 167.95 11.55 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.66 1.184 . . . . 0.0 110.756 171.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.63 -25.24 59.86 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -175.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -167.34 177.24 6.18 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.569 1.548 . . . . 0.0 111.329 174.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.0 p -60.49 -47.1 87.61 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 176.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.5 t -55.69 -42.06 74.64 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.503 1.921 . . . . 0.0 113.424 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.43 -52.71 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 125.38 1.472 . . . . 0.0 111.032 175.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.58 -46.93 83.4 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.36 0.664 . . . . 0.0 111.96 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -65.77 -28.86 69.34 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.3 t -59.46 -33.98 71.97 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.248 1.019 . . . . 0.0 112.69 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -72.44 -3.63 25.4 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.145 1.778 . . . . 0.0 113.998 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.92 -12.29 65.77 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 126.807 2.146 . . . . 0.0 115.334 172.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.5 m -88.22 135.71 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.836 1.654 . . . . 0.0 111.855 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.3 p -68.62 164.66 20.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.928 1.291 . . . . 0.0 112.726 173.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.3 mm -90.79 110.8 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 123.996 0.918 . . . . 0.0 110.263 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -45.97 90.78 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.256 1.022 . . . . 0.0 110.97 172.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.7 t -164.18 166.06 21.49 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.727 0.775 . . . . 0.0 112.777 173.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -86.78 154.99 20.5 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.628 1.971 . . . . 0.0 112.719 176.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.06 157.56 11.6 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.958 1.266 . . . . 0.0 111.806 -168.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.3 m -59.45 126.95 29.68 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.784 -0.833 . . . . 0.0 109.958 168.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.544 0.739 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -176.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.1 m . . . . . 0 CA--C 1.55 0.955 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.98 158.2 38.43 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.35 2.7 . . . . 0.0 112.106 -174.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -100.14 4.37 44.45 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.573 1.949 . . . . 0.0 114.435 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.7 mt -68.29 143.2 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.744 1.618 . . . . 0.0 109.905 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.89 79.58 9.58 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.129 1.772 . . . . 0.0 110.199 173.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -131.64 63.07 67.98 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 125.605 1.562 . . . . 0.0 111.721 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.33 166.12 24.57 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.309 2.672 . . . . 0.0 112.714 -173.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.6 m -142.55 152.54 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.835 1.654 . . . . 0.0 110.904 -175.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.8 t -89.42 113.55 24.9 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 166.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.87 162.56 52.96 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-N 118.906 0.776 . . . . 0.0 112.939 175.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 t -67.05 -14.08 62.55 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -72.53 -14.2 61.59 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.942 1.297 . . . . 0.0 113.479 168.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.55 -6.86 77.77 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 126.245 1.878 . . . . 0.0 114.706 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.2 mmt85 -74.29 161.99 29.35 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.776 1.631 . . . . 0.0 112.006 170.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.5 m -115.05 137.47 51.97 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.456 1.502 . . . . 0.0 109.763 167.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -127.18 166.84 16.95 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.894 1.678 . . . . 0.0 110.622 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.09 -23.75 64.05 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -165.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -164.42 -176.53 4.42 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.703 2.001 . . . . 0.0 111.353 172.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 54.8 m -67.17 -34.62 77.93 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 176.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.2 t -65.91 -38.1 87.83 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.796 1.638 . . . . 0.0 113.48 -175.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.0 tp -70.9 -50.22 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.843 170.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.53 -51.06 64.07 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.139 1.376 . . . . 0.0 112.882 -177.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.42 -34.82 72.96 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.044 1.337 . . . . 0.0 113.543 175.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.8 t -63.87 -30.92 71.96 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.504 1.122 . . . . 0.0 113.075 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -67.8 -8.15 33.52 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.059 1.344 . . . . 0.0 114.045 173.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.34 11.91 60.48 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.994 1.283 . . . . 0.0 115.086 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -128.74 151.26 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.538 1.535 . . . . 0.0 110.321 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 p -82.29 160.36 22.93 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.319 1.848 . . . . 0.0 112.847 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -73.09 126.04 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 125.75 1.62 . . . . 0.0 109.495 171.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -81.41 -38.21 26.88 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.557 1.143 . . . . 0.0 111.617 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.6 p -157.57 162.7 38.78 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.337 1.455 . . . . 0.0 112.788 169.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -75.1 150.25 38.87 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.238 1.415 . . . . 0.0 112.445 171.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.77 161.29 19.56 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.554 1.549 . . . . 0.0 112.403 -171.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.0 t -58.97 148.55 30.2 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 122.012 -0.699 . . . . 0.0 111.024 165.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 CA--C 1.542 0.65 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 179.807 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 43.0 m . . . . . 0 CA--C 1.548 0.892 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.1 146.8 41.81 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.272 2.648 . . . . 0.0 110.981 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -80.26 6.57 11.55 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.944 1.698 . . . . 0.0 115.006 176.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.7 tt -57.91 139.63 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 126.291 1.837 . . . . 0.0 113.186 -173.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.8 mt -84.9 72.01 10.83 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.11 1.364 . . . . 0.0 110.683 175.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -139.16 71.48 40.29 Favored Pre-proline 0 N--CA 1.47 0.54 0 C-N-CA 125.243 1.417 . . . . 0.0 109.944 173.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -66.64 166.64 21.42 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.367 2.045 . . . . 0.0 112.179 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.8 m -144.71 154.43 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.112 1.765 . . . . 0.0 111.027 -172.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 t -94.23 115.18 27.4 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.522 0.729 . . . . 0.0 109.186 167.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.9 160.66 53.58 Favored Glycine 0 CA--C 1.536 1.369 0 O-C-N 121.336 -0.853 . . . . 0.0 113.085 173.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.1 t -64.56 -20.62 66.34 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -70.79 -6.18 35.76 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.084 1.353 . . . . 0.0 114.364 170.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.48 19.97 55.52 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.71 1.148 . . . . 0.0 114.833 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -118.25 162.89 17.51 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.448 1.899 . . . . 0.0 111.332 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.1 m -116.53 129.62 56.29 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.237 1.415 . . . . 0.0 110.748 -175.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -123.9 165.86 16.65 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.721 1.608 . . . . 0.0 110.767 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.8 -29.96 70.53 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -167.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -166.41 171.06 12.34 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.908 1.683 . . . . 0.0 111.358 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.3 m -59.16 -42.78 91.55 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -171.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.2 t -56.08 -43.56 78.12 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.236 1.814 . . . . 0.0 113.264 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.5 tp -72.8 -38.77 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.899 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.33 -52.61 64.54 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.926 0.89 . . . . 0.0 111.766 174.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -60.05 -28.45 67.79 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.8 t -58.04 -31.51 67.08 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.118 1.367 . . . . 0.0 113.413 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -73.75 -3.97 31.7 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.238 1.415 . . . . 0.0 114.31 173.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.11 11.46 63.07 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.214 1.388 . . . . 0.0 114.908 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.35 146.83 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 126.076 1.75 . . . . 0.0 110.57 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 p -79.87 162.45 25.01 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.868 1.667 . . . . 0.0 113.111 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.3 pp -72.11 123.04 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.371 1.468 . . . . 0.0 109.611 170.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -68.66 -41.47 79.26 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.915 1.286 . . . . 0.0 111.173 170.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.9 p -156.98 158.17 36.1 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.17 1.788 . . . . 0.0 112.362 174.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -72.69 149.78 43.51 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.099 1.36 . . . . 0.0 110.653 171.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.32 158.46 20.77 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.922 1.249 . . . . 0.0 112.057 -174.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.3 t -59.87 145.02 47.2 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.739 -0.86 . . . . 0.0 110.912 167.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.542 0.64 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -178.147 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 16.6 m . . . . . 0 CA--C 1.551 1.005 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -73.85 171.78 17.19 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.819 3.013 . . . . 0.0 111.449 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.75 17.8 10.27 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.877 1.671 . . . . 0.0 113.978 -173.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.9 mt -63.84 141.56 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.505 1.522 . . . . 0.0 109.814 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.4 mt -79.59 70.47 6.07 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.732 1.213 . . . . 0.0 110.584 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -134.9 72.16 68.65 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 124.941 1.296 . . . . 0.0 109.866 172.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.17 164.03 33.79 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.109 1.873 . . . . 0.0 111.745 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.7 m -144.48 140.69 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.884 1.673 . . . . 0.0 110.58 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 t -79.14 114.78 18.35 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.85 163.09 45.44 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 121.546 -0.721 . . . . 0.0 113.159 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.1 m -68.11 -11.91 59.92 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -77.23 -10.52 59.47 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.929 1.692 . . . . 0.0 114.192 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.05 13.98 35.07 Favored Glycine 0 CA--C 1.539 1.541 0 N-CA-C 115.894 1.118 . . . . 0.0 115.894 175.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -137.05 168.24 19.97 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.317 1.847 . . . . 0.0 110.944 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.0 t -105.47 150.31 25.42 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.61 1.164 . . . . 0.0 111.699 175.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -124.19 170.28 10.89 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.233 1.813 . . . . 0.0 110.39 173.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.04 -35.17 77.8 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -167.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -163.16 168.04 21.32 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.474 1.51 . . . . 0.0 112.077 175.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.2 m -60.13 -32.11 70.7 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -167.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.7 t -61.22 -43.94 98.07 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.905 1.682 . . . . 0.0 113.514 176.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.9 tp -72.44 -39.59 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.747 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.48 -28.64 69.97 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.451 1.1 . . . . 0.0 113.418 176.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -88.04 -30.13 20.16 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.141 1.376 . . . . 0.0 114.377 173.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 37.5 t -55.09 -39.82 69.73 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.99 1.316 . . . . 0.0 113.13 -174.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -70.26 -11.34 60.83 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 126.076 1.75 . . . . 0.0 115.164 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.91 -8.29 42.45 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 126.488 1.994 . . . . 0.0 116.247 175.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.5 t -93.58 168.99 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 125.507 1.523 . . . . 0.0 110.654 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.6 p -112.24 155.9 23.27 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 127.477 2.311 . . . . 0.0 112.37 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -67.64 123.17 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.623 1.569 . . . . 0.0 110.075 176.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -77.34 -42.23 37.4 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.507 1.123 . . . . 0.0 110.832 172.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.0 p -153.75 157.93 40.2 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.461 1.504 . . . . 0.0 112.508 174.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -82.74 149.25 27.38 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.721 1.208 . . . . 0.0 111.269 177.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.81 162.04 24.34 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.54 1.066 . . . . 0.0 111.676 -169.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.1 t -60.33 148.27 37.59 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 122.125 -0.633 . . . . 0.0 110.942 167.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -179.58 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 18.6 m . . . . . 0 CA--C 1.549 0.932 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.48 147.26 31.97 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.354 2.702 . . . . 0.0 111.664 -176.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.61 3.63 55.2 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.263 1.825 . . . . 0.0 114.645 177.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.2 mt -65.06 140.6 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.207 1.403 . . . . 0.0 109.995 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tt -80.75 74.2 7.7 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.981 1.712 . . . . 0.0 109.357 175.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.23 69.73 77.87 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 124.424 1.09 . . . . 0.0 110.474 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.29 167.28 18.85 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.835 2.356 . . . . 0.0 112.5 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.6 m -144.84 153.18 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 126.006 1.722 . . . . 0.0 110.358 -173.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.5 t -98.53 113.62 25.72 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.181 0.992 . . . . 0.0 108.766 171.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.63 159.16 53.53 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 118.773 0.715 . . . . 0.0 113.296 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.3 t -59.83 -24.09 63.89 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -67.57 -13.7 62.29 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 125.227 1.411 . . . . 0.0 114.017 171.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.97 -3.29 64.62 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 126.439 1.971 . . . . 0.0 114.697 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -84.11 164.64 19.08 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.941 1.696 . . . . 0.0 111.937 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.6 m -114.76 138.68 50.44 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.997 1.319 . . . . 0.0 110.508 171.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -124.92 166.87 15.53 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.981 1.712 . . . . 0.0 110.624 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.48 -24.23 61.96 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -167.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -164.18 179.28 6.99 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.158 2.183 . . . . 0.0 110.629 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.5 p -65.24 -42.47 93.32 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.8 t -57.17 -41.52 79.38 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.522 1.929 . . . . 0.0 113.972 -176.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.6 tt -70.59 -48.38 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.948 1.299 . . . . 0.0 111.966 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.54 -52.94 42.86 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.183 0.993 . . . . 0.0 112.051 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -62.75 -27.64 69.42 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 178.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.9 t -61.93 -31.69 72.03 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.562 1.145 . . . . 0.0 112.786 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -73.84 -4.16 33.15 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.625 1.57 . . . . 0.0 114.178 171.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.82 -7.02 83.09 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 126.207 1.861 . . . . 0.0 115.072 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.7 m -93.31 146.0 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 126.341 1.857 . . . . 0.0 111.581 176.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.2 p -84.99 160.95 19.95 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.074 1.35 . . . . 0.0 112.0 171.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.4 pt -73.24 128.02 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.48 1.112 . . . . 0.0 110.031 172.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -77.54 -39.48 45.84 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.058 0.943 . . . . 0.0 111.494 169.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.4 t -154.76 170.59 21.25 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.474 1.109 . . . . 0.0 113.071 173.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -85.06 151.57 24.06 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.433 2.293 . . . . 0.0 112.684 174.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.29 162.5 10.65 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.475 1.512 . . . . 0.0 112.286 -170.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.7 m -59.39 130.0 44.75 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.85 -0.794 . . . . 0.0 109.588 163.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.542 0.666 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.0 m . . . . . 0 CA--C 1.549 0.914 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.56 167.87 26.13 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.691 2.927 . . . . 0.0 112.027 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.69 8.24 13.73 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.345 2.258 . . . . 0.0 114.008 -173.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.9 mt -68.8 140.74 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.3 1.44 . . . . 0.0 109.785 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tt -82.01 72.93 9.07 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.166 1.787 . . . . 0.0 110.584 -176.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -134.73 68.67 71.82 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 125.554 1.541 . . . . 0.0 111.406 -175.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.27 162.2 43.26 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.0 2.466 . . . . 0.0 112.914 -175.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.8 m -144.85 163.73 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 127.045 2.138 . . . . 0.0 111.244 -172.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.2 t -94.41 122.46 37.0 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.523 0.729 . . . . 0.0 110.39 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.46 161.39 53.56 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.079 0.847 . . . . 0.0 113.61 172.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.0 t -61.73 -27.48 68.75 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.239 1.016 . . . . 0.0 113.567 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -82.86 -5.92 59.21 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.311 1.844 . . . . 0.0 114.488 174.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.17 2.04 66.47 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.556 1.55 . . . . 0.0 115.956 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -73.38 166.03 23.95 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 119.814 1.807 . . . . 0.0 111.622 170.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.5 m -121.54 123.7 42.62 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.814 1.646 . . . . 0.0 109.203 172.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.403 ' HB3' ' CG2' ' A' ' 26' ' ' ILE . 35.4 m-85 -113.21 170.58 8.11 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.763 1.625 . . . . 0.0 110.812 174.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.29 -31.85 71.58 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -168.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.09 170.32 19.39 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.634 1.574 . . . . 0.0 110.96 176.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.3 m -59.74 -40.8 89.33 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -172.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.9 t -55.89 -45.71 78.54 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.079 1.752 . . . . 0.0 113.203 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.403 ' CG2' ' HB3' ' A' ' 21' ' ' TYR . 2.2 tp -72.27 -36.25 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.183 -177.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.04 -55.24 37.44 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.395 0.678 . . . . 0.0 111.299 169.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -63.91 -26.75 68.74 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.3 t -57.6 -34.62 69.45 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.585 1.154 . . . . 0.0 112.909 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -74.23 -4.35 35.48 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.699 1.6 . . . . 0.0 114.435 173.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.87 -11.28 72.55 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 126.39 1.947 . . . . 0.0 115.263 175.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 m -83.07 151.43 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.811 1.644 . . . . 0.0 111.495 173.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.7 t -80.55 176.02 10.15 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.937 0.875 . . . . 0.0 111.634 167.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 pp -101.2 119.95 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 128.307 2.643 . . . . 0.0 109.661 174.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -59.94 -44.8 94.14 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.542 0.737 . . . . 0.0 111.552 176.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.1 t -161.49 171.01 18.86 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.42 1.488 . . . . 0.0 112.129 170.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -72.83 152.85 41.33 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.258 1.823 . . . . 0.0 112.641 171.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.51 146.15 4.42 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.858 1.218 . . . . 0.0 112.248 -175.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 p -59.37 133.75 56.38 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.528 -0.983 . . . . 0.0 111.569 171.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.541 0.601 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -172.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 33.2 m . . . . . 0 CA--C 1.546 0.826 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.59 140.06 23.48 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.054 2.502 . . . . 0.0 111.242 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -75.16 -1.98 25.65 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.8 mt -66.36 140.79 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.637 1.575 . . . . 0.0 109.724 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.1 mt -89.1 80.11 7.06 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.159 1.784 . . . . 0.0 110.085 175.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -127.66 68.56 74.61 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 124.003 0.921 . . . . 0.0 110.593 176.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.6 163.34 27.69 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.95 2.434 . . . . 0.0 112.453 -173.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.1 m -145.24 157.01 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.889 1.676 . . . . 0.0 110.7 -171.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.6 t -101.18 110.34 22.35 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.987 0.915 . . . . 0.0 109.424 170.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.74 158.21 52.17 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-N 118.981 0.81 . . . . 0.0 112.905 173.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.5 p -70.09 -9.19 54.68 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -64.32 -14.59 57.03 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.37 1.468 . . . . 0.0 113.45 163.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.17 19.58 45.71 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.324 1.44 . . . . 0.0 114.085 -177.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.9 ttm-85 -119.24 160.27 22.5 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.528 1.931 . . . . 0.0 111.682 -174.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.9 m -116.61 131.52 56.93 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.386 1.475 . . . . 0.0 110.683 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -125.23 169.97 11.73 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.621 1.568 . . . . 0.0 110.925 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.87 -21.6 61.63 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -165.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -161.01 -174.54 4.44 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.987 2.115 . . . . 0.0 109.815 174.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.7 p -72.64 -38.34 67.74 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.1 t -58.2 -41.81 84.78 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.777 1.631 . . . . 0.0 113.953 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 tp -72.1 -43.75 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.836 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.61 -49.49 76.25 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.288 1.035 . . . . 0.0 112.106 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -60.97 -25.45 66.85 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.0 t -59.27 -31.26 68.94 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.92 1.288 . . . . 0.0 113.146 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -74.73 -2.83 28.15 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.362 1.465 . . . . 0.0 114.211 172.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.61 15.08 62.32 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.089 1.328 . . . . 0.0 114.951 177.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 t -128.46 149.04 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.559 1.544 . . . . 0.0 110.856 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 p -87.81 162.8 16.78 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 126.53 1.932 . . . . 0.0 112.43 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.4 pt -73.47 126.54 34.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.708 1.203 . . . . 0.0 110.113 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -75.35 -40.53 58.09 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.641 1.177 . . . . 0.0 111.032 169.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.7 p -150.33 161.4 42.54 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.585 1.554 . . . . 0.0 112.751 171.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.17 153.49 25.97 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.286 1.434 . . . . 0.0 111.034 170.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.41 160.17 12.2 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.172 1.368 . . . . 0.0 112.073 -169.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.2 m -59.51 130.61 47.74 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.729 -0.865 . . . . 0.0 109.981 165.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.546 0.792 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -176.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.8 m . . . . . 0 CA--C 1.548 0.866 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.21 166.93 27.93 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.403 2.735 . . . . 0.0 111.265 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -109.86 10.79 24.43 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.35 1.46 . . . . 0.0 114.36 -173.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.7 mt -58.66 139.16 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.27 1.428 . . . . 0.0 110.217 -176.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.1 mt -80.94 71.9 7.93 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.461 1.505 . . . . 0.0 110.055 172.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -135.62 71.21 65.41 Favored Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 124.718 1.207 . . . . 0.0 109.136 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -68.83 159.07 55.32 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.141 1.894 . . . . 0.0 111.599 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 m -144.85 146.93 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.1 1.36 . . . . 0.0 111.52 -169.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.9 t -89.65 115.24 26.89 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.752 1.221 . . . . 0.0 110.583 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.59 164.61 50.82 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 121.78 -0.575 . . . . 0.0 113.905 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.2 m -62.27 -20.08 63.9 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.56 -8.82 57.58 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.407 1.483 . . . . 0.0 113.571 171.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.36 -2.64 85.16 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.949 1.737 . . . . 0.0 114.929 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -86.18 165.07 16.84 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.019 1.328 . . . . 0.0 111.884 172.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 65.2 m -115.13 138.37 50.97 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.13 1.372 . . . . 0.0 110.455 175.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -121.63 164.32 17.51 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.42 1.888 . . . . 0.0 110.08 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.18 -26.94 67.64 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -168.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -167.12 172.51 9.96 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.382 1.873 . . . . 0.0 111.031 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 t -60.21 -43.57 95.86 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -176.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.4 t -57.8 -44.19 86.16 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.654 1.582 . . . . 0.0 113.41 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.4 tp -70.41 -38.41 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.05 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.08 -55.12 39.04 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.417 1.087 . . . . 0.0 111.279 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -60.1 -37.96 81.53 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.606 0.762 . . . . 0.0 112.865 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 23.6 t -65.16 -38.68 91.34 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.097 0.959 . . . . 0.0 112.817 174.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.12 -21.85 66.46 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.225 1.41 . . . . 0.0 113.866 173.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.34 8.8 18.82 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.088 1.328 . . . . 0.0 115.618 174.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.84 149.05 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 119.301 1.55 . . . . 0.0 110.937 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.57 151.1 29.28 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.225 1.41 . . . . 0.0 111.394 172.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.13 126.75 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 126.849 2.06 . . . . 0.0 107.985 165.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -85.47 -48.21 9.19 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.18 0.592 . . . . 0.0 111.337 162.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.5 m -138.53 156.58 47.37 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.022 1.329 . . . . 0.0 112.501 -176.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -82.62 155.05 24.63 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.855 1.262 . . . . 0.0 112.483 172.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.25 159.42 13.14 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.042 1.306 . . . . 0.0 112.012 -172.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 m -60.18 128.02 34.69 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 121.956 -0.732 . . . . 0.0 109.673 164.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.546 0.802 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -175.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.6 m . . . . . 0 CA--C 1.548 0.886 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -73.38 142.24 33.08 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.217 2.611 . . . . 0.0 110.986 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -78.45 6.4 8.58 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.998 1.719 . . . . 0.0 114.877 176.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.3 tt -58.47 143.4 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 126.117 1.767 . . . . 0.0 112.723 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 tt -92.85 70.11 4.69 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.047 1.339 . . . . 0.0 109.643 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -135.4 72.6 64.81 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 125.603 1.561 . . . . 0.0 110.358 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.65 166.21 26.77 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.565 2.177 . . . . 0.0 112.24 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.8 m -141.26 156.27 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.356 1.863 . . . . 0.0 110.515 -176.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.2 t -90.13 113.87 25.71 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 164.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.32 160.05 47.37 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 121.454 -0.779 . . . . 0.0 113.263 176.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.7 t -62.11 -22.65 65.99 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.563 1.145 . . . . 0.0 113.603 -178.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -68.87 -13.15 62.24 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.434 1.494 . . . . 0.0 114.239 172.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.0 9.84 65.29 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.079 1.324 . . . . 0.0 114.53 -175.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -103.45 163.26 12.4 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.316 1.846 . . . . 0.0 111.409 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.5 m -115.29 129.02 56.5 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.19 1.796 . . . . 0.0 109.747 175.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -120.31 169.57 10.15 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.95 1.7 . . . . 0.0 110.72 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.77 -28.44 65.77 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -171.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.5 172.19 17.66 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.537 1.535 . . . . 0.0 111.093 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.9 p -63.04 -40.27 97.23 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.5 t -56.89 -46.88 81.6 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.23 1.812 . . . . 0.0 113.439 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.2 tp -70.68 -36.82 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.841 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.79 -55.42 35.15 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.694 0.798 . . . . 0.0 111.605 170.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -60.69 -28.6 68.75 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.158 1.169 . . . . 0.0 114.158 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.6 m -63.25 -20.36 65.38 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 174.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -84.91 -6.42 59.34 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.756 1.222 . . . . 0.0 113.787 167.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.43 -10.84 63.26 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 126.705 2.098 . . . . 0.0 115.157 177.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.0 m -99.02 142.56 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 126.39 1.876 . . . . 0.0 111.771 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.6 t -91.31 169.18 11.03 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.307 1.051 . . . . 0.0 112.584 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -72.16 132.04 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 127.58 2.352 . . . . 0.0 110.246 176.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -91.35 -36.6 13.74 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.049 1.34 . . . . 0.0 112.209 173.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.5 p -157.09 160.56 39.0 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.219 1.407 . . . . 0.0 112.75 171.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -73.35 146.91 44.87 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.065 1.346 . . . . 0.0 112.454 172.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.98 153.01 6.05 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.165 1.364 . . . . 0.0 111.871 -172.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.1 p -59.32 142.88 50.97 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.731 -0.864 . . . . 0.0 112.036 169.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.541 0.627 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -178.036 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.5 m . . . . . 0 CA--C 1.55 0.959 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -72.91 144.34 38.34 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 123.368 2.712 . . . . 0.0 111.767 -175.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -75.39 5.96 5.12 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.293 1.837 . . . . 0.0 115.18 175.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.8 tt -61.8 149.91 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.987 1.715 . . . . 0.0 112.829 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 tt -102.81 75.0 1.37 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.167 1.787 . . . . 0.0 109.512 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -142.69 73.88 19.38 Favored Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 124.791 1.236 . . . . 0.0 110.593 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.77 167.29 17.8 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.056 2.504 . . . . 0.0 112.743 -176.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.9 m -141.93 158.97 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.839 1.655 . . . . 0.0 110.789 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.9 t -99.81 118.3 35.98 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.928 0.891 . . . . 0.0 109.116 166.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.17 163.57 54.55 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 118.963 0.801 . . . . 0.0 113.268 172.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.5 t -63.43 -20.95 66.0 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -67.35 -14.29 62.78 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.37 1.468 . . . . 0.0 113.784 169.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.55 1.49 71.31 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 126.028 1.775 . . . . 0.0 114.666 -178.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -87.03 160.74 18.51 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.043 1.737 . . . . 0.0 111.591 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 91.1 m -109.79 136.37 49.23 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.303 1.441 . . . . 0.0 110.517 175.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -126.75 168.44 14.39 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.48 1.512 . . . . 0.0 111.603 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.46 -23.79 61.89 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -166.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -162.18 -179.64 7.21 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.218 1.807 . . . . 0.0 111.239 171.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 61.0 p -63.89 -40.96 97.73 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 175.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.2 t -59.18 -44.34 92.17 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.077 1.751 . . . . 0.0 113.57 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.4 tp -70.33 -42.93 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.054 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.88 -52.98 62.17 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.975 0.91 . . . . 0.0 111.522 177.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -60.12 -27.89 67.41 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.0 t -58.55 -29.69 66.55 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.775 1.23 . . . . 0.0 113.064 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -70.47 -12.63 61.7 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.651 1.58 . . . . 0.0 114.387 174.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.53 -0.39 77.36 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.878 1.704 . . . . 0.0 114.998 -175.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -104.33 149.54 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.759 1.624 . . . . 0.0 109.89 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.85 160.17 20.23 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.775 1.63 . . . . 0.0 112.209 174.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.6 pt -71.84 129.05 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 124.284 1.034 . . . . 0.0 110.13 170.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -73.69 -38.29 64.93 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.907 1.283 . . . . 0.0 111.227 170.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.0 p -158.59 163.79 36.66 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.009 1.724 . . . . 0.0 112.359 168.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.47 154.94 34.27 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.569 1.548 . . . . 0.0 112.007 166.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.41 158.61 9.96 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 125.404 1.478 . . . . 0.0 112.022 -168.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.0 t -62.17 146.71 49.89 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.657 -0.907 . . . . 0.0 110.743 166.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.541 0.605 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -177.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 35.5 m . . . . . 0 CA--C 1.549 0.909 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.67 159.14 53.72 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.588 2.859 . . . . 0.0 111.884 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -113.35 4.01 16.16 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.554 1.542 . . . . 0.0 114.024 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.51 ' H ' HD12 ' A' ' 9' ' ' ILE . 4.2 mp -69.75 146.19 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.425 1.09 . . . . 0.0 109.914 175.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.7 tt -77.84 74.3 4.4 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.837 2.055 . . . . 0.0 109.672 176.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.4 mmmt -129.39 63.56 68.07 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 125.63 1.572 . . . . 0.0 111.851 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.65 166.22 28.19 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.27 2.647 . . . . 0.0 112.625 -176.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.0 m -146.98 143.02 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.348 1.859 . . . . 0.0 110.553 -172.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.7 t -79.77 111.64 16.28 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.72 153.84 39.02 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 119.233 0.924 . . . . 0.0 112.851 175.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 90.2 p -69.92 -9.8 56.29 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -69.86 -15.93 63.17 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.354 1.461 . . . . 0.0 113.779 169.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.42 15.65 22.56 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 124.675 1.131 . . . . 0.0 115.645 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 51.6 ttm-85 -136.08 168.08 20.04 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.237 1.815 . . . . 0.0 111.021 178.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.2 t -106.44 151.74 24.54 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.44 1.096 . . . . 0.0 111.697 172.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -121.36 175.74 6.0 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.569 1.947 . . . . 0.0 110.018 173.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.31 -25.74 61.69 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -171.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -160.66 -176.49 5.59 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.901 1.68 . . . . 0.0 111.487 174.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.4 p -72.77 -25.99 61.38 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 177.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.5 t -71.48 -43.78 65.95 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.698 1.599 . . . . 0.0 112.54 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.5 tp -68.75 -41.44 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.637 0.775 . . . . 0.0 111.12 176.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.54 -56.17 19.32 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.72 1.208 . . . . 0.0 111.844 173.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -61.71 -36.11 79.99 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 32.3 m -59.06 -33.76 71.16 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.428 0.691 . . . . 0.0 112.722 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -67.52 -9.92 46.89 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 173.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.82 10.38 72.64 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.762 1.172 . . . . 0.0 114.88 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 t -116.88 156.37 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.318 1.847 . . . . 0.0 109.085 176.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.2 t -107.42 167.63 9.8 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 122.515 1.15 . . . . 0.0 111.754 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.6 pt -77.49 123.81 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 126.009 1.723 . . . . 0.0 109.965 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.3 tttt -71.89 -40.76 68.65 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.168 0.987 . . . . 0.0 111.349 168.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.0 t -156.93 171.53 20.28 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.079 1.352 . . . . 0.0 112.871 172.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -75.54 148.16 39.14 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.014 2.126 . . . . 0.0 112.528 171.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.98 159.09 6.97 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.175 1.369 . . . . 0.0 112.594 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.7 m -58.69 138.66 56.89 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.748 0.819 . . . . 0.0 111.18 170.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 CA--C 1.54 0.567 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -179.709 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.4 m . . . . . 0 CA--C 1.55 0.965 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -74.64 168.37 24.97 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.57 2.847 . . . . 0.0 112.419 -175.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -114.19 8.7 16.95 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.18 2.192 . . . . 0.0 114.164 -177.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 26.6 mt -66.32 144.03 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.356 1.462 . . . . 0.0 109.854 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 tt -84.62 71.79 10.75 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.417 1.887 . . . . 0.0 110.001 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -135.03 67.13 69.41 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 125.135 1.374 . . . . 0.0 111.38 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.58 168.51 18.05 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.329 2.686 . . . . 0.0 112.792 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.3 m -145.82 162.63 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.444 1.898 . . . . 0.0 110.765 -174.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.0 t -102.81 121.84 43.31 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.957 0.903 . . . . 0.0 109.364 166.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.97 166.8 53.17 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 119.108 0.867 . . . . 0.0 112.951 174.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.0 m -65.32 -15.45 62.55 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -74.91 -6.61 50.11 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.451 1.1 . . . . 0.0 113.851 168.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.96 19.41 61.27 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.955 1.264 . . . . 0.0 114.56 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.46 153.8 24.53 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.384 1.874 . . . . 0.0 111.45 -174.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.8 m -102.9 117.96 35.77 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.956 1.702 . . . . 0.0 111.886 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -104.29 163.11 12.65 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 128.078 2.551 . . . . 0.0 110.949 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.78 -25.38 56.38 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -175.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -161.43 178.61 8.98 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.007 1.723 . . . . 0.0 111.432 173.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.9 m -63.96 -37.4 87.26 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 177.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.6 t -59.68 -45.18 92.85 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.872 1.669 . . . . 0.0 112.966 -177.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.8 tt -73.39 -40.1 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.566 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.06 -28.53 67.87 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 174.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -90.44 -27.29 19.37 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 174.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.3 t -55.26 -38.99 69.26 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.966 1.307 . . . . 0.0 113.044 -176.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -69.82 -10.66 59.26 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 126.17 1.788 . . . . 0.0 115.25 175.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.33 -8.2 52.31 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 126.377 1.941 . . . . 0.0 116.131 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 t -92.94 164.99 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 125.496 1.518 . . . . 0.0 110.203 177.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 p -98.16 165.89 11.67 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.806 2.042 . . . . 0.0 112.089 174.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 pt -75.67 128.35 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.182 0.993 . . . . 0.0 109.731 169.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -69.43 -44.15 71.91 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.46 1.104 . . . . 0.0 110.784 168.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.0 t -156.49 170.71 21.72 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.067 1.347 . . . . 0.0 112.072 170.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -77.4 153.03 34.06 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.46 1.904 . . . . 0.0 111.528 173.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.89 152.67 5.77 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.372 1.463 . . . . 0.0 112.45 -173.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 p -58.03 139.72 53.96 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.836 0.855 . . . . 0.0 111.675 167.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.542 0.657 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -175.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.9 m . . . . . 0 CA--C 1.551 0.99 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -81.77 173.67 11.03 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.492 2.795 . . . . 0.0 113.068 -173.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -124.09 15.04 9.16 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.324 1.85 . . . . 0.0 114.152 -171.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.3 pp -61.43 174.03 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 125.714 1.605 . . . . 0.0 112.575 165.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.4 mt -110.7 85.96 2.22 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.17 1.388 . . . . 0.0 109.489 171.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.09 69.9 41.54 Favored Pre-proline 0 N--CA 1.473 0.693 0 C-N-CA 123.989 0.916 . . . . 0.0 110.756 174.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.15 171.99 11.72 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.745 2.297 . . . . 0.0 112.376 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.7 m -141.59 163.58 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.228 1.811 . . . . 0.0 111.455 -173.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.5 t -104.25 115.45 30.41 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.001 0.92 . . . . 0.0 109.213 166.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.41 162.2 54.0 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 123.891 0.757 . . . . 0.0 114.14 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.9 t -59.11 -28.63 66.7 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.567 1.147 . . . . 0.0 114.036 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -79.64 -1.14 36.83 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 125.97 1.708 . . . . 0.0 113.861 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.62 5.63 86.47 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.172 1.367 . . . . 0.0 113.983 -171.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.59 163.86 15.37 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.637 1.975 . . . . 0.0 112.344 176.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 27.4 m -135.57 113.01 10.67 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.447 1.499 . . . . 0.0 109.659 170.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -105.55 157.26 17.51 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.7 1.2 . . . . 0.0 111.131 173.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.57 -36.03 73.29 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.386 1.474 . . . . 0.0 113.893 -176.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.59 171.62 16.82 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.43 0.692 . . . . 0.0 111.448 171.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.8 m -60.87 -40.71 94.02 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.9 t -53.57 -41.95 67.05 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.674 1.99 . . . . 0.0 112.89 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 44.9 mm -70.99 -46.87 65.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 114.191 -1.368 . . . . 0.0 111.09 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.05 -53.63 47.4 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 173.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -61.26 -37.52 83.41 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 177.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.9 t -61.71 -39.0 89.96 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.041 0.936 . . . . 0.0 112.343 176.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -72.53 -2.46 19.83 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.812 1.645 . . . . 0.0 114.376 172.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.03 4.93 64.48 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.03 1.3 . . . . 0.0 115.777 169.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 m -119.48 135.85 58.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 126.382 1.873 . . . . 0.0 111.271 -177.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -75.41 154.93 36.86 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.605 1.162 . . . . 0.0 112.231 176.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 pt -78.58 125.49 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.861 1.264 . . . . 0.0 109.557 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -78.67 -36.42 43.79 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.386 1.075 . . . . 0.0 111.829 172.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.8 t -153.83 168.84 24.97 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.672 1.189 . . . . 0.0 112.461 169.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -85.06 146.49 27.14 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.584 2.354 . . . . 0.0 110.807 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.64 149.22 5.2 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.67 1.128 . . . . 0.0 111.767 -170.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.0 p -59.1 135.57 57.68 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.569 -0.959 . . . . 0.0 111.287 168.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -177.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.6 m . . . . . 0 CA--C 1.551 0.993 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.34 160.24 35.87 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.535 2.823 . . . . 0.0 112.317 -172.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.85 4.09 13.86 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.194 1.797 . . . . 0.0 115.582 -172.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pp -71.59 168.81 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 126.897 2.079 . . . . 0.0 112.894 173.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.6 mt -96.33 89.93 5.26 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.426 1.49 . . . . 0.0 109.915 169.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -139.42 69.3 39.48 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 123.475 0.71 . . . . 0.0 110.976 169.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.45 167.16 17.48 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.046 2.497 . . . . 0.0 112.506 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.4 m -144.88 155.89 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.766 1.626 . . . . 0.0 110.678 -174.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.5 t -102.05 117.88 35.72 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.055 0.942 . . . . 0.0 109.666 172.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.55 165.99 53.12 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 121.51 -0.744 . . . . 0.0 113.659 175.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.7 p -61.63 -21.39 64.35 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -70.11 -12.77 61.84 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.559 1.543 . . . . 0.0 113.681 171.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.37 -0.85 75.47 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.935 1.731 . . . . 0.0 115.112 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -90.43 160.54 15.99 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.331 1.452 . . . . 0.0 111.512 176.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 40.4 m -109.26 131.65 54.87 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.279 1.431 . . . . 0.0 110.513 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -113.3 167.95 10.14 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.793 1.637 . . . . 0.0 110.481 173.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.73 -26.42 62.46 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -167.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -161.25 177.63 10.02 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.949 2.099 . . . . 0.0 110.681 174.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.8 p -62.17 -43.1 99.58 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 t -56.69 -37.98 71.62 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.471 1.908 . . . . 0.0 114.554 -176.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 tt -73.18 -52.75 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.844 0.858 . . . . 0.0 111.528 172.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.79 -56.05 6.87 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.799 1.24 . . . . 0.0 112.305 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.13 -27.69 69.25 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.205 1.802 . . . . 0.0 115.385 177.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 9.5 t -59.78 -33.29 71.52 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.361 1.064 . . . . 0.0 112.79 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -67.33 -17.83 64.92 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.171 1.389 . . . . 0.0 113.917 173.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.47 -9.95 57.6 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 126.594 2.045 . . . . 0.0 115.242 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.6 m -86.55 149.87 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 119.164 1.482 . . . . 0.0 111.516 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.01 156.18 20.55 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.921 1.289 . . . . 0.0 111.607 170.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.9 pt -71.2 129.02 35.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.195 0.998 . . . . 0.0 110.018 171.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.4 tptp -78.49 -35.32 46.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.449 1.099 . . . . 0.0 111.28 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.0 p -156.36 162.48 40.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.879 1.672 . . . . 0.0 112.503 172.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -84.84 157.2 21.0 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.119 0.968 . . . . 0.0 112.418 169.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.14 161.74 11.69 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.15 1.357 . . . . 0.0 111.975 -166.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.1 m -59.02 131.74 51.96 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.95 -0.735 . . . . 0.0 109.765 164.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.545 0.774 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 14.3 m . . . . . 0 CA--C 1.547 0.862 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -77.97 166.96 24.33 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.238 2.625 . . . . 0.0 111.966 -176.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -119.74 15.33 12.68 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.763 2.025 . . . . 0.0 114.538 -170.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -60.64 170.29 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 126.736 2.014 . . . . 0.0 113.73 170.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.0 mt -104.83 80.1 1.6 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.565 1.546 . . . . 0.0 110.221 172.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.6 mmtt -138.92 66.24 39.46 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 125.132 1.373 . . . . 0.0 110.796 173.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.82 163.16 31.77 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.86 2.373 . . . . 0.0 111.944 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.0 m -146.51 160.75 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.561 1.544 . . . . 0.0 111.48 -170.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.5 t -96.28 116.88 29.72 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.012 1.325 . . . . 0.0 110.486 172.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.26 165.48 54.8 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 121.407 -0.808 . . . . 0.0 113.368 172.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.8 t -61.95 -26.93 68.49 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.35 1.06 . . . . 0.0 113.164 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -69.02 -8.01 40.96 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.603 1.961 . . . . 0.0 114.912 169.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.37 2.12 90.55 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.813 1.673 . . . . 0.0 115.3 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.2 mmt-85 -84.92 163.23 19.1 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.435 1.618 . . . . 0.0 111.615 173.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.3 m -118.42 117.59 29.45 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.589 1.555 . . . . 0.0 109.893 173.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -103.72 176.51 5.13 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.138 1.375 . . . . 0.0 110.298 170.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.87 -24.66 64.36 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -169.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.54 176.56 10.29 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.534 1.534 . . . . 0.0 110.869 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.7 p -62.24 -45.41 93.47 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 174.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.2 t -56.85 -44.26 81.97 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.404 1.882 . . . . 0.0 114.08 -177.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.44 -44.38 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.745 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.26 -49.56 77.38 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.022 0.929 . . . . 0.0 111.756 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -61.95 -28.65 69.69 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 174.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.9 t -61.29 -34.83 75.85 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.091 0.956 . . . . 0.0 112.844 176.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -72.47 -8.72 56.56 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.33 1.452 . . . . 0.0 114.144 170.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.93 -12.09 64.12 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.579 2.038 . . . . 0.0 115.335 174.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.6 m -79.97 141.18 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.266 1.426 . . . . 0.0 111.863 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.6 t -78.06 173.72 11.89 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.762 0.791 . . . . 0.0 112.036 171.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.0 mm -99.2 112.8 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 126.085 1.754 . . . . 0.0 110.196 -175.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -66.06 -38.6 88.73 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.533 0.733 . . . . 0.0 111.377 172.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.9 p -168.17 156.88 9.02 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.037 0.935 . . . . 0.0 112.949 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -82.11 153.87 25.85 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 122.304 1.05 . . . . 0.0 111.545 172.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.82 153.71 8.54 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.911 1.72 . . . . 0.0 111.618 -168.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.8 m -56.05 128.2 34.21 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.74 -0.859 . . . . 0.0 110.078 167.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.546 0.824 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -176.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 27.2 m . . . . . 0 CA--C 1.551 1.004 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.57 141.75 35.13 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.024 2.483 . . . . 0.0 111.441 -175.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -77.61 8.14 4.75 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.978 1.711 . . . . 0.0 114.868 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.4 tt -58.36 143.73 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 125.974 1.71 . . . . 0.0 112.702 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.5 tt -91.98 72.07 5.57 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.141 1.376 . . . . 0.0 109.573 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -138.24 72.45 45.51 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 125.415 1.486 . . . . 0.0 110.559 177.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -67.52 165.97 25.45 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.473 2.115 . . . . 0.0 112.037 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.7 m -141.35 156.68 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 126.238 1.815 . . . . 0.0 110.557 -175.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.4 t -91.95 117.0 29.4 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 165.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.18 162.18 45.93 Favored Glycine 0 CA--C 1.535 1.288 0 O-C-N 121.459 -0.776 . . . . 0.0 113.007 174.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.7 m -68.91 -14.27 62.94 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -176.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -74.31 -5.82 44.44 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.723 1.609 . . . . 0.0 113.27 169.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.82 21.08 54.43 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.787 1.184 . . . . 0.0 114.541 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -119.54 162.91 18.11 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.196 1.798 . . . . 0.0 111.788 -176.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.4 m -114.57 122.61 47.06 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.916 1.686 . . . . 0.0 110.133 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -115.34 169.07 9.42 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.635 1.574 . . . . 0.0 110.817 174.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.85 -30.35 66.73 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -166.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -164.51 170.3 16.06 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.28 1.432 . . . . 0.0 111.954 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.7 p -60.97 -39.85 91.16 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -171.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -54.08 -51.77 63.08 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.787 2.035 . . . . 0.0 112.997 176.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.6 tp -67.41 -40.43 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 121.387 -0.821 . . . . 0.0 110.865 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.97 -3.58 5.53 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.897 1.679 . . . . 0.0 114.905 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -116.09 -31.97 5.52 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.832 1.653 . . . . 0.0 114.489 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 56.4 m -60.41 -26.41 66.68 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.715 1.206 . . . . 0.0 113.633 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -72.94 -10.75 60.14 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 127.53 2.332 . . . . 0.0 115.472 170.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.27 1.17 59.43 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 125.642 1.591 . . . . 0.0 116.518 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 p -102.05 169.39 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-N 119.359 1.579 . . . . 0.0 111.064 172.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.1 149.79 29.53 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 127.115 2.166 . . . . 0.0 112.121 175.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -66.93 124.15 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 125.096 1.358 . . . . 0.0 110.089 176.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -78.98 -37.82 38.46 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.717 1.207 . . . . 0.0 111.523 174.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.8 p -160.03 162.13 34.15 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.472 1.509 . . . . 0.0 112.942 172.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -76.96 151.55 35.64 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.878 1.271 . . . . 0.0 112.615 171.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.54 156.94 8.48 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.097 1.332 . . . . 0.0 111.701 -169.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.2 p -60.1 146.08 44.4 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.71 -0.876 . . . . 0.0 111.837 167.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.542 0.652 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.6 m . . . . . 0 CA--C 1.55 0.944 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -79.61 173.71 12.69 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.973 3.116 . . . . 0.0 112.546 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -122.76 14.01 10.02 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.206 1.802 . . . . 0.0 114.065 -173.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.88 161.92 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 125.347 1.459 . . . . 0.0 112.52 172.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tt -98.25 75.94 2.3 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.765 1.226 . . . . 0.0 109.804 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -140.08 69.85 34.94 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 124.3 1.04 . . . . 0.0 111.428 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.88 168.04 24.17 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.176 2.584 . . . . 0.0 112.644 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.6 m -137.77 167.32 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 128.332 2.653 . . . . 0.0 111.518 -171.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.7 t -109.67 108.46 18.86 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.905 0.882 . . . . 0.0 109.569 167.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.13 156.17 53.55 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.008 0.813 . . . . 0.0 114.319 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.3 t -69.08 -14.26 62.91 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -78.3 -5.99 53.72 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.01 1.724 . . . . 0.0 113.86 168.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.23 4.43 74.3 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.752 1.644 . . . . 0.0 115.06 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -101.34 168.04 9.79 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.164 1.482 . . . . 0.0 111.727 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.2 m -121.27 135.51 55.11 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.733 1.613 . . . . 0.0 110.108 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -125.66 156.97 38.42 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.37 1.468 . . . . 0.0 110.863 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.84 -31.04 64.35 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.14 1.376 . . . . 0.0 114.108 -174.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -156.64 169.29 25.03 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.806 0.843 . . . . 0.0 111.605 175.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.1 t -60.61 -44.71 95.98 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.0 t -50.27 -44.19 53.65 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.113 1.765 . . . . 0.0 113.059 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.0 mm -64.03 -57.09 13.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.859 176.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.59 -52.87 16.31 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.396 0.678 . . . . 0.0 112.689 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -61.55 -38.19 86.56 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 30.6 t -63.16 -38.96 93.24 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.238 1.015 . . . . 0.0 112.138 176.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -67.51 -13.17 61.81 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.187 1.395 . . . . 0.0 113.463 173.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.12 -0.18 41.12 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 126.286 1.898 . . . . 0.0 115.529 172.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.2 m -112.91 134.07 56.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 126.229 1.812 . . . . 0.0 111.465 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 p -74.85 152.51 38.92 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.176 -0.953 . . . . 0.0 111.665 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.5 pt -73.49 127.47 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.114 0.965 . . . . 0.0 109.311 172.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -78.57 -37.05 43.56 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.838 -0.538 . . . . 0.0 111.269 171.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.0 p -152.74 162.39 41.33 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.588 1.555 . . . . 0.0 112.966 170.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -74.84 152.84 38.9 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.947 1.699 . . . . 0.0 111.22 169.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.54 152.63 6.32 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.215 1.388 . . . . 0.0 111.942 -175.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.5 t -58.33 147.39 31.17 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.783 -0.833 . . . . 0.0 110.871 167.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 CA--C 1.54 0.585 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -178.055 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 18.7 m . . . . . 0 CA--C 1.549 0.917 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.38 166.22 26.38 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.632 2.888 . . . . 0.0 112.197 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -115.04 25.52 10.84 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.311 1.844 . . . . 0.0 113.408 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.3 pt -58.01 173.71 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 127.195 2.198 . . . . 0.0 112.726 169.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 tt -123.57 75.12 1.31 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.029 1.332 . . . . 0.0 109.237 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -141.99 71.76 23.49 Favored Pre-proline 0 N--CA 1.471 0.622 0 C-N-CA 124.305 1.042 . . . . 0.0 110.371 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.66 159.54 53.22 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.262 1.975 . . . . 0.0 112.079 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.4 m -145.82 147.33 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.149 1.38 . . . . 0.0 111.724 -169.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.2 t -90.55 116.81 28.74 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.665 1.186 . . . . 0.0 110.762 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.99 165.18 53.38 Favored Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.56 -0.712 . . . . 0.0 113.197 174.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.9 p -65.55 -17.25 64.43 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -68.84 -16.87 63.9 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.759 1.624 . . . . 0.0 113.589 168.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.07 -4.91 78.42 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.993 1.758 . . . . 0.0 114.961 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.7 ttt85 -83.77 161.82 20.85 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.356 1.462 . . . . 0.0 111.458 170.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 62.5 m -111.35 135.48 51.83 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.296 1.838 . . . . 0.0 110.952 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -119.87 165.52 14.5 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.739 1.616 . . . . 0.0 110.958 174.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.84 -30.45 70.63 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -167.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.44 173.88 15.53 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.282 1.833 . . . . 0.0 110.353 172.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.1 p -59.8 -41.72 91.83 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -56.36 -45.67 80.37 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.709 1.604 . . . . 0.0 113.301 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.7 tp -69.21 -41.82 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.931 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.66 -56.21 19.26 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.283 1.033 . . . . 0.0 111.32 174.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -59.32 -37.95 79.06 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 63.9 m -71.33 -23.85 62.0 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 175.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -74.1 -20.46 60.25 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.029 1.332 . . . . 0.0 112.934 172.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.68 7.66 17.48 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.851 1.691 . . . . 0.0 115.807 174.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 t -133.36 151.52 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.043 1.421 . . . . 0.0 110.545 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.8 t -92.99 158.46 15.78 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.169 0.985 . . . . 0.0 112.184 174.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.62 122.5 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 128.667 2.787 . . . . 0.0 108.51 171.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -79.22 -49.8 11.95 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.745 -0.597 . . . . 0.0 110.584 161.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.8 p -143.61 161.24 39.01 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.161 1.385 . . . . 0.0 113.227 -176.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.31 154.0 20.44 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.485 1.514 . . . . 0.0 112.597 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.17 160.9 19.98 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.03 1.3 . . . . 0.0 111.818 -169.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 m -61.37 126.95 29.2 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.783 -0.833 . . . . 0.0 109.564 164.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -173.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.8 m . . . . . 0 CA--C 1.547 0.847 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.63 168.51 24.24 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.261 2.641 . . . . 0.0 111.916 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -122.81 16.2 10.16 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.822 2.049 . . . . 0.0 114.497 -170.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.95 168.28 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 126.584 1.954 . . . . 0.0 112.925 170.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 tt -105.47 69.28 0.83 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.943 1.297 . . . . 0.0 110.583 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -137.31 72.13 52.52 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 124.822 1.249 . . . . 0.0 110.572 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.79 166.87 18.93 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.728 2.286 . . . . 0.0 111.937 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 m -142.99 150.98 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.81 1.644 . . . . 0.0 110.55 -176.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.5 t -87.98 114.49 24.64 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 169.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.56 159.68 53.75 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 119.409 1.004 . . . . 0.0 112.364 171.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t -65.2 -20.13 66.29 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 121.271 -1.135 . . . . 0.0 114.024 -177.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.67 -17.15 64.39 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.057 1.743 . . . . 0.0 113.859 168.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.68 -6.63 62.84 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 126.44 1.971 . . . . 0.0 114.826 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -77.9 164.67 24.93 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 118.712 1.256 . . . . 0.0 111.859 173.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 60.5 m -117.93 133.7 55.67 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.422 1.489 . . . . 0.0 110.027 169.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -121.81 170.19 10.01 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.857 1.663 . . . . 0.0 110.565 172.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.04 -30.64 71.21 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -165.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -163.36 172.77 14.13 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.833 1.253 . . . . 0.0 111.609 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.5 m -59.8 -39.18 84.12 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -173.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.6 t -58.92 -44.55 91.32 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.529 1.931 . . . . 0.0 113.479 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.89 -40.34 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.317 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.67 -53.22 60.85 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.634 0.774 . . . . 0.0 111.292 174.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -61.58 -29.02 69.76 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 176.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 10.8 t -60.12 -35.13 74.58 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.102 0.961 . . . . 0.0 112.705 176.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -75.37 -3.67 34.95 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.872 1.669 . . . . 0.0 114.068 172.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.71 -10.55 73.27 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 126.528 2.013 . . . . 0.0 115.173 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.5 m -85.08 138.02 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.81 1.644 . . . . 0.0 111.637 176.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -76.96 154.67 33.35 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.396 1.079 . . . . 0.0 112.238 169.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 pp -74.05 123.15 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.384 1.474 . . . . 0.0 109.744 174.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -75.4 -42.59 53.41 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.806 1.242 . . . . 0.0 111.57 173.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.4 t -158.09 169.4 24.63 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.093 1.357 . . . . 0.0 112.209 173.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -79.93 152.2 29.69 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.756 2.022 . . . . 0.0 113.012 174.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.46 163.96 13.46 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.476 1.512 . . . . 0.0 112.309 -173.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 m -59.47 128.66 38.17 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.602 0.761 . . . . 0.0 109.563 164.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.544 0.739 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -176.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 120.497 0.189 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.0 mtpp -143.1 159.66 41.85 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.301 1.841 . . . . 0.0 110.754 173.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.4 m -74.9 -28.36 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.854 1.262 . . . . 0.0 113.206 173.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 86.3 m -82.59 152.49 25.92 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.874 1.27 . . . . 0.0 111.715 173.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -146.76 131.71 18.16 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.278 1.431 . . . . 0.0 110.525 173.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 45.3 m -64.56 154.76 83.62 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.426 1.091 . . . . 0.0 112.052 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.87 154.98 43.55 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.371 2.714 . . . . 0.0 111.482 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -104.58 5.42 33.78 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.911 2.084 . . . . 0.0 114.135 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 9.1 mt -70.16 143.07 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.897 1.679 . . . . 0.0 110.102 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.6 tt -80.75 74.99 7.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.558 1.943 . . . . 0.0 110.293 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -133.58 68.23 76.1 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 125.391 1.476 . . . . 0.0 111.509 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -67.6 165.95 25.66 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.024 2.483 . . . . 0.0 112.54 -176.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.6 m -142.94 152.23 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.973 1.709 . . . . 0.0 110.694 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.5 t -90.59 118.15 29.82 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 167.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.57 165.02 54.3 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-N 119.177 0.898 . . . . 0.0 112.799 172.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.7 p -67.42 -16.0 63.99 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.34 -9.28 58.53 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.227 1.411 . . . . 0.0 114.053 167.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.59 -1.58 88.21 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.609 1.576 . . . . 0.0 114.931 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.5 mmt-85 -72.28 159.44 34.06 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.011 1.324 . . . . 0.0 111.277 168.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 59.4 m -114.56 131.24 56.73 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.176 1.39 . . . . 0.0 109.564 169.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.406 ' HB3' HG23 ' A' ' 26' ' ' ILE . 16.3 m-85 -118.11 166.62 12.34 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.688 1.595 . . . . 0.0 109.916 175.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.73 -24.21 62.58 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -167.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -165.09 176.33 8.62 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.727 2.011 . . . . 0.0 111.12 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.1 m -65.26 -34.58 78.69 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.7 t -62.32 -45.65 92.25 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.953 1.701 . . . . 0.0 113.244 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.406 HG23 ' HB3' ' A' ' 21' ' ' TYR . 10.8 tp -69.96 -39.36 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.194 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.04 -54.87 37.51 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.102 0.961 . . . . 0.0 111.685 170.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -63.18 -32.22 73.56 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.9 m -62.82 -20.23 64.84 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -80.93 -2.81 49.21 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.526 1.13 . . . . 0.0 113.673 169.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.75 16.32 58.43 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.418 1.485 . . . . 0.0 114.774 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 t -129.8 148.99 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.332 1.453 . . . . 0.0 111.277 -172.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.1 p -85.25 158.31 20.36 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.929 1.692 . . . . 0.0 112.721 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.66 124.77 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 125.578 1.551 . . . . 0.0 109.606 172.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -76.15 -39.86 54.02 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.879 1.272 . . . . 0.0 111.317 172.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.3 p -158.98 162.91 36.84 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.54 1.536 . . . . 0.0 112.785 172.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -74.89 152.41 38.88 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.025 1.33 . . . . 0.0 112.539 170.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.24 162.42 20.09 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.597 1.57 . . . . 0.0 112.538 -172.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.4 t -59.93 148.04 36.51 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.987 -0.713 . . . . 0.0 110.87 164.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.6 p -100.6 153.35 37.79 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.59 122.56 8.7 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 124.03 3.153 . . . . 0.0 112.475 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.3 m -72.36 -12.29 61.06 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.937 1.295 . . . . 0.0 113.615 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -83.15 2.06 87.64 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 126.347 1.927 . . . . 0.0 115.742 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 52.9 mt . . . . . 0 C--O 1.253 1.247 0 C-N-CA 126.634 1.974 . . . . 0.0 110.278 -178.386 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 120.712 0.291 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -141.27 28.87 1.83 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 126.116 1.766 . . . . 0.0 113.297 -169.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.9 t -56.01 120.18 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 125.225 1.41 . . . . 0.0 111.96 -175.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 77.1 m -87.75 -35.72 17.73 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.101 1.36 . . . . 0.0 112.84 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.36 112.6 5.53 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.035 1.734 . . . . 0.0 110.731 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 13.7 m -63.47 159.26 52.33 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 125.027 1.331 . . . . 0.0 112.984 174.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -76.62 171.74 17.49 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.952 3.101 . . . . 0.0 112.211 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.1 tttm -119.37 9.41 11.62 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.97 1.708 . . . . 0.0 114.581 -174.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.5 mt -63.11 143.66 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.182 1.393 . . . . 0.0 110.069 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 71.6 mt -75.01 70.61 2.03 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.054 1.741 . . . . 0.0 111.108 173.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -132.92 63.38 66.94 Favored Pre-proline 0 N--CA 1.471 0.622 0 C-N-CA 125.374 1.469 . . . . 0.0 109.934 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.26 160.25 48.46 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.987 2.458 . . . . 0.0 111.455 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.7 m -144.71 162.39 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.833 1.253 . . . . 0.0 111.639 -172.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.4 t -98.45 113.81 25.95 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.171 1.388 . . . . 0.0 110.201 173.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.37 166.37 54.71 Favored Glycine 0 CA--C 1.535 1.34 0 O-C-N 121.604 -0.685 . . . . 0.0 113.425 172.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.1 t -60.13 -25.1 65.21 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.071 1.349 . . . . 0.0 113.717 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -68.08 -14.12 62.73 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.918 1.287 . . . . 0.0 113.827 172.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.84 -4.04 84.87 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 126.088 1.804 . . . . 0.0 114.634 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -78.13 159.87 28.38 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.782 1.233 . . . . 0.0 111.685 173.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 59.6 m -109.91 131.56 54.95 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.519 1.528 . . . . 0.0 109.793 170.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -119.72 167.95 11.55 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.66 1.184 . . . . 0.0 110.756 171.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.63 -25.24 59.86 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -175.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -167.34 177.24 6.18 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.569 1.548 . . . . 0.0 111.329 174.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.0 p -60.49 -47.1 87.61 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 176.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.5 t -55.69 -42.06 74.64 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.503 1.921 . . . . 0.0 113.424 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.43 -52.71 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 125.38 1.472 . . . . 0.0 111.032 175.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.58 -46.93 83.4 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.36 0.664 . . . . 0.0 111.96 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -65.77 -28.86 69.34 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.3 t -59.46 -33.98 71.97 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.248 1.019 . . . . 0.0 112.69 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -72.44 -3.63 25.4 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.145 1.778 . . . . 0.0 113.998 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.92 -12.29 65.77 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 126.807 2.146 . . . . 0.0 115.334 172.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.5 m -88.22 135.71 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.836 1.654 . . . . 0.0 111.855 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.3 p -68.62 164.66 20.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.928 1.291 . . . . 0.0 112.726 173.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.3 mm -90.79 110.8 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 123.996 0.918 . . . . 0.0 110.263 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -45.97 90.78 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.256 1.022 . . . . 0.0 110.97 172.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.7 t -164.18 166.06 21.49 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.727 0.775 . . . . 0.0 112.777 173.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -86.78 154.99 20.5 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.628 1.971 . . . . 0.0 112.719 176.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.06 157.56 11.6 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.958 1.266 . . . . 0.0 111.806 -168.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.3 m -59.45 126.95 29.68 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.784 -0.833 . . . . 0.0 109.958 168.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -72.99 156.96 89.27 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -176.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -66.19 140.62 59.82 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.451 2.768 . . . . 0.0 111.742 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.5 t -160.99 113.96 1.96 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.544 1.538 . . . . 0.0 110.594 -177.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 157.08 -27.5 0.51 Allowed Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.37 1.462 . . . . 0.0 115.227 171.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.7 tp . . . . . 0 C--O 1.253 1.264 0 C-N-CA 126.636 1.974 . . . . 0.0 111.999 176.005 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -131.49 72.61 1.5 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.814 1.646 . . . . 0.0 113.242 -173.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.2 t -89.52 -31.27 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.759 1.224 . . . . 0.0 112.385 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.8 p -115.45 -55.98 2.39 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.775 1.63 . . . . 0.0 112.362 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.91 84.75 3.46 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.73 1.212 . . . . 0.0 111.708 174.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.1 m -61.84 157.52 49.19 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.389 1.476 . . . . 0.0 112.198 171.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.98 158.2 38.43 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.35 2.7 . . . . 0.0 112.106 -174.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -100.14 4.37 44.45 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.573 1.949 . . . . 0.0 114.435 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.7 mt -68.29 143.2 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.744 1.618 . . . . 0.0 109.905 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.89 79.58 9.58 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.129 1.772 . . . . 0.0 110.199 173.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -131.64 63.07 67.98 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 125.605 1.562 . . . . 0.0 111.721 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.33 166.12 24.57 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.309 2.672 . . . . 0.0 112.714 -173.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.6 m -142.55 152.54 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.835 1.654 . . . . 0.0 110.904 -175.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.8 t -89.42 113.55 24.9 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 166.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.87 162.56 52.96 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-N 118.906 0.776 . . . . 0.0 112.939 175.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 t -67.05 -14.08 62.55 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -72.53 -14.2 61.59 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.942 1.297 . . . . 0.0 113.479 168.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.55 -6.86 77.77 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 126.245 1.878 . . . . 0.0 114.706 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.2 mmt85 -74.29 161.99 29.35 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.776 1.631 . . . . 0.0 112.006 170.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.5 m -115.05 137.47 51.97 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.456 1.502 . . . . 0.0 109.763 167.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -127.18 166.84 16.95 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.894 1.678 . . . . 0.0 110.622 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.09 -23.75 64.05 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -165.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -164.42 -176.53 4.42 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.703 2.001 . . . . 0.0 111.353 172.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 54.8 m -67.17 -34.62 77.93 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 176.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.2 t -65.91 -38.1 87.83 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.796 1.638 . . . . 0.0 113.48 -175.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.0 tp -70.9 -50.22 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.843 170.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.53 -51.06 64.07 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.139 1.376 . . . . 0.0 112.882 -177.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.42 -34.82 72.96 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.044 1.337 . . . . 0.0 113.543 175.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.8 t -63.87 -30.92 71.96 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.504 1.122 . . . . 0.0 113.075 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -67.8 -8.15 33.52 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.059 1.344 . . . . 0.0 114.045 173.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.34 11.91 60.48 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.994 1.283 . . . . 0.0 115.086 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -128.74 151.26 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.538 1.535 . . . . 0.0 110.321 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 p -82.29 160.36 22.93 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.319 1.848 . . . . 0.0 112.847 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -73.09 126.04 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 125.75 1.62 . . . . 0.0 109.495 171.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -81.41 -38.21 26.88 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.557 1.143 . . . . 0.0 111.617 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.6 p -157.57 162.7 38.78 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.337 1.455 . . . . 0.0 112.788 169.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -75.1 150.25 38.87 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.238 1.415 . . . . 0.0 112.445 171.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.77 161.29 19.56 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.554 1.549 . . . . 0.0 112.403 -171.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.0 t -58.97 148.55 30.2 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 122.012 -0.699 . . . . 0.0 111.024 165.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.7 p -101.36 152.96 38.08 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.0 131.63 18.47 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.901 3.067 . . . . 0.0 111.936 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.21 -3.58 37.17 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.322 1.449 . . . . 0.0 114.278 -176.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.89 -14.53 82.08 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 125.209 1.385 . . . . 0.0 116.468 -169.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mp . . . . . 0 C--O 1.253 1.257 0 C-N-CA 125.982 1.713 . . . . 0.0 109.934 177.546 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -143.03 116.52 9.12 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 126.156 1.782 . . . . 0.0 110.611 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.8 m -65.13 133.69 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.379 1.072 . . . . 0.0 112.115 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.1 t -78.64 -27.68 45.39 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.196 0.998 . . . . 0.0 112.842 175.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.99 96.71 5.28 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.178 1.791 . . . . 0.0 111.034 -176.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 43.0 m -60.7 156.17 46.56 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 125.568 1.547 . . . . 0.0 113.049 173.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.1 146.8 41.81 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.272 2.648 . . . . 0.0 110.981 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -80.26 6.57 11.55 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.944 1.698 . . . . 0.0 115.006 176.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.7 tt -57.91 139.63 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 126.291 1.837 . . . . 0.0 113.186 -173.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.8 mt -84.9 72.01 10.83 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.11 1.364 . . . . 0.0 110.683 175.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -139.16 71.48 40.29 Favored Pre-proline 0 N--CA 1.47 0.54 0 C-N-CA 125.243 1.417 . . . . 0.0 109.944 173.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -66.64 166.64 21.42 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.367 2.045 . . . . 0.0 112.179 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.8 m -144.71 154.43 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.112 1.765 . . . . 0.0 111.027 -172.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 t -94.23 115.18 27.4 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.522 0.729 . . . . 0.0 109.186 167.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.9 160.66 53.58 Favored Glycine 0 CA--C 1.536 1.369 0 O-C-N 121.336 -0.853 . . . . 0.0 113.085 173.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.1 t -64.56 -20.62 66.34 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -70.79 -6.18 35.76 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.084 1.353 . . . . 0.0 114.364 170.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.48 19.97 55.52 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.71 1.148 . . . . 0.0 114.833 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -118.25 162.89 17.51 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.448 1.899 . . . . 0.0 111.332 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.1 m -116.53 129.62 56.29 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.237 1.415 . . . . 0.0 110.748 -175.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -123.9 165.86 16.65 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.721 1.608 . . . . 0.0 110.767 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.8 -29.96 70.53 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -167.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -166.41 171.06 12.34 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.908 1.683 . . . . 0.0 111.358 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.3 m -59.16 -42.78 91.55 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -171.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.2 t -56.08 -43.56 78.12 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.236 1.814 . . . . 0.0 113.264 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.5 tp -72.8 -38.77 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.899 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.33 -52.61 64.54 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.926 0.89 . . . . 0.0 111.766 174.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -60.05 -28.45 67.79 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.8 t -58.04 -31.51 67.08 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.118 1.367 . . . . 0.0 113.413 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -73.75 -3.97 31.7 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.238 1.415 . . . . 0.0 114.31 173.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.11 11.46 63.07 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.214 1.388 . . . . 0.0 114.908 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.35 146.83 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 126.076 1.75 . . . . 0.0 110.57 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 p -79.87 162.45 25.01 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.868 1.667 . . . . 0.0 113.111 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.3 pp -72.11 123.04 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.371 1.468 . . . . 0.0 109.611 170.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -68.66 -41.47 79.26 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.915 1.286 . . . . 0.0 111.173 170.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.9 p -156.98 158.17 36.1 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.17 1.788 . . . . 0.0 112.362 174.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -72.69 149.78 43.51 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.099 1.36 . . . . 0.0 110.653 171.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.32 158.46 20.77 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.922 1.249 . . . . 0.0 112.057 -174.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.3 t -59.87 145.02 47.2 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.739 -0.86 . . . . 0.0 110.912 167.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.2 p -93.6 155.41 40.66 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -70.11 143.73 50.05 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.527 2.818 . . . . 0.0 111.92 177.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.04 5.87 9.05 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.957 1.703 . . . . 0.0 113.956 -177.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.99 20.77 17.49 Favored Glycine 0 CA--C 1.54 1.616 0 C-N-CA 125.387 1.47 . . . . 0.0 114.224 -173.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.9 pt . . . . . 0 C--O 1.252 1.23 0 C-N-CA 127.19 2.196 . . . . 0.0 114.279 178.929 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.39 153.68 42.2 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.425 1.49 . . . . 0.0 112.273 173.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.4 t -85.12 129.11 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.283 1.433 . . . . 0.0 110.396 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 84.1 m -73.67 -32.55 64.03 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.222 1.009 . . . . 0.0 113.603 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.56 94.0 2.68 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.174 1.789 . . . . 0.0 110.77 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 16.6 m -60.14 155.86 42.38 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 125.045 1.338 . . . . 0.0 112.847 176.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -73.85 171.78 17.19 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.819 3.013 . . . . 0.0 111.449 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.75 17.8 10.27 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.877 1.671 . . . . 0.0 113.978 -173.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.9 mt -63.84 141.56 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.505 1.522 . . . . 0.0 109.814 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.4 mt -79.59 70.47 6.07 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.732 1.213 . . . . 0.0 110.584 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -134.9 72.16 68.65 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 124.941 1.296 . . . . 0.0 109.866 172.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.17 164.03 33.79 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.109 1.873 . . . . 0.0 111.745 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.7 m -144.48 140.69 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.884 1.673 . . . . 0.0 110.58 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 t -79.14 114.78 18.35 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.85 163.09 45.44 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 121.546 -0.721 . . . . 0.0 113.159 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.1 m -68.11 -11.91 59.92 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -77.23 -10.52 59.47 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.929 1.692 . . . . 0.0 114.192 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.05 13.98 35.07 Favored Glycine 0 CA--C 1.539 1.541 0 N-CA-C 115.894 1.118 . . . . 0.0 115.894 175.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -137.05 168.24 19.97 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.317 1.847 . . . . 0.0 110.944 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.0 t -105.47 150.31 25.42 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.61 1.164 . . . . 0.0 111.699 175.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -124.19 170.28 10.89 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.233 1.813 . . . . 0.0 110.39 173.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.04 -35.17 77.8 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -167.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -163.16 168.04 21.32 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.474 1.51 . . . . 0.0 112.077 175.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.2 m -60.13 -32.11 70.7 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -167.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.7 t -61.22 -43.94 98.07 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.905 1.682 . . . . 0.0 113.514 176.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.9 tp -72.44 -39.59 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.747 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.48 -28.64 69.97 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.451 1.1 . . . . 0.0 113.418 176.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -88.04 -30.13 20.16 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.141 1.376 . . . . 0.0 114.377 173.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 37.5 t -55.09 -39.82 69.73 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.99 1.316 . . . . 0.0 113.13 -174.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -70.26 -11.34 60.83 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 126.076 1.75 . . . . 0.0 115.164 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.91 -8.29 42.45 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 126.488 1.994 . . . . 0.0 116.247 175.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.5 t -93.58 168.99 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 125.507 1.523 . . . . 0.0 110.654 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.6 p -112.24 155.9 23.27 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 127.477 2.311 . . . . 0.0 112.37 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -67.64 123.17 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.623 1.569 . . . . 0.0 110.075 176.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -77.34 -42.23 37.4 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.507 1.123 . . . . 0.0 110.832 172.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.0 p -153.75 157.93 40.2 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.461 1.504 . . . . 0.0 112.508 174.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -82.74 149.25 27.38 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.721 1.208 . . . . 0.0 111.269 177.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.81 162.04 24.34 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.54 1.066 . . . . 0.0 111.676 -169.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.1 t -60.33 148.27 37.59 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 122.125 -0.633 . . . . 0.0 110.942 167.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.2 p -98.48 157.47 34.28 Favored Pre-proline 0 CA--C 1.541 0.63 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -72.62 162.44 41.3 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.828 3.019 . . . . 0.0 112.038 173.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.9 p -133.36 80.13 1.86 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.604 1.562 . . . . 0.0 111.38 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.69 -18.38 6.1 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 125.14 1.352 . . . . 0.0 115.442 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.213 0 C-N-CA 126.69 1.996 . . . . 0.0 110.608 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 21.2 tptp . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 120.518 0.199 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -130.03 -18.59 3.33 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -172.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.9 m -71.94 -20.7 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.942 1.297 . . . . 0.0 113.895 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.4 p -67.85 137.76 55.56 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.441 1.096 . . . . 0.0 111.951 174.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.18 87.61 2.67 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.197 1.399 . . . . 0.0 110.333 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 18.6 m -60.15 154.95 48.29 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.856 1.263 . . . . 0.0 111.916 173.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.48 147.26 31.97 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.354 2.702 . . . . 0.0 111.664 -176.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.61 3.63 55.2 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.263 1.825 . . . . 0.0 114.645 177.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.2 mt -65.06 140.6 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.207 1.403 . . . . 0.0 109.995 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tt -80.75 74.2 7.7 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.981 1.712 . . . . 0.0 109.357 175.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.23 69.73 77.87 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 124.424 1.09 . . . . 0.0 110.474 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.29 167.28 18.85 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.835 2.356 . . . . 0.0 112.5 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.6 m -144.84 153.18 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 126.006 1.722 . . . . 0.0 110.358 -173.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.5 t -98.53 113.62 25.72 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.181 0.992 . . . . 0.0 108.766 171.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.63 159.16 53.53 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 118.773 0.715 . . . . 0.0 113.296 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.3 t -59.83 -24.09 63.89 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -67.57 -13.7 62.29 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 125.227 1.411 . . . . 0.0 114.017 171.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.97 -3.29 64.62 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 126.439 1.971 . . . . 0.0 114.697 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -84.11 164.64 19.08 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.941 1.696 . . . . 0.0 111.937 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.6 m -114.76 138.68 50.44 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.997 1.319 . . . . 0.0 110.508 171.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -124.92 166.87 15.53 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.981 1.712 . . . . 0.0 110.624 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.48 -24.23 61.96 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -167.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -164.18 179.28 6.99 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.158 2.183 . . . . 0.0 110.629 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.5 p -65.24 -42.47 93.32 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.8 t -57.17 -41.52 79.38 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.522 1.929 . . . . 0.0 113.972 -176.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.6 tt -70.59 -48.38 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.948 1.299 . . . . 0.0 111.966 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.54 -52.94 42.86 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.183 0.993 . . . . 0.0 112.051 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -62.75 -27.64 69.42 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 178.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.9 t -61.93 -31.69 72.03 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.562 1.145 . . . . 0.0 112.786 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -73.84 -4.16 33.15 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.625 1.57 . . . . 0.0 114.178 171.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.82 -7.02 83.09 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 126.207 1.861 . . . . 0.0 115.072 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.7 m -93.31 146.0 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 126.341 1.857 . . . . 0.0 111.581 176.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.2 p -84.99 160.95 19.95 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.074 1.35 . . . . 0.0 112.0 171.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.4 pt -73.24 128.02 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.48 1.112 . . . . 0.0 110.031 172.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -77.54 -39.48 45.84 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.058 0.943 . . . . 0.0 111.494 169.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.4 t -154.76 170.59 21.25 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.474 1.109 . . . . 0.0 113.071 173.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -85.06 151.57 24.06 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.433 2.293 . . . . 0.0 112.684 174.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.29 162.5 10.65 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.475 1.512 . . . . 0.0 112.286 -170.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.7 m -59.39 130.0 44.75 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.85 -0.794 . . . . 0.0 109.588 163.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.75 153.15 89.32 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -175.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -65.56 122.43 10.08 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.597 2.865 . . . . 0.0 110.755 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.9 m 55.1 28.58 11.12 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.531 1.533 . . . . 0.0 112.85 -172.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.89 -11.56 69.85 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 125.497 1.522 . . . . 0.0 115.733 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.2 mm . . . . . 0 C--O 1.254 1.315 0 C-N-CA 126.404 1.882 . . . . 0.0 110.44 173.397 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.34 -5.37 12.93 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 125.44 1.496 . . . . 0.0 114.446 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 t -78.09 138.89 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.211 1.404 . . . . 0.0 110.658 176.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 80.4 m -108.19 -37.51 6.01 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.758 1.223 . . . . 0.0 113.6 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.3 130.18 41.32 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.402 1.081 . . . . 0.0 111.849 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.0 m -63.06 152.92 82.87 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.772 0.829 . . . . 0.0 112.547 173.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.56 167.87 26.13 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.691 2.927 . . . . 0.0 112.027 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.69 8.24 13.73 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.345 2.258 . . . . 0.0 114.008 -173.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.9 mt -68.8 140.74 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.3 1.44 . . . . 0.0 109.785 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tt -82.01 72.93 9.07 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.166 1.787 . . . . 0.0 110.584 -176.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -134.73 68.67 71.82 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 125.554 1.541 . . . . 0.0 111.406 -175.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.27 162.2 43.26 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.0 2.466 . . . . 0.0 112.914 -175.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.8 m -144.85 163.73 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 127.045 2.138 . . . . 0.0 111.244 -172.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.2 t -94.41 122.46 37.0 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.523 0.729 . . . . 0.0 110.39 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.46 161.39 53.56 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.079 0.847 . . . . 0.0 113.61 172.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.0 t -61.73 -27.48 68.75 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.239 1.016 . . . . 0.0 113.567 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -82.86 -5.92 59.21 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.311 1.844 . . . . 0.0 114.488 174.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.17 2.04 66.47 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.556 1.55 . . . . 0.0 115.956 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -73.38 166.03 23.95 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 119.814 1.807 . . . . 0.0 111.622 170.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.5 m -121.54 123.7 42.62 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.814 1.646 . . . . 0.0 109.203 172.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.403 ' HB3' ' CG2' ' A' ' 26' ' ' ILE . 35.4 m-85 -113.21 170.58 8.11 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.763 1.625 . . . . 0.0 110.812 174.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.29 -31.85 71.58 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -168.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.09 170.32 19.39 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.634 1.574 . . . . 0.0 110.96 176.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.3 m -59.74 -40.8 89.33 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -172.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.9 t -55.89 -45.71 78.54 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.079 1.752 . . . . 0.0 113.203 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.403 ' CG2' ' HB3' ' A' ' 21' ' ' TYR . 2.2 tp -72.27 -36.25 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.183 -177.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.04 -55.24 37.44 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.395 0.678 . . . . 0.0 111.299 169.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -63.91 -26.75 68.74 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.3 t -57.6 -34.62 69.45 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.585 1.154 . . . . 0.0 112.909 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -74.23 -4.35 35.48 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.699 1.6 . . . . 0.0 114.435 173.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.87 -11.28 72.55 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 126.39 1.947 . . . . 0.0 115.263 175.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 m -83.07 151.43 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.811 1.644 . . . . 0.0 111.495 173.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.7 t -80.55 176.02 10.15 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.937 0.875 . . . . 0.0 111.634 167.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 pp -101.2 119.95 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 128.307 2.643 . . . . 0.0 109.661 174.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -59.94 -44.8 94.14 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.542 0.737 . . . . 0.0 111.552 176.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.1 t -161.49 171.01 18.86 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.42 1.488 . . . . 0.0 112.129 170.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -72.83 152.85 41.33 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.258 1.823 . . . . 0.0 112.641 171.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.51 146.15 4.42 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.858 1.218 . . . . 0.0 112.248 -175.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 p -59.37 133.75 56.38 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.528 -0.983 . . . . 0.0 111.569 171.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -88.41 156.36 50.99 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -172.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.49 153.17 78.99 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.272 2.648 . . . . 0.0 110.758 170.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.1 m 63.54 1.18 0.97 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.853 1.661 . . . . 0.0 114.593 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.21 -12.9 34.93 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.49 1.519 . . . . 0.0 115.054 -177.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.7 pt . . . . . 0 C--O 1.253 1.241 0 C-N-CA 126.237 1.815 . . . . 0.0 113.309 175.429 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.3 mmtp -140.81 146.64 37.86 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.328 1.851 . . . . 0.0 111.418 177.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.9 t -93.25 -31.2 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.975 1.31 . . . . 0.0 111.814 174.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.4 t -145.9 159.79 42.73 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.004 1.722 . . . . 0.0 111.845 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.96 -26.85 54.45 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.632 1.173 . . . . 0.0 113.946 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 33.2 m -65.8 159.33 69.95 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.484 1.514 . . . . 0.0 113.401 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.59 140.06 23.48 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.054 2.502 . . . . 0.0 111.242 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -75.16 -1.98 25.65 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.8 mt -66.36 140.79 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.637 1.575 . . . . 0.0 109.724 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.1 mt -89.1 80.11 7.06 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.159 1.784 . . . . 0.0 110.085 175.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -127.66 68.56 74.61 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 124.003 0.921 . . . . 0.0 110.593 176.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.6 163.34 27.69 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.95 2.434 . . . . 0.0 112.453 -173.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.1 m -145.24 157.01 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.889 1.676 . . . . 0.0 110.7 -171.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.6 t -101.18 110.34 22.35 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.987 0.915 . . . . 0.0 109.424 170.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.74 158.21 52.17 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-N 118.981 0.81 . . . . 0.0 112.905 173.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.5 p -70.09 -9.19 54.68 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -64.32 -14.59 57.03 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.37 1.468 . . . . 0.0 113.45 163.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.17 19.58 45.71 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.324 1.44 . . . . 0.0 114.085 -177.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.9 ttm-85 -119.24 160.27 22.5 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.528 1.931 . . . . 0.0 111.682 -174.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.9 m -116.61 131.52 56.93 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.386 1.475 . . . . 0.0 110.683 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -125.23 169.97 11.73 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.621 1.568 . . . . 0.0 110.925 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.87 -21.6 61.63 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -165.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -161.01 -174.54 4.44 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.987 2.115 . . . . 0.0 109.815 174.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.7 p -72.64 -38.34 67.74 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.1 t -58.2 -41.81 84.78 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.777 1.631 . . . . 0.0 113.953 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 tp -72.1 -43.75 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.836 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.61 -49.49 76.25 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.288 1.035 . . . . 0.0 112.106 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -60.97 -25.45 66.85 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.0 t -59.27 -31.26 68.94 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.92 1.288 . . . . 0.0 113.146 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -74.73 -2.83 28.15 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.362 1.465 . . . . 0.0 114.211 172.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.61 15.08 62.32 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.089 1.328 . . . . 0.0 114.951 177.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 t -128.46 149.04 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.559 1.544 . . . . 0.0 110.856 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 p -87.81 162.8 16.78 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 126.53 1.932 . . . . 0.0 112.43 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.4 pt -73.47 126.54 34.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.708 1.203 . . . . 0.0 110.113 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -75.35 -40.53 58.09 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.641 1.177 . . . . 0.0 111.032 169.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.7 p -150.33 161.4 42.54 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.585 1.554 . . . . 0.0 112.751 171.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.17 153.49 25.97 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.286 1.434 . . . . 0.0 111.034 170.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.41 160.17 12.2 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.172 1.368 . . . . 0.0 112.073 -169.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.2 m -59.51 130.61 47.74 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.729 -0.865 . . . . 0.0 109.981 165.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -71.73 153.78 93.19 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -176.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -71.43 140.14 36.01 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.568 2.846 . . . . 0.0 112.004 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -5.49 49.27 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.932 1.693 . . . . 0.0 114.993 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.03 -36.82 50.94 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.877 1.227 . . . . 0.0 115.563 -171.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.4 mp . . . . . 0 C--O 1.253 1.263 0 C-N-CA 126.436 1.895 . . . . 0.0 110.014 -178.692 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? . . . . . 0 N--CA 1.493 1.718 0 N-CA-C 110.48 -0.192 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -83.49 -34.25 25.39 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.5 m -61.77 142.74 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.756 1.222 . . . . 0.0 112.235 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.7 p -144.69 -39.72 0.26 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.879 1.271 . . . . 0.0 113.362 -177.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.03 87.19 0.74 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.094 1.357 . . . . 0.0 111.706 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.8 m -62.29 153.8 73.97 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 125.577 1.551 . . . . 0.0 112.693 176.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.21 166.93 27.93 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.403 2.735 . . . . 0.0 111.265 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -109.86 10.79 24.43 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.35 1.46 . . . . 0.0 114.36 -173.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.7 mt -58.66 139.16 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.27 1.428 . . . . 0.0 110.217 -176.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.1 mt -80.94 71.9 7.93 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.461 1.505 . . . . 0.0 110.055 172.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -135.62 71.21 65.41 Favored Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 124.718 1.207 . . . . 0.0 109.136 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -68.83 159.07 55.32 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.141 1.894 . . . . 0.0 111.599 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 m -144.85 146.93 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.1 1.36 . . . . 0.0 111.52 -169.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.9 t -89.65 115.24 26.89 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.752 1.221 . . . . 0.0 110.583 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.59 164.61 50.82 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 121.78 -0.575 . . . . 0.0 113.905 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.2 m -62.27 -20.08 63.9 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.56 -8.82 57.58 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.407 1.483 . . . . 0.0 113.571 171.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.36 -2.64 85.16 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.949 1.737 . . . . 0.0 114.929 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -86.18 165.07 16.84 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.019 1.328 . . . . 0.0 111.884 172.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 65.2 m -115.13 138.37 50.97 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.13 1.372 . . . . 0.0 110.455 175.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -121.63 164.32 17.51 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.42 1.888 . . . . 0.0 110.08 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.18 -26.94 67.64 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -168.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -167.12 172.51 9.96 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.382 1.873 . . . . 0.0 111.031 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 t -60.21 -43.57 95.86 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -176.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.4 t -57.8 -44.19 86.16 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.654 1.582 . . . . 0.0 113.41 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.4 tp -70.41 -38.41 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.05 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.08 -55.12 39.04 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.417 1.087 . . . . 0.0 111.279 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -60.1 -37.96 81.53 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.606 0.762 . . . . 0.0 112.865 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 23.6 t -65.16 -38.68 91.34 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.097 0.959 . . . . 0.0 112.817 174.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.12 -21.85 66.46 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.225 1.41 . . . . 0.0 113.866 173.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.34 8.8 18.82 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.088 1.328 . . . . 0.0 115.618 174.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.84 149.05 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 119.301 1.55 . . . . 0.0 110.937 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.57 151.1 29.28 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.225 1.41 . . . . 0.0 111.394 172.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.13 126.75 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 126.849 2.06 . . . . 0.0 107.985 165.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -85.47 -48.21 9.19 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.18 0.592 . . . . 0.0 111.337 162.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.5 m -138.53 156.58 47.37 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.022 1.329 . . . . 0.0 112.501 -176.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -82.62 155.05 24.63 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.855 1.262 . . . . 0.0 112.483 172.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.25 159.42 13.14 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.042 1.306 . . . . 0.0 112.012 -172.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 m -60.18 128.02 34.69 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 121.956 -0.732 . . . . 0.0 109.673 164.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.99 157.4 89.85 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -175.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.7 166.55 28.38 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.596 2.864 . . . . 0.0 112.116 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.67 1.88 32.47 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.746 1.218 . . . . 0.0 113.069 -173.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.53 56.39 0.56 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.606 1.574 . . . . 0.0 113.682 -173.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.526 ' H ' HD12 ' A' ' 44' ' ' ILE . 5.4 mp . . . . . 0 C--O 1.254 1.312 0 C-N-CA 125.798 1.639 . . . . 0.0 110.696 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 61.1 mttp . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 120.196 0.046 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -104.09 57.86 0.72 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.397 1.879 . . . . 0.0 111.427 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.0 t -67.21 127.48 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.899 0.88 . . . . 0.0 111.091 -176.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 78.7 m -102.37 -22.49 14.09 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.931 1.292 . . . . 0.0 113.719 177.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.3 94.91 2.46 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.618 1.567 . . . . 0.0 111.186 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.6 m -62.6 155.82 67.02 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.722 1.209 . . . . 0.0 112.209 171.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -73.38 142.24 33.08 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.217 2.611 . . . . 0.0 110.986 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -78.45 6.4 8.58 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.998 1.719 . . . . 0.0 114.877 176.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.3 tt -58.47 143.4 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 126.117 1.767 . . . . 0.0 112.723 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 tt -92.85 70.11 4.69 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.047 1.339 . . . . 0.0 109.643 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -135.4 72.6 64.81 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 125.603 1.561 . . . . 0.0 110.358 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.65 166.21 26.77 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.565 2.177 . . . . 0.0 112.24 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.8 m -141.26 156.27 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.356 1.863 . . . . 0.0 110.515 -176.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.2 t -90.13 113.87 25.71 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 164.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.32 160.05 47.37 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 121.454 -0.779 . . . . 0.0 113.263 176.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.7 t -62.11 -22.65 65.99 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.563 1.145 . . . . 0.0 113.603 -178.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -68.87 -13.15 62.24 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.434 1.494 . . . . 0.0 114.239 172.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.0 9.84 65.29 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.079 1.324 . . . . 0.0 114.53 -175.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -103.45 163.26 12.4 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.316 1.846 . . . . 0.0 111.409 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.5 m -115.29 129.02 56.5 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.19 1.796 . . . . 0.0 109.747 175.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -120.31 169.57 10.15 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.95 1.7 . . . . 0.0 110.72 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.77 -28.44 65.77 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -171.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.5 172.19 17.66 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.537 1.535 . . . . 0.0 111.093 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.9 p -63.04 -40.27 97.23 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.5 t -56.89 -46.88 81.6 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.23 1.812 . . . . 0.0 113.439 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.2 tp -70.68 -36.82 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.841 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.79 -55.42 35.15 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.694 0.798 . . . . 0.0 111.605 170.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -60.69 -28.6 68.75 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.158 1.169 . . . . 0.0 114.158 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.6 m -63.25 -20.36 65.38 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 174.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -84.91 -6.42 59.34 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.756 1.222 . . . . 0.0 113.787 167.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.43 -10.84 63.26 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 126.705 2.098 . . . . 0.0 115.157 177.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.0 m -99.02 142.56 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 126.39 1.876 . . . . 0.0 111.771 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.6 t -91.31 169.18 11.03 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.307 1.051 . . . . 0.0 112.584 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -72.16 132.04 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 127.58 2.352 . . . . 0.0 110.246 176.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -91.35 -36.6 13.74 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.049 1.34 . . . . 0.0 112.209 173.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.5 p -157.09 160.56 39.0 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.219 1.407 . . . . 0.0 112.75 171.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -73.35 146.91 44.87 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.065 1.346 . . . . 0.0 112.454 172.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.98 153.01 6.05 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.165 1.364 . . . . 0.0 111.871 -172.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.1 p -59.32 142.88 50.97 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.731 -0.864 . . . . 0.0 112.036 169.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.2 p -92.05 155.07 43.33 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.83 144.61 43.92 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.795 2.997 . . . . 0.0 111.757 175.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.2 t -80.75 -15.27 56.91 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.74 -16.53 1.8 Allowed Glycine 0 CA--C 1.538 1.481 0 C-N-CA 126.663 2.078 . . . . 0.0 115.021 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.2 mt . . . . . 0 C--O 1.252 1.221 0 C-N-CA 127.15 2.18 . . . . 0.0 109.615 176.032 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 48.8 tptt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -142.4 131.36 23.04 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.632 1.573 . . . . 0.0 110.611 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.0 m -67.26 143.73 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.787 1.235 . . . . 0.0 112.539 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.6 m -138.93 -62.48 0.55 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.462 1.505 . . . . 0.0 111.039 177.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.25 112.92 5.44 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.882 1.273 . . . . 0.0 111.785 174.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.5 m -62.39 156.28 62.43 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.79 1.236 . . . . 0.0 112.31 170.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -72.91 144.34 38.34 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 123.368 2.712 . . . . 0.0 111.767 -175.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -75.39 5.96 5.12 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.293 1.837 . . . . 0.0 115.18 175.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.8 tt -61.8 149.91 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.987 1.715 . . . . 0.0 112.829 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 tt -102.81 75.0 1.37 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.167 1.787 . . . . 0.0 109.512 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -142.69 73.88 19.38 Favored Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 124.791 1.236 . . . . 0.0 110.593 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.77 167.29 17.8 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.056 2.504 . . . . 0.0 112.743 -176.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.9 m -141.93 158.97 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.839 1.655 . . . . 0.0 110.789 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.9 t -99.81 118.3 35.98 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.928 0.891 . . . . 0.0 109.116 166.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.17 163.57 54.55 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 118.963 0.801 . . . . 0.0 113.268 172.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.5 t -63.43 -20.95 66.0 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -67.35 -14.29 62.78 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.37 1.468 . . . . 0.0 113.784 169.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.55 1.49 71.31 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 126.028 1.775 . . . . 0.0 114.666 -178.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -87.03 160.74 18.51 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.043 1.737 . . . . 0.0 111.591 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 91.1 m -109.79 136.37 49.23 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.303 1.441 . . . . 0.0 110.517 175.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -126.75 168.44 14.39 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.48 1.512 . . . . 0.0 111.603 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.46 -23.79 61.89 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -166.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -162.18 -179.64 7.21 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.218 1.807 . . . . 0.0 111.239 171.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 61.0 p -63.89 -40.96 97.73 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 175.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.2 t -59.18 -44.34 92.17 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.077 1.751 . . . . 0.0 113.57 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.4 tp -70.33 -42.93 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.054 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.88 -52.98 62.17 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.975 0.91 . . . . 0.0 111.522 177.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -60.12 -27.89 67.41 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.0 t -58.55 -29.69 66.55 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.775 1.23 . . . . 0.0 113.064 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -70.47 -12.63 61.7 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.651 1.58 . . . . 0.0 114.387 174.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.53 -0.39 77.36 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.878 1.704 . . . . 0.0 114.998 -175.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -104.33 149.54 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.759 1.624 . . . . 0.0 109.89 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.85 160.17 20.23 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.775 1.63 . . . . 0.0 112.209 174.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.6 pt -71.84 129.05 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 124.284 1.034 . . . . 0.0 110.13 170.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -73.69 -38.29 64.93 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.907 1.283 . . . . 0.0 111.227 170.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.0 p -158.59 163.79 36.66 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.009 1.724 . . . . 0.0 112.359 168.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.47 154.94 34.27 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.569 1.548 . . . . 0.0 112.007 166.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.41 158.61 9.96 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 125.404 1.478 . . . . 0.0 112.022 -168.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.0 t -62.17 146.71 49.89 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.657 -0.907 . . . . 0.0 110.743 166.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -92.27 156.35 41.87 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -177.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.13 130.62 20.45 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.575 2.85 . . . . 0.0 111.751 177.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.8 m -71.09 -15.86 62.54 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.706 1.202 . . . . 0.0 113.521 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 160.1 -34.11 0.43 Allowed Glycine 0 CA--C 1.535 1.315 0 C-N-CA 126.607 2.051 . . . . 0.0 113.738 174.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 tt . . . . . 0 C--O 1.254 1.311 0 C-N-CA 127.149 2.18 . . . . 0.0 111.917 174.103 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 64.6 mttm . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -152.31 176.26 11.8 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.826 1.65 . . . . 0.0 112.468 178.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.2 m -59.01 101.48 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.907 2.083 . . . . 0.0 112.474 176.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 88.6 m -135.16 153.17 52.07 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.707 1.603 . . . . 0.0 111.448 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.66 94.25 6.26 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.11 1.364 . . . . 0.0 110.148 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 35.5 m -59.65 153.66 50.34 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 124.419 1.087 . . . . 0.0 112.304 175.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.67 159.14 53.72 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.588 2.859 . . . . 0.0 111.884 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -113.35 4.01 16.16 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.554 1.542 . . . . 0.0 114.024 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.51 ' H ' HD12 ' A' ' 9' ' ' ILE . 4.2 mp -69.75 146.19 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.425 1.09 . . . . 0.0 109.914 175.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.7 tt -77.84 74.3 4.4 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.837 2.055 . . . . 0.0 109.672 176.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.4 mmmt -129.39 63.56 68.07 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 125.63 1.572 . . . . 0.0 111.851 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.65 166.22 28.19 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.27 2.647 . . . . 0.0 112.625 -176.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.0 m -146.98 143.02 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.348 1.859 . . . . 0.0 110.553 -172.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.7 t -79.77 111.64 16.28 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.72 153.84 39.02 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 119.233 0.924 . . . . 0.0 112.851 175.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 90.2 p -69.92 -9.8 56.29 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -69.86 -15.93 63.17 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.354 1.461 . . . . 0.0 113.779 169.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.42 15.65 22.56 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 124.675 1.131 . . . . 0.0 115.645 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 51.6 ttm-85 -136.08 168.08 20.04 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.237 1.815 . . . . 0.0 111.021 178.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.2 t -106.44 151.74 24.54 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.44 1.096 . . . . 0.0 111.697 172.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -121.36 175.74 6.0 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.569 1.947 . . . . 0.0 110.018 173.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.31 -25.74 61.69 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -171.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -160.66 -176.49 5.59 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.901 1.68 . . . . 0.0 111.487 174.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.4 p -72.77 -25.99 61.38 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 177.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.5 t -71.48 -43.78 65.95 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.698 1.599 . . . . 0.0 112.54 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.5 tp -68.75 -41.44 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.637 0.775 . . . . 0.0 111.12 176.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.54 -56.17 19.32 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.72 1.208 . . . . 0.0 111.844 173.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -61.71 -36.11 79.99 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 32.3 m -59.06 -33.76 71.16 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.428 0.691 . . . . 0.0 112.722 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -67.52 -9.92 46.89 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 173.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.82 10.38 72.64 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.762 1.172 . . . . 0.0 114.88 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 t -116.88 156.37 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.318 1.847 . . . . 0.0 109.085 176.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.2 t -107.42 167.63 9.8 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 122.515 1.15 . . . . 0.0 111.754 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.6 pt -77.49 123.81 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 126.009 1.723 . . . . 0.0 109.965 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.3 tttt -71.89 -40.76 68.65 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.168 0.987 . . . . 0.0 111.349 168.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.0 t -156.93 171.53 20.28 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.079 1.352 . . . . 0.0 112.871 172.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -75.54 148.16 39.14 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.014 2.126 . . . . 0.0 112.528 171.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.98 159.09 6.97 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.175 1.369 . . . . 0.0 112.594 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.7 m -58.69 138.66 56.89 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.748 0.819 . . . . 0.0 111.18 170.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.7 p -96.76 155.99 37.07 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -75.51 158.48 40.18 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 124.202 3.268 . . . . 0.0 112.077 173.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.14 -1.92 57.65 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.001 1.321 . . . . 0.0 113.27 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.68 9.91 53.63 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 126.338 1.923 . . . . 0.0 116.38 -172.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.203 0 C-N-CA 126.562 1.945 . . . . 0.0 112.203 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -133.85 -84.47 0.44 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 125.86 1.664 . . . . 0.0 111.34 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.8 p -70.14 -26.34 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.337 1.455 . . . . 0.0 113.492 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.8 t 64.51 -7.37 0.25 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 128.263 2.625 . . . . 0.0 115.961 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.98 120.33 21.25 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.683 1.993 . . . . 0.0 110.773 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.4 m -58.94 156.32 26.58 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 124.671 1.188 . . . . 0.0 112.317 173.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -74.64 168.37 24.97 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.57 2.847 . . . . 0.0 112.419 -175.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -114.19 8.7 16.95 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.18 2.192 . . . . 0.0 114.164 -177.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 26.6 mt -66.32 144.03 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.356 1.462 . . . . 0.0 109.854 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 tt -84.62 71.79 10.75 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.417 1.887 . . . . 0.0 110.001 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -135.03 67.13 69.41 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 125.135 1.374 . . . . 0.0 111.38 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.58 168.51 18.05 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.329 2.686 . . . . 0.0 112.792 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.3 m -145.82 162.63 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.444 1.898 . . . . 0.0 110.765 -174.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.0 t -102.81 121.84 43.31 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.957 0.903 . . . . 0.0 109.364 166.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.97 166.8 53.17 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 119.108 0.867 . . . . 0.0 112.951 174.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.0 m -65.32 -15.45 62.55 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -74.91 -6.61 50.11 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.451 1.1 . . . . 0.0 113.851 168.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.96 19.41 61.27 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.955 1.264 . . . . 0.0 114.56 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.46 153.8 24.53 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.384 1.874 . . . . 0.0 111.45 -174.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.8 m -102.9 117.96 35.77 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.956 1.702 . . . . 0.0 111.886 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -104.29 163.11 12.65 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 128.078 2.551 . . . . 0.0 110.949 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.78 -25.38 56.38 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -175.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -161.43 178.61 8.98 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.007 1.723 . . . . 0.0 111.432 173.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.9 m -63.96 -37.4 87.26 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 177.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.6 t -59.68 -45.18 92.85 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.872 1.669 . . . . 0.0 112.966 -177.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.8 tt -73.39 -40.1 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.566 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.06 -28.53 67.87 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 174.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -90.44 -27.29 19.37 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 174.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.3 t -55.26 -38.99 69.26 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.966 1.307 . . . . 0.0 113.044 -176.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -69.82 -10.66 59.26 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 126.17 1.788 . . . . 0.0 115.25 175.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.33 -8.2 52.31 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 126.377 1.941 . . . . 0.0 116.131 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 t -92.94 164.99 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 125.496 1.518 . . . . 0.0 110.203 177.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 p -98.16 165.89 11.67 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.806 2.042 . . . . 0.0 112.089 174.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 pt -75.67 128.35 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.182 0.993 . . . . 0.0 109.731 169.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -69.43 -44.15 71.91 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.46 1.104 . . . . 0.0 110.784 168.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.0 t -156.49 170.71 21.72 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.067 1.347 . . . . 0.0 112.072 170.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -77.4 153.03 34.06 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.46 1.904 . . . . 0.0 111.528 173.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.89 152.67 5.77 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.372 1.463 . . . . 0.0 112.45 -173.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 p -58.03 139.72 53.96 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.836 0.855 . . . . 0.0 111.675 167.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -90.86 155.63 45.14 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -175.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.82 143.27 50.05 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.687 2.925 . . . . 0.0 111.312 174.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.9 t -165.7 119.07 1.16 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.592 1.557 . . . . 0.0 110.321 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 158.18 -69.78 0.26 Allowed Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.67 1.605 . . . . 0.0 113.082 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 77.4 mt . . . . . 0 C--O 1.254 1.334 0 C-N-CA 126.306 1.843 . . . . 0.0 110.854 177.747 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 44.0 tptt . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.103 0.478 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -96.09 101.59 13.27 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.622 1.569 . . . . 0.0 110.473 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.5 p -62.58 142.88 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.801 0.841 . . . . 0.0 112.145 178.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 81.7 m -114.92 -28.41 7.05 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.873 1.269 . . . . 0.0 113.768 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.93 99.06 2.93 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.543 1.537 . . . . 0.0 110.962 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.9 m -63.77 156.26 73.27 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 124.379 1.072 . . . . 0.0 112.716 173.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -81.77 173.67 11.03 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.492 2.795 . . . . 0.0 113.068 -173.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -124.09 15.04 9.16 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.324 1.85 . . . . 0.0 114.152 -171.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.3 pp -61.43 174.03 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 125.714 1.605 . . . . 0.0 112.575 165.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.4 mt -110.7 85.96 2.22 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.17 1.388 . . . . 0.0 109.489 171.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.09 69.9 41.54 Favored Pre-proline 0 N--CA 1.473 0.693 0 C-N-CA 123.989 0.916 . . . . 0.0 110.756 174.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.15 171.99 11.72 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.745 2.297 . . . . 0.0 112.376 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.7 m -141.59 163.58 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.228 1.811 . . . . 0.0 111.455 -173.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.5 t -104.25 115.45 30.41 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.001 0.92 . . . . 0.0 109.213 166.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.41 162.2 54.0 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 123.891 0.757 . . . . 0.0 114.14 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.9 t -59.11 -28.63 66.7 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.567 1.147 . . . . 0.0 114.036 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -79.64 -1.14 36.83 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 125.97 1.708 . . . . 0.0 113.861 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.62 5.63 86.47 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.172 1.367 . . . . 0.0 113.983 -171.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.59 163.86 15.37 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.637 1.975 . . . . 0.0 112.344 176.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 27.4 m -135.57 113.01 10.67 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.447 1.499 . . . . 0.0 109.659 170.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -105.55 157.26 17.51 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.7 1.2 . . . . 0.0 111.131 173.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.57 -36.03 73.29 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.386 1.474 . . . . 0.0 113.893 -176.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.59 171.62 16.82 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.43 0.692 . . . . 0.0 111.448 171.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.8 m -60.87 -40.71 94.02 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.9 t -53.57 -41.95 67.05 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.674 1.99 . . . . 0.0 112.89 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 44.9 mm -70.99 -46.87 65.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 114.191 -1.368 . . . . 0.0 111.09 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.05 -53.63 47.4 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 173.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -61.26 -37.52 83.41 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 177.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.9 t -61.71 -39.0 89.96 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.041 0.936 . . . . 0.0 112.343 176.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -72.53 -2.46 19.83 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.812 1.645 . . . . 0.0 114.376 172.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.03 4.93 64.48 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.03 1.3 . . . . 0.0 115.777 169.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 m -119.48 135.85 58.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 126.382 1.873 . . . . 0.0 111.271 -177.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -75.41 154.93 36.86 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.605 1.162 . . . . 0.0 112.231 176.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 pt -78.58 125.49 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.861 1.264 . . . . 0.0 109.557 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -78.67 -36.42 43.79 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.386 1.075 . . . . 0.0 111.829 172.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.8 t -153.83 168.84 24.97 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.672 1.189 . . . . 0.0 112.461 169.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -85.06 146.49 27.14 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.584 2.354 . . . . 0.0 110.807 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.64 149.22 5.2 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.67 1.128 . . . . 0.0 111.767 -170.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.0 p -59.1 135.57 57.68 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.569 -0.959 . . . . 0.0 111.287 168.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -82.23 155.87 69.32 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -177.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.39 154.61 60.85 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.536 2.824 . . . . 0.0 111.386 172.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.24 -1.95 32.19 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.882 1.273 . . . . 0.0 114.345 -176.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.6 16.91 78.55 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.02 1.295 . . . . 0.0 114.64 -176.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.7 tt . . . . . 0 C--O 1.253 1.26 0 C-N-CA 127.058 2.143 . . . . 0.0 113.759 179.922 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.428 0.156 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -76.56 70.43 3.09 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.467 1.907 . . . . 0.0 111.581 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.1 m -60.81 152.06 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.002 1.321 . . . . 0.0 112.258 175.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 52.4 t -133.73 -77.56 0.47 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.927 1.291 . . . . 0.0 110.695 -178.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.48 82.97 4.71 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.112 0.965 . . . . 0.0 111.164 171.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.6 m -62.63 156.34 64.41 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 124.894 1.278 . . . . 0.0 111.899 172.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.34 160.24 35.87 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.535 2.823 . . . . 0.0 112.317 -172.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.85 4.09 13.86 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.194 1.797 . . . . 0.0 115.582 -172.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pp -71.59 168.81 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 126.897 2.079 . . . . 0.0 112.894 173.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.6 mt -96.33 89.93 5.26 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.426 1.49 . . . . 0.0 109.915 169.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -139.42 69.3 39.48 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 123.475 0.71 . . . . 0.0 110.976 169.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.45 167.16 17.48 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.046 2.497 . . . . 0.0 112.506 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.4 m -144.88 155.89 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.766 1.626 . . . . 0.0 110.678 -174.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.5 t -102.05 117.88 35.72 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.055 0.942 . . . . 0.0 109.666 172.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.55 165.99 53.12 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 121.51 -0.744 . . . . 0.0 113.659 175.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.7 p -61.63 -21.39 64.35 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -70.11 -12.77 61.84 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.559 1.543 . . . . 0.0 113.681 171.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.37 -0.85 75.47 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.935 1.731 . . . . 0.0 115.112 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -90.43 160.54 15.99 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.331 1.452 . . . . 0.0 111.512 176.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 40.4 m -109.26 131.65 54.87 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.279 1.431 . . . . 0.0 110.513 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -113.3 167.95 10.14 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.793 1.637 . . . . 0.0 110.481 173.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.73 -26.42 62.46 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -167.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -161.25 177.63 10.02 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.949 2.099 . . . . 0.0 110.681 174.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.8 p -62.17 -43.1 99.58 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 t -56.69 -37.98 71.62 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.471 1.908 . . . . 0.0 114.554 -176.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 tt -73.18 -52.75 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.844 0.858 . . . . 0.0 111.528 172.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.79 -56.05 6.87 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.799 1.24 . . . . 0.0 112.305 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.13 -27.69 69.25 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.205 1.802 . . . . 0.0 115.385 177.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 9.5 t -59.78 -33.29 71.52 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.361 1.064 . . . . 0.0 112.79 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -67.33 -17.83 64.92 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.171 1.389 . . . . 0.0 113.917 173.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.47 -9.95 57.6 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 126.594 2.045 . . . . 0.0 115.242 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.6 m -86.55 149.87 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 119.164 1.482 . . . . 0.0 111.516 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.01 156.18 20.55 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.921 1.289 . . . . 0.0 111.607 170.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.9 pt -71.2 129.02 35.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.195 0.998 . . . . 0.0 110.018 171.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.4 tptp -78.49 -35.32 46.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.449 1.099 . . . . 0.0 111.28 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.0 p -156.36 162.48 40.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.879 1.672 . . . . 0.0 112.503 172.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -84.84 157.2 21.0 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.119 0.968 . . . . 0.0 112.418 169.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.14 161.74 11.69 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.15 1.357 . . . . 0.0 111.975 -166.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.1 m -59.02 131.74 51.96 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.95 -0.735 . . . . 0.0 109.765 164.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -71.66 154.54 93.05 Favored Pre-proline 0 CA--C 1.545 0.774 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -177.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.78 155.08 58.77 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.377 2.718 . . . . 0.0 112.007 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.41 7.41 45.62 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.122 1.369 . . . . 0.0 113.2 -173.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.16 30.99 26.78 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.813 1.196 . . . . 0.0 114.021 -177.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.7 mt . . . . . 0 C--O 1.253 1.253 0 C-N-CA 127.173 2.189 . . . . 0.0 110.581 -176.455 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.65 115.1 14.24 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 120.503 1.502 . . . . 0.0 111.518 -178.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.7 m -66.3 132.35 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.029 1.331 . . . . 0.0 111.872 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 82.0 m -74.14 159.8 32.09 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.854 0.862 . . . . 0.0 112.219 175.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.12 91.08 4.37 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.932 1.293 . . . . 0.0 110.829 174.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 14.3 m -61.15 154.78 59.83 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.898 1.279 . . . . 0.0 112.393 173.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -77.97 166.96 24.33 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.238 2.625 . . . . 0.0 111.966 -176.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -119.74 15.33 12.68 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.763 2.025 . . . . 0.0 114.538 -170.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -60.64 170.29 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 126.736 2.014 . . . . 0.0 113.73 170.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.0 mt -104.83 80.1 1.6 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.565 1.546 . . . . 0.0 110.221 172.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.6 mmtt -138.92 66.24 39.46 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 125.132 1.373 . . . . 0.0 110.796 173.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.82 163.16 31.77 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.86 2.373 . . . . 0.0 111.944 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.0 m -146.51 160.75 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.561 1.544 . . . . 0.0 111.48 -170.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.5 t -96.28 116.88 29.72 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.012 1.325 . . . . 0.0 110.486 172.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.26 165.48 54.8 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 121.407 -0.808 . . . . 0.0 113.368 172.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.8 t -61.95 -26.93 68.49 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.35 1.06 . . . . 0.0 113.164 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -69.02 -8.01 40.96 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.603 1.961 . . . . 0.0 114.912 169.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.37 2.12 90.55 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.813 1.673 . . . . 0.0 115.3 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.2 mmt-85 -84.92 163.23 19.1 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.435 1.618 . . . . 0.0 111.615 173.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.3 m -118.42 117.59 29.45 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.589 1.555 . . . . 0.0 109.893 173.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -103.72 176.51 5.13 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.138 1.375 . . . . 0.0 110.298 170.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.87 -24.66 64.36 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -169.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.54 176.56 10.29 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.534 1.534 . . . . 0.0 110.869 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.7 p -62.24 -45.41 93.47 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 174.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.2 t -56.85 -44.26 81.97 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.404 1.882 . . . . 0.0 114.08 -177.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.44 -44.38 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.745 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.26 -49.56 77.38 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.022 0.929 . . . . 0.0 111.756 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -61.95 -28.65 69.69 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 174.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.9 t -61.29 -34.83 75.85 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.091 0.956 . . . . 0.0 112.844 176.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -72.47 -8.72 56.56 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.33 1.452 . . . . 0.0 114.144 170.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.93 -12.09 64.12 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.579 2.038 . . . . 0.0 115.335 174.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.6 m -79.97 141.18 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.266 1.426 . . . . 0.0 111.863 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.6 t -78.06 173.72 11.89 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.762 0.791 . . . . 0.0 112.036 171.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.0 mm -99.2 112.8 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 126.085 1.754 . . . . 0.0 110.196 -175.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -66.06 -38.6 88.73 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.533 0.733 . . . . 0.0 111.377 172.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.9 p -168.17 156.88 9.02 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.037 0.935 . . . . 0.0 112.949 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -82.11 153.87 25.85 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 122.304 1.05 . . . . 0.0 111.545 172.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.82 153.71 8.54 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.911 1.72 . . . . 0.0 111.618 -168.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.8 m -56.05 128.2 34.21 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.74 -0.859 . . . . 0.0 110.078 167.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -72.49 154.32 91.7 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -176.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.63 131.05 20.6 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.649 2.899 . . . . 0.0 112.026 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.65 -0.98 28.85 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.137 1.375 . . . . 0.0 113.39 -174.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.93 -18.88 71.45 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 124.8 1.19 . . . . 0.0 115.306 -176.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.4 mm . . . . . 0 C--O 1.253 1.25 0 C-N-CA 126.167 1.787 . . . . 0.0 110.685 174.741 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 20.8 tptp . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 110.631 -0.137 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -90.95 73.07 6.48 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.163 1.385 . . . . 0.0 111.912 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.6 m -75.65 -22.06 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.455 1.502 . . . . 0.0 113.635 170.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 71.8 m -71.99 177.67 4.2 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.379 1.072 . . . . 0.0 112.132 172.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 59.83 26.31 15.48 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.666 1.587 . . . . 0.0 115.254 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 27.2 m -52.4 151.21 7.72 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 125.625 1.57 . . . . 0.0 112.262 167.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.57 141.75 35.13 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.024 2.483 . . . . 0.0 111.441 -175.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -77.61 8.14 4.75 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.978 1.711 . . . . 0.0 114.868 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.4 tt -58.36 143.73 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 125.974 1.71 . . . . 0.0 112.702 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.5 tt -91.98 72.07 5.57 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.141 1.376 . . . . 0.0 109.573 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -138.24 72.45 45.51 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 125.415 1.486 . . . . 0.0 110.559 177.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -67.52 165.97 25.45 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.473 2.115 . . . . 0.0 112.037 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.7 m -141.35 156.68 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 126.238 1.815 . . . . 0.0 110.557 -175.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.4 t -91.95 117.0 29.4 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 165.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.18 162.18 45.93 Favored Glycine 0 CA--C 1.535 1.288 0 O-C-N 121.459 -0.776 . . . . 0.0 113.007 174.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.7 m -68.91 -14.27 62.94 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -176.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -74.31 -5.82 44.44 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.723 1.609 . . . . 0.0 113.27 169.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.82 21.08 54.43 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.787 1.184 . . . . 0.0 114.541 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -119.54 162.91 18.11 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.196 1.798 . . . . 0.0 111.788 -176.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.4 m -114.57 122.61 47.06 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.916 1.686 . . . . 0.0 110.133 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -115.34 169.07 9.42 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.635 1.574 . . . . 0.0 110.817 174.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.85 -30.35 66.73 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -166.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -164.51 170.3 16.06 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.28 1.432 . . . . 0.0 111.954 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.7 p -60.97 -39.85 91.16 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -171.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -54.08 -51.77 63.08 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.787 2.035 . . . . 0.0 112.997 176.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.6 tp -67.41 -40.43 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 121.387 -0.821 . . . . 0.0 110.865 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.97 -3.58 5.53 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.897 1.679 . . . . 0.0 114.905 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -116.09 -31.97 5.52 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.832 1.653 . . . . 0.0 114.489 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 56.4 m -60.41 -26.41 66.68 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.715 1.206 . . . . 0.0 113.633 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -72.94 -10.75 60.14 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 127.53 2.332 . . . . 0.0 115.472 170.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.27 1.17 59.43 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 125.642 1.591 . . . . 0.0 116.518 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 p -102.05 169.39 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-N 119.359 1.579 . . . . 0.0 111.064 172.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.1 149.79 29.53 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 127.115 2.166 . . . . 0.0 112.121 175.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -66.93 124.15 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 125.096 1.358 . . . . 0.0 110.089 176.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -78.98 -37.82 38.46 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.717 1.207 . . . . 0.0 111.523 174.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.8 p -160.03 162.13 34.15 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.472 1.509 . . . . 0.0 112.942 172.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -76.96 151.55 35.64 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.878 1.271 . . . . 0.0 112.615 171.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.54 156.94 8.48 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.097 1.332 . . . . 0.0 111.701 -169.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.2 p -60.1 146.08 44.4 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.71 -0.876 . . . . 0.0 111.837 167.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -93.98 155.04 40.61 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -179.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.03 157.05 55.21 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.831 3.021 . . . . 0.0 112.106 176.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 17.1 p -134.39 77.86 1.72 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.645 1.578 . . . . 0.0 111.428 -176.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.73 26.07 0.07 OUTLIER Glycine 0 CA--C 1.539 1.563 0 C-N-CA 124.413 1.006 . . . . 0.0 115.242 -175.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.4 tt . . . . . 0 C--O 1.253 1.283 0 C-N-CA 126.653 1.981 . . . . 0.0 112.491 -176.278 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -131.38 8.76 4.67 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.748 1.619 . . . . 0.0 114.758 -172.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.0 t -115.85 132.49 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 125.251 1.42 . . . . 0.0 110.774 -173.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 69.8 m -71.81 169.13 16.39 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.3 1.44 . . . . 0.0 113.193 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.24 -26.42 63.84 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 173.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.6 m -66.67 156.05 87.53 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 125.299 1.44 . . . . 0.0 112.969 174.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -79.61 173.71 12.69 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.973 3.116 . . . . 0.0 112.546 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -122.76 14.01 10.02 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.206 1.802 . . . . 0.0 114.065 -173.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.88 161.92 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 125.347 1.459 . . . . 0.0 112.52 172.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tt -98.25 75.94 2.3 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.765 1.226 . . . . 0.0 109.804 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -140.08 69.85 34.94 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 124.3 1.04 . . . . 0.0 111.428 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.88 168.04 24.17 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.176 2.584 . . . . 0.0 112.644 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.6 m -137.77 167.32 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 128.332 2.653 . . . . 0.0 111.518 -171.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.7 t -109.67 108.46 18.86 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.905 0.882 . . . . 0.0 109.569 167.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.13 156.17 53.55 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.008 0.813 . . . . 0.0 114.319 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.3 t -69.08 -14.26 62.91 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -78.3 -5.99 53.72 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.01 1.724 . . . . 0.0 113.86 168.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.23 4.43 74.3 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.752 1.644 . . . . 0.0 115.06 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -101.34 168.04 9.79 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.164 1.482 . . . . 0.0 111.727 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.2 m -121.27 135.51 55.11 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.733 1.613 . . . . 0.0 110.108 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -125.66 156.97 38.42 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.37 1.468 . . . . 0.0 110.863 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.84 -31.04 64.35 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.14 1.376 . . . . 0.0 114.108 -174.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -156.64 169.29 25.03 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.806 0.843 . . . . 0.0 111.605 175.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.1 t -60.61 -44.71 95.98 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.0 t -50.27 -44.19 53.65 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.113 1.765 . . . . 0.0 113.059 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.0 mm -64.03 -57.09 13.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.859 176.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.59 -52.87 16.31 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.396 0.678 . . . . 0.0 112.689 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -61.55 -38.19 86.56 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 30.6 t -63.16 -38.96 93.24 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.238 1.015 . . . . 0.0 112.138 176.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -67.51 -13.17 61.81 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.187 1.395 . . . . 0.0 113.463 173.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.12 -0.18 41.12 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 126.286 1.898 . . . . 0.0 115.529 172.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.2 m -112.91 134.07 56.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 126.229 1.812 . . . . 0.0 111.465 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 p -74.85 152.51 38.92 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.176 -0.953 . . . . 0.0 111.665 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.5 pt -73.49 127.47 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.114 0.965 . . . . 0.0 109.311 172.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -78.57 -37.05 43.56 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.838 -0.538 . . . . 0.0 111.269 171.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.0 p -152.74 162.39 41.33 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.588 1.555 . . . . 0.0 112.966 170.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -74.84 152.84 38.9 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.947 1.699 . . . . 0.0 111.22 169.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.54 152.63 6.32 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.215 1.388 . . . . 0.0 111.942 -175.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.5 t -58.33 147.39 31.17 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.783 -0.833 . . . . 0.0 110.871 167.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.8 p -102.23 157.51 33.56 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -73.69 161.33 42.1 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.673 2.915 . . . . 0.0 111.787 173.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.81 -0.21 12.75 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.914 1.686 . . . . 0.0 114.738 173.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.12 0.71 59.81 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 125.829 1.68 . . . . 0.0 114.713 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.9 mm . . . . . 0 C--O 1.254 1.311 0 C-N-CA 127.244 2.218 . . . . 0.0 110.361 176.975 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 63.5 mttm . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 120.349 0.119 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -134.7 163.25 30.19 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.902 2.081 . . . . 0.0 110.169 169.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.7 m -70.89 168.35 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.066 1.346 . . . . 0.0 112.533 175.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 76.7 m -63.38 -63.28 1.23 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.906 0.882 . . . . 0.0 111.737 174.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -161.36 124.79 3.25 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.025 1.73 . . . . 0.0 110.806 174.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 18.7 m -68.94 156.01 92.3 Favored Pre-proline 0 CA--C 1.549 0.917 0 O-C-N 121.434 -0.791 . . . . 0.0 111.855 168.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.38 166.22 26.38 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.632 2.888 . . . . 0.0 112.197 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -115.04 25.52 10.84 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.311 1.844 . . . . 0.0 113.408 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.3 pt -58.01 173.71 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 127.195 2.198 . . . . 0.0 112.726 169.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 tt -123.57 75.12 1.31 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.029 1.332 . . . . 0.0 109.237 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -141.99 71.76 23.49 Favored Pre-proline 0 N--CA 1.471 0.622 0 C-N-CA 124.305 1.042 . . . . 0.0 110.371 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.66 159.54 53.22 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.262 1.975 . . . . 0.0 112.079 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.4 m -145.82 147.33 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.149 1.38 . . . . 0.0 111.724 -169.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.2 t -90.55 116.81 28.74 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.665 1.186 . . . . 0.0 110.762 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.99 165.18 53.38 Favored Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.56 -0.712 . . . . 0.0 113.197 174.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.9 p -65.55 -17.25 64.43 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -68.84 -16.87 63.9 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.759 1.624 . . . . 0.0 113.589 168.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.07 -4.91 78.42 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.993 1.758 . . . . 0.0 114.961 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.7 ttt85 -83.77 161.82 20.85 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.356 1.462 . . . . 0.0 111.458 170.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 62.5 m -111.35 135.48 51.83 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.296 1.838 . . . . 0.0 110.952 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -119.87 165.52 14.5 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.739 1.616 . . . . 0.0 110.958 174.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.84 -30.45 70.63 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -167.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.44 173.88 15.53 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.282 1.833 . . . . 0.0 110.353 172.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.1 p -59.8 -41.72 91.83 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -56.36 -45.67 80.37 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.709 1.604 . . . . 0.0 113.301 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.7 tp -69.21 -41.82 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.931 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.66 -56.21 19.26 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.283 1.033 . . . . 0.0 111.32 174.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -59.32 -37.95 79.06 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 63.9 m -71.33 -23.85 62.0 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 175.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -74.1 -20.46 60.25 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.029 1.332 . . . . 0.0 112.934 172.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.68 7.66 17.48 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.851 1.691 . . . . 0.0 115.807 174.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 t -133.36 151.52 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.043 1.421 . . . . 0.0 110.545 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.8 t -92.99 158.46 15.78 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.169 0.985 . . . . 0.0 112.184 174.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.62 122.5 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 128.667 2.787 . . . . 0.0 108.51 171.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -79.22 -49.8 11.95 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.745 -0.597 . . . . 0.0 110.584 161.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.8 p -143.61 161.24 39.01 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.161 1.385 . . . . 0.0 113.227 -176.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.31 154.0 20.44 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.485 1.514 . . . . 0.0 112.597 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.17 160.9 19.98 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.03 1.3 . . . . 0.0 111.818 -169.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 m -61.37 126.95 29.2 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.783 -0.833 . . . . 0.0 109.564 164.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.99 155.1 94.04 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -173.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.81 153.58 64.05 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.47 2.78 . . . . 0.0 111.992 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.52 -4.59 43.54 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -173.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.19 -74.0 0.97 Allowed Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.78 1.657 . . . . 0.0 114.058 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 79.9 mt . . . . . 0 C--O 1.253 1.247 0 C-N-CA 125.974 1.71 . . . . 0.0 110.871 -179.424 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -139.88 -24.78 0.82 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.2 t -70.09 -48.79 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.828 1.251 . . . . 0.0 110.299 176.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.2 p -73.81 155.79 38.45 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.55 1.14 . . . . 0.0 111.872 165.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.53 96.96 2.77 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.586 1.554 . . . . 0.0 109.932 174.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.8 m -59.87 150.59 67.99 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.142 0.977 . . . . 0.0 112.462 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.63 168.51 24.24 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.261 2.641 . . . . 0.0 111.916 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -122.81 16.2 10.16 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.822 2.049 . . . . 0.0 114.497 -170.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.95 168.28 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 126.584 1.954 . . . . 0.0 112.925 170.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 tt -105.47 69.28 0.83 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.943 1.297 . . . . 0.0 110.583 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -137.31 72.13 52.52 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 124.822 1.249 . . . . 0.0 110.572 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.79 166.87 18.93 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.728 2.286 . . . . 0.0 111.937 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 m -142.99 150.98 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.81 1.644 . . . . 0.0 110.55 -176.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.5 t -87.98 114.49 24.64 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 169.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.56 159.68 53.75 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 119.409 1.004 . . . . 0.0 112.364 171.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t -65.2 -20.13 66.29 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 121.271 -1.135 . . . . 0.0 114.024 -177.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.67 -17.15 64.39 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.057 1.743 . . . . 0.0 113.859 168.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.68 -6.63 62.84 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 126.44 1.971 . . . . 0.0 114.826 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -77.9 164.67 24.93 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 118.712 1.256 . . . . 0.0 111.859 173.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 60.5 m -117.93 133.7 55.67 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.422 1.489 . . . . 0.0 110.027 169.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -121.81 170.19 10.01 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.857 1.663 . . . . 0.0 110.565 172.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.04 -30.64 71.21 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -165.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -163.36 172.77 14.13 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.833 1.253 . . . . 0.0 111.609 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.5 m -59.8 -39.18 84.12 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -173.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.6 t -58.92 -44.55 91.32 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.529 1.931 . . . . 0.0 113.479 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.89 -40.34 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.317 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.67 -53.22 60.85 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.634 0.774 . . . . 0.0 111.292 174.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -61.58 -29.02 69.76 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 176.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 10.8 t -60.12 -35.13 74.58 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.102 0.961 . . . . 0.0 112.705 176.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -75.37 -3.67 34.95 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.872 1.669 . . . . 0.0 114.068 172.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.71 -10.55 73.27 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 126.528 2.013 . . . . 0.0 115.173 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.5 m -85.08 138.02 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.81 1.644 . . . . 0.0 111.637 176.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -76.96 154.67 33.35 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.396 1.079 . . . . 0.0 112.238 169.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 pp -74.05 123.15 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.384 1.474 . . . . 0.0 109.744 174.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -75.4 -42.59 53.41 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.806 1.242 . . . . 0.0 111.57 173.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.4 t -158.09 169.4 24.63 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.093 1.357 . . . . 0.0 112.209 173.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -79.93 152.2 29.69 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.756 2.022 . . . . 0.0 113.012 174.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.46 163.96 13.46 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.476 1.512 . . . . 0.0 112.309 -173.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 m -59.47 128.66 38.17 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.602 0.761 . . . . 0.0 109.563 164.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.83 154.36 94.32 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -176.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.89 144.92 49.25 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.297 2.664 . . . . 0.0 111.633 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.3 m -76.09 -10.57 59.52 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -176.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.23 -11.22 56.41 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.621 1.581 . . . . 0.0 116.169 -172.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.1 mt . . . . . 0 N--CA 1.483 1.19 0 C-N-CA 126.088 1.755 . . . . 0.0 110.149 -179.952 . . . . . . . . 0 0 . 1 stop_ save_